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CHAPTER 1 
GENERAL INTRODUCTION AND AIM OF THIS THESIS 

1 . G E N E R A L I N T R O D U C T I O N 
1.1 Strategies for the Elucidation of Hereditary Disorders 
All human medical conditions, perhaps even self indicted trauma, may have a genetic 
component These genetic components may vary from single gene defects, 
resulting in monogenic patterns of inheritance, to many genes interacting in a 
complex way as in polygenic and multifactorial disorders Until now, efforts to 
identify genetic factors underlying inherited disease have focused on monogenic 
traits of which by now over 500 (1) have been regionally mapped or elucidated at 
the molecular level, and for most of the common monogenic disorders, the 
underlying gene defect is known 
There are three main strategies to uncover the nature of these disease genes (2) During 
functional cloning, the information on the biochemical defect or the structure of 
the corresponding protein is the key for the gene identification Linus Pauling for 
example, correctly postulated that a molecular abnormality of the hemoglobin 
protein was the cause for sickle cell anemia (3) Subsequent isolation and 
sequencing of the protein eventually led to the actual cloning of the underlying 
gene defect (4) Unfortunately, our knowledge on the fundamental biochemical 
pathways involved in complex issues such as cell-cell interactions, cellular 
signalling, and development is very limited and hampers the large scale routine 
application of this strategy 
Positional cloning is based on the chromosomal localization of the gene, ι e the 
position of the gene in the human genome In general, this information can be 
obtained through linkage analyses in affected families However, in 
approximately 60% of the genes cloned in this way, cytogenetic rearrangements 
such as deletions or translocations have facilitated the precise mapping of the 
gene, and in many more, submicroscopic deletions have aided their identification 
(2) Positional cloning was first successfully applied in 1986 when the gene for 
X-linked chronic granulomatous disease was isolated (5) Another major 
breakthrough was the cloning of the gene for cystic fibrosis (CF) on chromosome 
7, the most common autosomal recessive disorder of Caucasians, which was 
achieved without the help of chromosome rearrangements (6) At present, over 60 
genes have been identified in this way and the number is still growing 
Very often, however, the available mapping information is insufficient on its own to 
allow the isolation of disease genes by positional cloning, and only rarely, the 
function of these genes can be directly inferred from the clinical phenotype In 
the majority of cases therefore, positional and functional information has to be 
combined in order to define promising candidate genes, whose identitj has to be 
confirmed by subsequent mutation screening in (unrelated) patients As the 
number of cloned, mapped, and sequenced transcripts is rapidly increasing, such 
positional and/or functional candidate gene approaches will become more 
successful These disease genes will help clinical geneticists to understand 
pathogenic pathways and help molecular geneticists to isolate related genes This, 
in turn, will enhance the number of successful 'educated guesses' for related 
disorders For example, the availability of the gene coding for the luteinizing 
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hormone (LH) receptor enabled the rapid testing and verification of the 
hypothesis that an autonomously activated g-couphng of the LH receptor might 
explain the overproduction of testosterone in the absence of stimulation by LH in 
patients with familial male precocious pubert\ (testotoxicosis) (7 8) Soon 
afterwards, the same authors found that loss of function mutations in this gene 
lead to male pseudohermaphroditism with Ley dig cell hypoplasia (9,10) 
Two criteria have to be met to successfully apply the latter method First, the linkage 
interval must represent a rather small segment of the chromosome and secondly, 
most or all genes that map to this interval must be known To meet the first 
criterion, the development of genome-wide human linkage maps with markers at 
an average density of 0 7 centiMorgan (cM) (11) has greatly improved the 
accurate mapping of disease genes to intervals of 0,5-5cM Moreover, projects 
aiming at the large scale generation of expressed sequence tags (ESTs), partial 
DNA sequences of expressed genes, has already led to the identification of 
87,983 distinct sequences (12,13) However, without information about the exact 
map position, these ESTs will be of little help These ESTs, the rapidly evolving 
Yeast Artificial Chromosome (YAC a vector system m which up to 2Mb of 
genomic DNA can be cloned and propagated in yeast cells (14)) maps of the 
human genome (15), and the initiatives of the Human Genome Project to entirely 
sequence the human genome before the year 2005, will finally reveal all human 
genes and greatly facilitate the positional candidate approach One of the most 
stunning examples of this approach is the identification of 4 genes involved in 
DNA mismatch repair that had been implied in hereditary non-polyposis colon 
cancer, where linkage to chromosome 2p and phenot\pic information about DNA 
instability in colon cancers from affected patients was instrumental for the 
identification of these four genes (16-18) 
So tar, almost all approaches mentioned above have been applied to single gene 
disorders However, many of the most frequent medical conditions like 
hypertension, diabetes, asthma, schizophrenia, neural tube defects, cleft lip and 
palate, and manic depression, show a murkier pattern of inheritance The genetic 
dissection of these complex traits, ι e all medical conditions that do not show a 
Mendelian pattern of inheritance, will challenge geneticists for manv years to 
come 
1 2 Chromosome Rearrangements and the Positional Cloning of Disease 
Genes 
Linkage analysis is a universal strategy to map genes underlying specific disease 
phenotypes that segregate in families, but the resolution of linkage mapping is 
mostly limited by the number and size ot the families available Frequently, 
therefore, these studies leave us with wide linkage intervals Particularly, this 
holds true for heterogeneous disorders where linkage data from different families 
cannot be pooled 
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Balanced chromosomal rearrangements such as translocations and inversions have 
greatly facilitated the identification of disease-associated genes (2) De novo 
balanced chromosome abnormalities have an incidence of approximate!) 1 3000 
newborns, and 6% of these rearrangements are associated with disease (19) 
Comparison with the incidence of conspicuous phenotypic alterations in the 
newborn population suggests that in 50% of the patients with disease associated 
balanced chromosome rearrangements, the aberrant clinical phenotype and the 
karyotypic changes are causally related (20) Although in balanced chromosome 
rearrangements no genetic material is lost, they will give rise to disease 
phenotypes if chromosome breakage hits a gene for which two functional gene 
copies are required (20) Disease phenotypes may also arise if the other allele 
happens to be mutated ('unmasking of heterozygosity' (21)), if the rearrangement 
results in dominant mutations as in several collagen disorders and human 
neoplasias, respectively (22,23), or if there is only one functional gene copy as 
for imprinted (24-27) and X (or Y) chromosomal genes (chapter 2 3) In fact, the 
presence of several X chromosomal breakpoints in females with Duchenne 
Muscular Dystrophy (DMD) carrying balanced X,autosome (X,a) translocations 
were among the first mutations described for DMD and their co-localization 
greatly facilitated the isolation of the dystrophin gene (28) Also, specific 
balanced translocations have been implicated in human neoplasias The majority 
of patients with chronic myeloid leukemia (CML) carry a balanced reciprocal 
translocation between the chromosomes 9 and 22, t(9,22)(q34,ql 1), which was 
instrumental for the identification of the molecular mechanisms underlying CML 
(29,30) This translocation links the oncogene с ABL at 9q34 proximal to the 
BCR gene on chromosome 22 resulting in a fusion protein which gives rise to the 
malignant process (31,32) 
Unbalanced chromosome rearrangements such as deletions and duplications are also 
valuable tools for the identification of disease-associated genes Many of the 
microscopic or submicroscopic deletions affect more than one gene thereby 
giving rise to complex contiguous gene syndromes (CGS) The clinical and 
molecular characterization of partially overlapping CGSs allows the genetic 
dissection of the complex CGSs into specific subtraits (33) For example, the 
characterization of various deletions and translocations involving the 11 ρ 13 
region allowed the identification of several genes that can explain the complexity 
of the WAGR syndrome, including genes for Wilms' tumour (ÌYT1), aniridia 
[AN2 / PAX6), genitourinary malformations, and mental retardation (34-39) 
Duplications can give rise to CGSs as a result of dosage enhancement of the 
genes involved Dosage sensitivity is best illustrated by inherited peripheral 
neuropathies (reviewed in 40) Charcot-Mane-Tooth disease type 1A (CMT1 A) 
is an autosomal dominant peripheral neuropathy associated with a 1,5 Mb tandem 
duplication at 17pl 1 2-pl2 (41,42) This duplication is the result of an unequal 
cross-over mediated by flanking repeat sequences (43) The reciprocal deletion ol 
this duplication resulting from the same unequal cross-over, has been implicated 
in the milder autosomal dominant hereditary neuropathy with liability to pressure 
palsies (HNPP) (44,45) Moreover, point mutations in the peripheral myelin 
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protein 22 (PMP22) gene which maps to this 1,5 Mb duplication have been 
identified in other families with CMT 1(46,47). These results strongly suggests 
that the PMP22 gene is (one of) the relevant dosage-sensitive gene(s) in this 1,5 
Mb duplication. 
To generate a disease phenotype, the rearrangement does not necessarily have to affect 
the gene itself, but the translocation of genes to a 'wrong' chromosomal 
environment may also disturb proper gene expression. This phenomenon, named 
position effect variegation (PEV), was first discovered in D melanogaster (48). 
Schultz showed that when genes were moved from euchromatic regions of the 
chromosomes to regions of centric heterochromatin by inversions or 
translocations, these genes lost their activity in some cells but not in others (49). 
However, when the gene was relocated to its proper position, it regained its 
normal transcriptional activity. Failure of gene expression by PEV can be 
explained in two ways. First, the packaging of DNA may extend from the 
heterochromatic region into the relocated euchromatic gene. Alternatively, genes 
placed near heterochromatic regions do not complete replication until late S 
phase, and by that time transcription factors are already bound up by genes in 
earlier replicating euchromatin (50). Several observations suggest that position 
effects exist in humans, too. Campomelic dysplasia, a skeletal malformation 
syndrome with autosomal sex reversal is caused by mutations in the SOX9 gene 
on chromosome 17q25, and by translocations located over 50kb upstream of the 
SOX9 gene (51-53). Similarly, aniridia can be caused by translocations 85kb 
upstream from the PAX6 gene (54), and position effects may also play a role in 
some patients with the most frequent form of X-linked deafness, DFN3, as 
outlined in chapter 7 of this thesis. Moreover, very recently a translocation has 
been identified that juxtaposes an IgH enhancer approximately 2 kb upstream of 
the first PAX5 exon in diffuse large-cell lymphomas (55). In mice, the first 
examples of PEV have been observed in transgenic animals (56), as for example 
in the position dependent variegation of globin transgene expression (57). 
Disruptions of the zinc finger gene GLI3 have been identified in patients with the 
rare autosomal dominant Greig cephalopolysyndactily syndrome (GCPS) (58). 
Deletions in the mouse homologue Giù are associated with the Extra toes (Xt and 
Xr) phenotype (59) whereas anterior digit deformation (add), a mild recessive 
allelic form of Xt, has a complicated transgene integration and a deletion 
approximately 40kb upstream of GU3 (60). Also, deletions outside the testis 
determining region were found in sex-reversed XY female mice (61). These 
deletions position Sry closer to the Y centromere which is in agreement with the 
hypothesis that the silencing of Sry activity is due to a position effect and does 
not affect the Sry gene itself (62). The recently identified chromosomal 
rearrangements in the mouse models Steel-panda (Sfan) and Steel-contrasted 
(57e0") >100kb upstream of the Steel (SI) locus are a particularly well studied 
example (63). The SI locus encodes the mast cell growth factor (Mgf) which is a 
ligand for c-kit, a receptor tyrosine kinase, and is essential for the development of 
germ cells, hematopoietic cells, and melanocytes. Female Sf" and Sfon mice are 
sterile whereas the fertility of the males of the same genotype is unaffected. In 
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these mice, chromosomal rearrangements 115kb and 195kb upstream of the Mgf 
locus, result in tissue specific up- or down-regulation of MgfmKNA expression 
The fact that the two rearrangements are 80kb apart, result in positive and 
negative regulation of Mg/"expression, and that neither of the two alleles could be 
complemented by other SI mutant alleles (which excludes the involvement of 
another closely linked gene), strongly suggests that the Sfan and Sf" 
rearrangements alter Mgf expression through PEV (63) Interestingly, all above 
mentioned genes are involved in the regulation of transcription Although the 
association of PEV with transcriptional regulators may suggest a higher 
sensitivity of transcriptional regulator activity to their chromosomal environment, 
it is more likely due to the strict stoichiometry that is required for the interactions 
in which they participate (64) In Drosophtla, an intracellular concentration-
dependent function for the kruppel gene has been demonstrated that has 
repressive activity as a dimer and activating properties as a monomer (65) 
Therefore, it is conceivable that slight alterations in the transcription levels of 
these regulators may, unlike many genes where 50% down- or up-regulation 
often remains unnoticed, disturb a delicate balance in the interactions between 
transcription factors and their accessory proteins Finally, the variable spreading 
of X-inactivation into autosomal segments in different cells of individuals with 
X,a translocations, can also be considered as a mammalian PEV {chapter 2 3) 
1.3 X Chromosomal Rearrangements: a Special Case 
The human X chromosome is the best studied human chromosome due to its unique 
properties Unlike the autosomes, which are present in two copies, the X 
chromosome is only present in one functional copy in somatic cells of males and 
females (see below) Therefore, disorders with an X chromosomal recessive 
pattern of inheritance are easily recognizable because of their characteristic 
pattern of transmission 
The X chromosome is estimated to comprise 200Mb, which corresponds to 
approximately 6% of the human genome At present, about 90% of the human X 
chromosome has already been cloned in overlapping YAC contigs Moreover, 
more than 150 breakpoints have been identified in individuals with rearranged X 
chromosomes The regional assignment of these breakpoints has greatly 
facilitated the integration of the physical and genetic map of the human X 
chromosome 
In males, rearrangements involving the X chromosome may lead to deletion, 
duplication, disruption, or silencing of the only X chromosomal gene copy which 
is why they are frequently associated with aberrant phenotypes Also in females, 
as the result of preferential X-inactivation of the normal or rearranged X 
chromosome, X chromosomal rearrangements are more frequently associated 
with disease than autosomal rearrangements Therefore, X chromosomal 
rearrangements have been extremely valuable tools for the identification of X-
linked disease genes (2) X chromosome inactivation, a process exclusively found 
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in mammals, compensates gene dosage differences between XY males and XX 
females. The Y chromosome is relatively devoid of genes and its major function 
is to instruct the undifferentiated gonad to become testis. In contrast, the X 
chromosome harbors thousands of genes. X-inaclivation is a process which in a 
random manner transcriptionally silences one of the X chromosomes in female 
somatic cells (66). This inaclivation is stable and clonally heritable during 
subsequent cell divisions. Inactive X chromosomes are easily recognizable as 
heterochromatic condensed Barr bodies that are attached to the nuclear 
membrane, and they replicate their DNA late in the S phase (reviews in 67,68). 
Studies of humans and mice with deletions or translocations involving the X 
chromosome have shown that the locus determining X-inactivation maps to the 
proximal long arm of the X chromosome; the X-inactivation centre (XIC) in man 
(X controlling element (Ace) in mice). Four years ago, a gene was cloned that 
meets all criteria for playing a major role in X-inactivation (68,69). The XIST 
gene (X inactive specific transcript, Xist in mice) maps to the XIC locus, is 
exclusively expressed from the inactive X chromosome (70), and seems to 
encode a nuclear RNA that is associated with the inactive X chromosome 
(69,71). X-inactivation can be divided into initiation, spreading and maintenance. 
XIC is involved in both the initiation and spreading of X-inactivation but not in 
its maintenance (72). Several genes have been identified that escape X-
inaclivation in man (reviewed in 73). Some of these genes have been assigned to 
the X pseudoautosomal region like MIC2 (74-76) and are expressed from both X 
chromosomes while others map outside this region and have Y chromosomal 
homologous genes (ZFX, RPS4X) (77,78), or pscudogenes (STS) (79,80). Some 
genes, like UBE1, escape inactivation and do not have a homologue on the Y 
chromosome suggesting that gene dosage is not always critical or that different 
regulatory mechanisms underlie the expression of these genes in males and 
females (81,82). 
Due to X chromosome inactivation, mammalian cells of both sexes are functionally 
hemizygous for most X-linked genes. As a result of the randomness of this 
process during early embryogenesis, and the stable transmission of the X-
inactivation status to daughter cells, female tissues and organs are mosaics of cell 
clones expressing the genes of the maternal or paternal X chromosome, 
respectively. Females heterozygous for X-linkcd mutations are mostly 
asymptomatic or mildly affected as compared with males that carry the mutation. 
About half of the cells in the relevant tissues and organs express the defect 
whereas the remainder of the cells express the normal allele. For most of the 
diseases, this proportion of normal cells is generally high enough to ensure 
normal functioning of the tissues in the entire organism which is why 
heterozygotes are mostly unaffected. Occasionally, heterozygous females show 
the full manifestation of X-linked recessive trails mostly ascribed to 'unfortunate 
Lyonization'. However, the preferential inactivation of one of the X 
chromosomes observed in these females may also be caused by the presence of 
additional X-linked loci involved in the inactivation process. A recently described 
family in which a grandmaternally inherited X chromosome (and XIST allele) is 
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preferentially inactivated in seven granddaughters while preferentially active in 
the grandmother supports the presence of these additional loci (83) 
Also, other mechanisms may explain skewed X-inactivation obsened in females (84-
87) Skewed X-inactivation may result from balanced and unbalanced X,a 
translocations Since initial X-inactivation is generally a random process, cells in 
which the derivative chromosome carrying XISTis inactivated, are apparently at 
a selective disadvantage Individuals with a preferentially inactivated normal X 
chromosome mostly have a normal phenotype Sometimes, females carrying a 
balanced X,a translocation show a specific disease phenotype Disease 
phenotypes can arise when the normal X chromosome is preferentially 
inactivated and the translocation disrupts an X chromosomal gene thereby 
generating functional nullisomy for this locus These cases have been extremely 
valuable for mapping and cloning of X chromosomal disease genes, as mentioned 
earlier (2) Interestingly, approximately 20-25% of all females carrying an X,a 
translocation do not show a complete inactivation of the normal X Typically, as 
a consequence of aneuploidy, these incomplete X-inactivation patterns may result 
in a variety of multiple congenital anomalies/mental retardation phenotypes, 
single gene disorders, and CGSs (88,89) At least partly, variable spreading of X-
ïnactivation from the derivative X chromosome carrying the XIC into the 
autosomal segment can explain these anomalies The extent of inactivation of 
autosomal segments by XIC may diflcr between various cell types, it may be 
discontinuous, and may even vary within one clone However, the functional X 
chromosomal disomy resulting from non-inactivation of X chromosomal 
segments may be equally deleterious since a double dosage of X chromosomal 
genes is mostly not allowed (89) The presence of active normal X chromosomes 
in affected skin areas of patients carrying X,a translocations associated with 
hypomelanosis of Ito not only supports this view but also demonstrates that 
selection against cells with a double functional dose of X chromosomal genes 
occurs relatively late during embryonic development (90,91) X,a translocations 
involving the most distal regions of Xp and Xq are exceptional because they 
show a more random inactivation Apparently, lunUional disomies of these outer 
segments of the X chromosome are, possibly due to their small size and their 
intrinsic properties (pseudoautosomal regions), compatible with life and are 
mostly under a mild selective pressure Patients which show a complete 
inactivation of the translocated X, may have a mutation on their normal X 
chromosome that is incompatible with life (88,89) Functional Xp disomies are 
more common than Xq disomies which may be a reflection of the 
pseudoautosomal region in which a substantial number of genes escape 
inactivation (89) Therefore, not only the size of the chromosomal segment, but 
also the nature of the sequences is important for these cellular selection 
mechanisms Thus, inactivation patterns observed in females with balanced X,a 
translocations may be the result of balance between gene defects on the normal X 
on one hand and, an autosomal monosomy and partial disomy X on the other 
hand 
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Finally, single gene mutations that cause a growth disadvantage or cell death ( e.g. X-
linked a-thalassaemia with menial retardation syndrome (92) and X-linked 
immune deficiencies (93)), or selection for an active mutant X chromosome as in 
X-linked adrenoleukodystrophy for which the mechanism is unknown (84), may 
influence the random inactivation pattern of the X chromosome. 
1.4 Rearrangements of the Xq21 Band: Association with Blindness, 
Deafness, and Mental Retardation 
The Giemsa-dark staining Xq21 band is relatively devoid of genes which explains why 
large interstitial deletions of this chromosomal segment can be viable in males. 
These deletions encompass up to 15 Mb of DNA, which is approximately 8-10% 
of the human X chromosome (20,94,95). Clinically, these deletions are associated 
with a CGS consisting of X-linked deafness with a temporal bone defect (DFN3), 
mental retardation (MR), and choroideremia (CHM), a chorioretinal disorder 
resulting in peripheral vision loss and eventually in blindness (96-100). Also, 
deletions have been found in patients with a combination of CHM and DFN3, or 
CHM and MR depending on the size and position of the deletion (97-99,101,102, 
chapters 4 and 5). The presence of genes for CHM and DFN3 in Xq21 had also 
been suggested by linkage studies (103-111). The molecular characterization of 
these deletions has allowed the establishment of the physical order of these 
disease genes as Xcen-DFN3-MR-CHM-qter, and subsequently the cloning of the 
genes for CHM {CHM) (112,113) and DFN3 (POU3F4) {chapter 6). Additional 
clinical features in some patients with deletions in Xq21 are obesity (114), 
hypogonadism (99), and cleft lip and palate (115). In three families with cleft 
palate and/or ankyloglossia (CPX), the gene defect has also been linked to Xq21, 
which supports the presence of a gene involved in palate closure in this segment 
(116-120). 
The gene for MR in Xq21 has not been identified yet. In several families with non-
syndromic MR, the underlying gene defect has been mapped to large intervals on 
the X chromosome that include Xq21.1. Most of these patients are only mildly or 
moderately affected (121). Moreover, Allan-Herndon-Dudley syndrome (AHDS), 
which includes severe MR, muscle hypoplasia, spastic paraplegia, and ataxia, has 
been linked to markers in Xq21 (122,123). However, the severity of MR in these 
families, as compared to the milder MR in patients carrying interstitial deletions 
of Xq21.1, and the additional clinical features in AHDS suggests the presence of 
more than one gene for XLMR in Xq21. 
1.5 Aim of this Thesis 
In this study, we initially aimed at the cloning of the genes for DFN3 and non-specific 
MR in Xq21.1. As a prerequisite for the cloning of these genes, we first set out to 
characterize this chromosomal segment by the generation of YAC contigs 
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covering the region {chapters 4 and 5). This enabled us to improve the physical 
map of this region, to identify and fine-map several deletion patients, and to 
further define the critical regions for the MR and DFN3 loci. The actual cloning 
of the DFN3 gene {chapter 6) was eventually aided by the mapping of the murine 
POU domain transcription factor Pou3f4 to a segment homologous to the human 
Xql3.3-q21.1 region (124). The putative presence of transcription regulatory 
sequences upstream OÏPOU3F4 and their involvement in DFN3 is further 
discussed in chapter 7. 
In order to identify candidate genes for XLMR, we have set out to collect, and map 
balanced X;a translocations that are associated with MR assuming that disruption 
of an X chromosomal gene is the cause for the associated phenotype. As a 
prerequisite for the cloning of these genes, we mapped the X chromosomal 
breakpoints of MR-associated X;a translocations by fluorescence in situ 
hybridization {chapter 8) The apparent colocalization of one of these X 
chromosomal breakpoints (125) with the deletions of the Xq21.1 band associated 
with MR, initially prompted us to characterize this breakpoint in detail. The 
refined localization of this breakpoint in Xq 13.1, the molecular analysis and 
identification of a candidate gene for XLMR is presented in chapter 9. 
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Abstract 
Microscopically detectable deletions and X;autosome translo­
cations have previously facilitated the construction of a high-
resolution interval map of the Xq21 region. Here, we have 
generated three yeast artificial chromosome contigs spanning 
approximately 7 megabases of the Xql3.3-q21.31 region. In 
addition, a novel deletion associated with choroideremia and 
mental retardation was identified and mapped in detail. The 
proximal deletion endpoint was positioned between the loci 
DXS995 and DXS232, which enabled us to confirm the criti­
cal region for a locus involved in mental retardation. The dis­
tal deletion endpoint is situated in the Xq21.33 band, which 
allowed us to refine the order of several markers in this 
region. 
Introduction 
In the Giemsa-dark-staining Xq21 band, 
numerous large male-viable deletions have 
been described which encompass up to 15 
megabases (Mb) of DNA, or 8-10% of the 
estimated size of the human X chromosome 
[1, 2]. These deletions often give rise to con­
tiguous gene syndromes including choroider­
emia (CHM), X-linked deafness (DFN3) and 
29 
nonspecific mental retardation (MR) [3-7]. 
Sizeable deletions have also been found in 
patients with nonsyndromic CHM or DFN3 
[4-6, 8, 9]. 
Employing positional cloning strategies, 
the genes underlying CHM and DFN3 have 
been isolated. Analysis of patients with Xq21 
deletions and syndromic and nonsyndromic 
forms of MR has enabled us to map the gene 
for X-linked MR lo a region between CHM 
andDFN3[4, 7, 10-13]. 
As a prerequisite for the isolation of this 
and other genes in Xq21, we have set out to 
generate a ladder of overlapping yeast artifi­
cial chromosomes (YACs) spanning the entire 
Xq21 region To this end, we first employed 
numerous X;autosome translocations and de­
letions to subdivide the Xq21 band into 24 
different intervals [8, 14; Philippe, unpubl. 
results]. Moreover, we have previously de­
scribed a 850-kb YAC and cosmid contig 
encompassing the DFN3 locus and a 350-kb 
YAC encompassing the CHM gene [9,12,13]. 
Here, we report on three YAC contigs span­
ning approximately 7 Mb of the Xql3.3-
q21.31 region and on the localization of a 
novel deletion associated with CHM and 
MR. 
Materials and Methods 
Patients 
All patients except patient AP have been described 
elsewhere and are listed in table 1. 
YAC Clones 
YAC clones were initially identified by PCR am­
plification of YAC DNA pools or by hybridization of 
probes to filters containing gndded YAC DNA YACs 
were isolated from previously described СЕРН [15] 
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" The mild mental handicap does not cosegregate with the deletion in this family [47] 
and ICRF YAC libraries [16] All relevant markers 
used in this study are listed in table 2 
Positive YAC clones were plated on NZYM agar 
[17], and three yeast clones each were picked and cul­
tured as described elsewhere [18] Yeast cells were 
embedded in low-melting agarose, incubated for 2 h 
in the presence of zymolyasc (Seikagu) and incubat­
ed overnight with pronase (Boehnngcr Mannheim) 
Yeast chromosomes were separated using pulsed-field 
gel electrophoresis (PFGE) and blotted to a GeneS-
creen Plus membrane (NEN Duponl) YAC blots 
were hybridized with 32P-labelled total human DNA 
to estimate the size of the human insert Subsequent­
ly, the identity of the YACs was checked with the 
marker originally used for their isolation YACs were 
further characterized by screening of adjacent mark­
ers and through the generation of lelt- and right-end 
fragments by ligation-mediated PCR (LM-PCR, see 
below) 
In addition, we screened the СЕРН YAC data base 
with new DNA markers from this region and for YAC 
clones which overlap with previously mapped YACs 
Southern Biol Analysis 
Hybridization of 3:P-labclled DNA fragments to 
nylon Filters containing DNA from patients or from 
YAC clones was essentially done as described else­
where [9] 
LM-PCR and Sequence Analysis 
The LM-PCR method was employed essentially as 
described by Kere et al [19] Yeast DNA was digested 
with Alu\, EcoKV, Rsa\ or P\uU prior to ligation of 
adaptors LM-PCR end fragment products ot the YAC 
clones were separated on an agarose gel and purified 
with the Qiaquick gel extraction kit (Quiagen) Puri­
fied DNA was sequenced using fluorescent dideoxynu-
cleotides on an Applied Biosystems 373A DNA se­
quencer Sequencing reactions were done with a Taq 
DyeDeoxy Terminator Cycle Sequencing Kit (Applied 
Biosystems) according to the manufacturer's in­
structions The oligonucleotides of end fragment 
753elOEV/L (ATTTATTCTTCCAGGCCCATA and 
CGGAATTCTGAAAAAGAGATC) were designed 
(Isogen Bioscience, The Netherlands) to generate a 
product of 94 bp For end fragment 5045H5, the oligo­
nucleotides TGGATAAAGTAAAAAGCACACAAG 
and TGGTAGTTGTCTCATAGCTCTTG amplify a 
product of 260 bp Finally, a 152-bp PCR product 
(A0822EV/L) can be amplified from the left end of 
YAC A0822 with the oligonucleotides CCTAATTT-
GGGAAGAACATATC and AATTTAAGAGAGA-
AATTATTCATATT 
Table 2. Markers used in this study 
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Fig. 1. Physical map of the Xql3 3-q21.3 region. 
On the upper horizontal bar, the previously and newly 
mapped DNA loci are indicated The YACs arc repre­
sented by solid bars for X chromosomal sequences and 
wavy bars for autosomal sequences Vertical bars indi­
cate the presence of the markers on the YACs and in 
the DNA of patients with deletions. Open circles are 
right-end fragments while solid circles indicate left-end 
fragments of the YACs Solid and open diamonds 
represent the outermost X-chromosomal cosmid 
clones derived from their respective YACs used for 
direct-visual-hybndization analysis The identification 
numbers of the YACs are depicted adjacent to the 
YACs, while their estimated sizes are depicted under­
neath in parentheses The gaps between the three YAC 
contigs are indicated with double arrowheads The 
deletions found in several patients used m this study 
are depicted at the bottom of the figure. The solid bar 
represents the chromosomal segments present in the 
patients The molecular characterization of all patients 
has been reported elsewhere except for patient AP (in­
dicated with an arrow), who suffers from MR and 
CHM The mapping results of the YAC end fragments 
are only indicated for overlapping YACs. For purposes 
of clanty, the region between POU3F4 and DXS233 is 
not true to scale but expanded twofold At the bottom, 
the intervals from this region as defined by Philippe et 
al [ 14, unpubl. data] are depicted. 
Results 
Construction of a YAC Contig 
Several markers from the Xq21 region 
were employed to screen the ICRF and СЕРН 
YAC libraries [15, 16]. All YAC clones were 
extensively screened for the presence of X-
linked markers and for the absence of autoso­
mal sequences. In this way, a YAC map was 
generated consisting of three nonoverlapping 
contigs encompassing the Xql3.3-q21.31 re­
gion. From these contigs, YAC 4893 and 
32 
YAC 5045 have been published elsewhere [9] 
To establish novel sequence-tagged sites 
(STSs) and to check the integrity of the YACs, 
we employed the LM-PCR technique [19] 
LM-PCR products were hybridized to adja-
cent YACs and to DNAs of a large number of 
patients with deletions in Xq21 to localize 
and orient the YACs (fig 1) End fragments 
mapping to the Xq21 region were sequenced, 
and oligonucleotides were designed for PCR 
amplification to generate new STSs 
The middle and most distal YAC contigs 
span approximately 3 and 2 5 Mb, respective-
ly Although the size of the most proximal 
contig has not been determined precisely, we 
estimate that together, the resulting YAC con-
tigs encompass a chromosomal segment of 
approximately 7 Mb, extending from PGK1 
proximally to DXS1002 distally with a gap 
between DXS986 and DXS738 and between 
end fragment 5045H5 and the DXS232 locus 
The most proximal contig is linked to a pre-
viously published YAC contig spanning the 
PGK1 locus [20, 21] The most distal contig 
overlaps a previously reported YAC contig in 
theXq21 3 region [22] 
Identification and Fine Mapping of a 
Deletion Associated v. ith CHM and MR 
Patient AP is a 40-year-old mentally re-
tarded man with CHM Ophthalmologic find-
ings suggest that two of his sisters (II-1 
and II-4) and his mother (1-2) are carriers 
of CHM Apart from a microdeletion in 
the Xq21 band (see below) patient AP car-
ries a balanced translocation 46,XY,t(10,15) 
(q26 3,q24 3), which is also present in his 
mentally normal sister (II-4) and father, and 
apparently is not associated with a clinical 
phenotype (fig 2) 11-1 and II-2 have not been 
investigated for the presence of the transloca-
tion 
Patient AP was investigated for the pres-
ence of a deletion by PCR amplification of 
1 2 
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Fig. 2. Pedigree of kindred with CHM and MR 
Patient AP (11-3) was ascertained via his sister (II-4) 
who was prenatally counselled Two of his sisters (II-1 
and II-4) and his mother (1-2) are carriers of the dele-
tion AP, his father (I-1 ) and one of his sisters (II-4) also 
carry a balanced translocation t(10,15)(q26 3,q24 3) 
II 1 and 11-2 have not been tested for chromosomal 
abnormalities 
several exons from the CHM gene All exons 
tested were absent, which prompted us to 
investigate the extent of the deletion in greater 
detail On the proximal side, the markers 
DXS26 and DXS995 were found to be 
present in patient AP, while DXS232 and 
DXS121 were absent Also, the POU3F4 
gene, previously shown to be involved in 
DFN3, appeared to be present m this patient 
[13] These findings located the proximal 
breakpoint of patient AP between the pre-
viously defined intervals 7 and 8 of the Xq21 
band(fig 1)[14,Philippe,unpubl data] Sub-
sequently, several cosmids from a previously 
published 850-kb cosmid contig [9] were hy-
bridized to precisely map the proximal end-
point of this deletion The breakpoint is lo-
cated in cosmid 5045H3, which detects a nov-
el restriction fragment carrying the deletion 
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Fig. 3. Mapping of the proximal deletion breakpoint in patient AP 
Hybridization of the cosmids 5045E7 (a), 5045H3 (b) and 5045A6 (c) to a 
Southern blot of EcoRI-digcsted DNA of patients with deletions and a 
female control In patient AP, cosmid 5045H3 detects a novel restriction 
Iragmcnt indicative ofthe proximal breakpoint of the deletion. 
junction (fig 3) A cosmid located proximal to 
this breakpoint (cosmid 5045A6) is entirely 
present in patient AP, while the first cosmid 
(5045E7) distal to cosmid 5045H3 is com­
pletely absent. These results confirm the ini­
tial localization of the breakpoint in cosmid 
5045H3 (fig. 3). It is noteworthy that the dis­
tal breakpoint of another deletion, detected 
previously in a patient with DFN3 (TD) [9], is 
also located in cosmid 5045H3, approximate­
ly 10 kb from the proximal deletion break­
point in patient AP (data not shown). 
Several markers from the Xq21.2-q21.31 
region, i.e. DXS1002, DXS95, DXS262, 
DXS110 and DXS472, appeared to be absent 
in patient AP, thus the distal breakpoint ofthe 
deletion in patient AP could be assigned to the 
Xq21.32-q21.33 segment. To localize this 
breakpoint more precisely, several markers 
from a previously defined interval (interval 
20) [14; Philippe, unpubl. data] were em­
ployed PCR analysis revealed that DXS3 is 
absent, while DXS1170 and DXS990 are 
present in the DNA of AP. Conventional 
Southern blot analysis showed that the 
DXS112 locus is also located proximal to this 
deletion breakpoint (data not shown) There­
fore, the distal breakpoint ofthe AP deletion 
subdivides this interval [Philippe, unpubl. 
data] in two distinct intervals: 20A and 20B. 
The loci DXS3 and DXS112 are located in 
interval 20A, whereas interval 20B harbors 
DXS1170andDXS990. 
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Mapping of Neu Mai kers и uh Respect to 
Knov^n Markers 
These data and the previously established 
deletion interval map [14, Philippe et al, 
unpubl data] have enabled us to define the 
physical order for several markers Four 
markers have been mapped to interval 2 
based on their presence in patient XL62 and 
in C56N, a human-rodent cell hybrid contain­
ing the Xq21 1-qter segment [Philippe et a l , 
unpubl data] DXSI225 is present on YAC 
910hl and absent from YAC 752el0 There­
fore, this marker is located proximal to 
DXS1197 and DXS986 which are both 
present on YAC 753elO Since DXS1197 is 
present on both above-mentioned YACs, the 
order must be Xcen-DXS1225-DXSl 197-
DXS986-Xqter DXS346 also maps to in­
terval 2 and is absent in both YACs Since 
the left-end fragment of YAC 753elO 
(753elOEV/L) is also located in this interval 
(data not shown), DXS346 can be placed dis­
tal to this end fragment 
DXS738 is located in interval 3, based on 
its presence in patient 1/10 and absence from 
patient XL62 (fig 1) [Philippe et al, unpubl 
data] DXS738 is absent from both YAC 
753elOand 32 lf8, which positions it proximal 
to DXS72 Since the end fragment A0822EV/L 
of YAC A0822 is also present in YAC 321f8 
while DXS72 is absent from YAC A0822, the 
end fragment is positioned proximal from 
DXS72 in interval 3 By combining these 
results with previous mapping data [14, 
Philippe et al, unpubl data] we propose 
the following order Xcen-PGKl-DXS566-
DXS1225-DXS1197-DXS896-753el0EV/L· 
DXS346 - DXS738 - A0822EV/L - DXS72 -
DXS169-Xqter 
A third relevant end fragment, 5045H5, 
maps distal to POU3F4 and proximal to 
DXS232 This end fragment is located ouside 
the deletions found in patients TD and 
LGL2905, which assigns this marker to inter­
val 8 753el0EV/L, A0822EV/L and 5045H5 
were sequenced and oligonucleotides were de­
signed for PCR amplification. In this way, 
three new STSs could be generated (see Mate­
rials and Methods) 
More distally, DXS1167 bould be placed 
between DXS326 and DXS165 because of its 
localization on YAC 949ell and its absence 
from YAC 4887 This marker has been 
mapped previously to interval 10 [14, Phi­
lippe et al, unpubl data] (fig 1) DXS1209 
and ZNF6, a gene containing a zinc finger 
motif, which has been mapped to Xq21 [23] 
could be localized in the same way DXS95, 
DXS349, DXS364 and DXS1168 could be 
placed distal to DXS1002 on the basis of their 
absence from YAC 949el 1 A comprehensive 
overview of the Xq21 region, including the 
YAC contigs, all above-mentioned markers 
and the relevant deletions is given in figure 1 
Discussion 
In this study we have established three 
YAC contigs encompassing the Xql3 3-
q21 31 region except for a gap between 
DXS986 and DXS738, and a gap between 
POU3F4 and DXS232 To estimate the size 
of the latter gap, cosmids from the proximal 
segment of YAC 4886 and the most distal cos-
mid of YAC 5045 were employed as probes 
for direct-visual-hybndization analyses [24] 
(fig 1) These experiments revealed that the 
size of the gap does not exceed 100 kb [Мегкх 
and van der Maarel, unpubl data] We are 
currently screening for cosmids from the 
ICRF Cosmid Reference Library [25] and 
Chromosome X Cosmid Library LL0XNC01 
'U' to fill this gap Despite extensive screening 
of the ICRF and СЕРН YAC libraries [15, 
16], we have not yet been able to fill the 
remaining two gaps The generation of the 
end clone 753el0EV/L will hopefully lead to 
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the identification of new YACs between 
DXS986 and DXS738 
We confirmed the localization of 19 DNA 
markers and 4 genes from the Xql3 3-
Xq21 31 region and were able to map them in 
the correct order In addition, three STS 
clones were generated and positioned in the 
contigs 
We assume that the DXS566 locus maps to 
an internal deletion in YAC 91 Ohi, because 
in this YAC, the respective primer pair has 
failed to yield a PCR product We cannot rule 
out the possibility that DXS346 also maps to 
this deletion interval If so, DXS346 should 
be located between DXS566 and DXS1225 
Many of the microscopically detectable de-
letions in the Xq21 region are associated with 
DFN3, MR and CHM [2, 6, 7, 26, 27] The 
identification of submicroscopic deletions as-
sociated with either CHM [28] or DFN3 [6, 9] 
has enabled the subsequent cloning of the 
relevant genes [10-13] Characterization of 
these deletions has revealed that the physical 
order of these disease genes is Xcen-DFN3-
MR-CHM-qter Some patients with deletions 
in Xq21 show clinical features which are not 
observed in others and which do not seem to 
fit the contiguous gene syndrome model The 
most striking additional features are obesity 
[29], hypogonadism [6] and cleft lip and pal-
ate [30] The presence of a gene in Xq21 
involved in palate closure is also suggested by 
linkage studies in three families with X-hnked 
cleft palate and/or ankyloglossia (CPX) The 
critical region for CPX was demarcated proxi-
mally by DXS1002 and distally by DXYS1 
[Stanier, pers commun , 31-35] In view of 
the large number of deletions known in Xq21, 
it is striking that thus far no small deletions 
have been found with nonspecific mental re-
tardation or with a combination of MR with 
either DFN3 or CHM 
Here, we are the first to report on a dele-
tion associated with MR and CHM The dele-
tion encompasses the CHM gene and extends 
into the chromosomal region between the 
DFN3 and CHM genes confirming the initial 
localization of a MR locus in Xq21 1 Since 
the deletion in AP encompasses a large seg-
ment of Xq21, one could speculate that the 
deletion disrupts a MR gene in Xq21 33, dis-
tal to the CHM gene There are two argu-
ments against this hypothesis First, the MR 
gene would be located distal to several dele-
tions associated with a complex phenotype 
including MR, e g XL45, SD, and DM Sec-
ond, two patients with nonsyndromic CHM 
have been described [8], in whom deletions 
extend into or beyond interval 20 (patient 
LUN3 and LUN1) Together, these data 
strongly suggest that a locus for XLMR is situ-
ated in the chromosomal region defined by 
intervals 8, 9 and 10 At the proximal side, 
this region is demarcated by the deletions 
found in DFN3 patients II/7, 1/10, and TD 
[9] The proximal deletion breakpoint in AP 
does not significantly narrow down the local-
ization of the MR locus, since it is located 
only 10 kb from the distal deletion breakpoint 
in TD At the distal side, deletions associated 
with CHM in patients C759, 3 5, 25 6, MS, 
and 7 6 [8] commence between ZNF6 and 
DXS165 and extend telomencally The dele-
tion in patient LGL2905 who has CHM but 
no MR, restricts the critical region for MR to 
interval 8 
It is remarkable that apart from DFN3, 
patient TD shows hypogonadism and mild 
MR Five affected family members are not 
mentally retarded but show marked antisocial 
and immature behavior and possibly mild 
learning deficits [36] Since the deletion in 
patient TD is close to the MR locus [7], it 
could affect the proper transcription of the 
MR gene This might explain the complex 
clinical findings in TD and his family 
So far, we found no evidence for microde-
letions in the critical region for MR (interval 
36 
8) in 40 patients with XLMR [van der Maarel, 
unpubl. results], whereas in patients with 
CHM or DFN3, deletions were detected in 
approximately 25% of cases [8, 9; de Kok and 
Cremers, unpubl. results]. It is very likely that 
the main reason for this discrepancy is the 
genetic heterogeneity of XLMR [37]. Indeed, 
the Xq21.1 locus may only be involved in a 
small proportion of cases with XLMR. Thus 
far, several syndromic forms of MR, like Al-
lan-Hemdon-Dudley syndrome, Juberg-Mar-
sidi, and a-thalassemia/MR (ATR-X) have 
been mapped to Xql3-q21 [38-43], but re-
cent linkage studies of our group in families 
with nonspecific XLMR point to a clustering 
in the Xpl 1 region [44]. Recently, mutations 
in a putative global transcriptional regulator 
(XH2) have been shown to be causative for 
ATR-X [45] 
Definite proof for the existence of a gene 
for MR in Xq21.1 can only be obtained by 
cloning of candidate genes from the relevant 
region and identification of mutations in syn-
dromic or nonsyndromic cases of XLMR. 
These studies will be greatly facilitated by the 
XqI3.3-q21 31 YAC contigs reported here. 
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We have found that the microsatelllte marker 
AFM207zg5 (DXS995) maps to all previously described 
deletions which are associated with X-linked mixed 
deafness (DFN3) with or without chorolderemia and 
mental retardation. Employing this marker and pHU16 
(DXS26) we have identified two partially overlapping 
yeast artificial chromosome clones which were used 
to construct a complete 650 kb cosmid contig. Cosmids 
from this contig have been tested by Southern blot 
analysis on DNA from 16 unrelated males with X-linked 
deafness. Two novel microdeletions were detected in 
patients which exhibit the characteristic DFN3 
phenotype. Both deletions are completely contained 
within one of the known DFN3-deletions, but one of 
them does not overlap with two previously described 
deletions in patients with contiguous gene syndromes 
consisting of DFN3, choroideremla, and mental 
retardation. Assuming that only a single gene is 
involved, this suggests that the DFN3 gene spans a 
chromosomal region of at least 400 kb. 
INTRODUCTION 
X-linked mixed deafness with perilymphatic gusher at surgery 
in таіеь (DFN3, MIM 304400) is characterized by a severe 
hearing loss involving all frequencies, that may be progressive 
About 50% of female heterozygotes show mild to moderate 
hearing impairment Audiological studies indicate a basic 
sensorineural hearing loss, with the variable conductive element 
postulated to reflect outward perilymphatic pressure splinting the 
stapes footplate in the oval window ( 1 ) On opening of the stapes 
footplate during surgery, an abnormal amount of perilymph is 
encountered Computerized tomography (CT) studies have 
demonstrated an abnormal dilatation of the internal acoustic canal 
(IAC) as well as an insufficient structural separation between the 
I AC and the basal coil of the cochlea (2-4) 
Linkage studies in families with X-linked deafness have 
assigned the underlying gene to the Xql3-q2l region (4—7) 
This localization is supported by the phenotype of patients with 
cytogenetically visible deletions of Xq21 region, which includes 
choroideremia (CHM), mental retardation (MR) and DFN3 
(8—12) Molecular characterization of Xq21 deletions has enabled 
us and others to refine the assignment of the DFN3 gene to a 
small segment of Xq21 1(13-15) Subsequent examination of 
patients with classic DFN3 revealed the existence of two 
submicroscopic deletions encompassing DXS26 (cases TD and 
1/10, Figure 1) (16) 
We now have employed yeast artificial chromosome (YAC) 
and cosmid contig cloning to characterize a 850 kb chromosomal 
segment encompassing DXS26 and DXS995 This has enabled 
us to fine map several classic and syndromic DFN3 deletions 
and to identify two novel microdeletions Some of the deletions 
are non-overlapping, which suggests that we have cloned a 
sizeable part of the DFN3 gene in cosmid clones 
RESULTS 
Identification of YACs from the DFN3 region and 
construction of a cosmid contig 
Physical mapping of several recently isolated X-chromosomal 
markers using a deletion panel described by Philippe el al (17) 
revealed that the microsatelllte marker AFM207zg5 (DXS995) 
does not only map to large deletions of the Xq21 band which 
are associated with X-linked deafness, CHM, and MR, but also 
to two previously described microdeletions (TD and 1/10) in 
patients with non-syndromic DFN3 (Philippe et al. in 
preparation) 
By screening a human YAC library (18) with the probes 
AFM207zg5 and pHU16, we were able to isolate two YAC 
clones, nos 5045 and 4893, respectively Physical mapping of 
YAC endclones generated by the ligation-mediated polymerase 
chain reaction (LM-PCR) procedure (19), indicated that YAC 
5045 is chimaenc containing an autosomal fragment at its 
proximal side (Figure 1) High molecular weight DNA from both 
YACs was used to construct cosmid libraries consisting of 
approximately 2500 independent clones for each YAC clone 
Cosmids containing human inserts were identified and gndded 
on to several nylon membranes Cosmid contigs were established 
by colony hybridization or Southern blot analysis of EcoRl-
digested cosmid DNAs with pHU16, YAC endclones, and 
iterative hybridization of cosmid inserts Two EcoR] restriction 
maps were constructed spanning a total of approximately 800 
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Figure 1 Physical map of thi_ DFN3 region The X chromosomal parts of the YACs are given in the upper part as bars The position of the cosmids subcloned 
from the YACs or identified in the 1CRF X chromosome cosmid library by cosmid walking (ICI -IC3) are depiclid below ine YACs Deleted segments are depicicd 
by stippled lines The clinical features of (he patients are given on the right side 
kb YAC 4893 was completely represented in the contig whereas 
both the distal end of YAC 5045 as well as the chromosomal 
region spanning DXS995 were found to be absent 
To close the gap in the vicinity of DXS995, cosmids 5045F4 
and 5045B12 were used to perform cosmid walking employing 
the ICRF Cosmid Reference Library (20) Three rounds of 
cosmid walking resulted in the identification of three new cosmids 
(ICI -IC3), which close the cosmid gap (Figure 1) 
Fine mapping of deletions associated vt ith complex sy ndromes 
and identification of novel microdeletions in DFN3 patients 
Noil/BssHll inserts of the cosmid clones indicated in Figure 1 
were hybridized to £coRI or Taq\ digested DNAs from 
syndromic and classic DFN3 patients as well as to ЕсоЯІ digested 
DNA from a patient showing choroideremia and mental 
retardation The latter patient, AP, has a deletion which 
encompasses exons 2 through 15 of the CHM gene as well as 
the more proximally located DNA markers DXS165 DXS233 
DXSI21, and DXS232 (van der Maarel et al in preparation) 
The proximal deletion endpoint is situated in cosmid 5045B11 
approximately 30 kb from the distal end of the cosmid contig 
Detailed analysis of the deletions found in the syndromic' DFN3 
patients D20 and XL45 positioned their respective breakpoints 
just proximal to DXS995 and DXS26, respectively (Figure 1) 
The proximal deletion breakpoints in other patients with 
syndromic deafness (DM and SD) mapped proximal to the cosmid 
contig and therefore do not provide additional mapping 
information 
Southern blot analysis of DNA from 16 unrelated patients with 
non-syndromic X linked deafness using all cosmids from the 
contig resulted in the identification of two novel microdeletions, 
II 7 and G8314 as shown in Figure 2 This figure is a typical 
example of using Noi\IBss\i\l cosmid inserts in a competitive 
DNA hybridization assay The deletion in patient 1/10 
encompasses the DNA loci DXS995, DXS26, and DXSI69 The 
deletions in patients Π 7 and G83I4 merely span DXS26 and thus 
are entirely contained within the microdeleiion seen in patient 
1/10 (Figure 1) Interestingly the G8314 deletion docs not 
overlap the deletions of patients D20 and XL45 The distance 
between the proximal deletion endpoint in D20 and the distal 
deletion endpoint in G8314 is approximately 400 kb 
DISCUSSION 
We have established a cosmid contig spanning the critical region 
for DFN3 and have identified two novel, highly informative 
deletions associated with X-lmked deafness Taken together, we 
have now found four microdeletions (TD, 1/10 Π/7, and G83I4) 
among 16 patients with X linked dealness In all four patients 
with microdeletions the bony changes indicative of DFN3 were 
observed For two patients suffering from X linked deafness 
choroideremia and mental retardation, D20 and XL45 the 
deletions were shown not to overlap with the deletion in patient 
G83I4 In patient D20, the structural changes of the inner ear 
indicative of DFN3 has been demonstrated by CT (21 ) Although 
patient XL45 was reported to have sensorineural deafness (22) 
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Figure 2. Southern blot analysis of £coRJ digested genomic DNAs from patients 
with X linked deafness employing cosmid 4893EI. Size markers are given to 
the right X-only represents cell line 578. a hamster cell line containing one human 
X chromosome 
it is possible that the DFN3 gene is involved in this case too. 
Glasscock (23) hypothesized that a very rapid progression of the 
sensorineural component of DFN3 can mask the conductive 
element. Since in a younger brother of XL45 mixed deafness 
was diagnosed (13), it is tempting to speculate that deafness in 
both brothers is caused by a (partial) deletion of the DFN3 gene. 
Linkage studies suggest that X-linked sensorineural deafness is 
genetically heterogeneous (7), but this has not been demonstrated 
for the mixed type of X-linked deafness. Assuming that only one 
gene is involved in DFN3, our results indicate that the DFN3 
gene spans a chromosomal segment of at least 400 kb containing 
both the DXS995 and DXS26 loci. However, it is possible that 
there are additional rearrangements in the X-chromosome of some 
of the patients with deletions. Within the limits of resolution of 
conventional Southern blotting, this has been excluded in the 
cosmid contig region for patients TD, G8314 and II/7, but not 
for patients 1/10, D20, and XL45. If the rearrangements in the 
DFN3 patients presented here are not complex, the DFN3 gene 
might well be the second largest gene known to date, after the 
Duchenne muscular dystrophy (DMD) gene which spans 
approximately 2.3 Mb (24 — 26). The DMD and DFN3 genes 
are located in Xp21 and Xq21, respectively, the most prominent 
Giemsa dark-staining regions of the X-chromosome. Another 
gene from Xq21, the choroideremia gene, also spans a sizeable 
( > 150 kb) chromosomal segment (27). Only two of 15 deletions 
associated with classic CHM are intragenic; the others extend 
both proximal and distal of the gene spanning a chromosomal 
segment of approximately 15 Mb (14,27). The classic DFN3 
deletions described here encompass chromosomal segments of 
a minimum of 250 kb (patient G8314) to several megabases 
(patient 1/10). Together, these findings support the idea that the 
Xq21 band contains a relatively small number of large genes. 
If so, this has important implications for cloning strategies aiming 
at the identification of sequences of the DFN3 gene proper. 
We did not find smaller-sized deletions among our X-linked 
deafness patients, which might narrow down the search for some 
of the protein coding sequences of the DFN3 gene. In the cosmid 
contig presented here, no CpG island indicative of the presence 
of the 5' end of the DFN3 gene was found. It is, however, 
possible that a sizeable portion of the gene is located proximal 
to YAC 4893. To investigate this chromosomal segment, we have 
identified a YAC clone spanning DXS26 and DXS169, which 
is currently under investigation. 
Assuming the existence of widely spaced small exons, as for 
example in the DMD and CHM genes, it might be difficult to 
find exons of the DFN3 gene by analysing cosmid clones for 
evolutionary conserved sequences. Alternative methods as for 
example exon trapping and cDNA enrichment protocols are 
underway, which should soon enable us to identify DFN3 protein 
coding sequences. 
MATERIAL AND METHODS 
Patients 
All patients except ΑΡ. Π/7. and G8314 have been extensively described elsewhere 
(15.16: and references therein). Patient AP suffers from CHM and MR (van der 
Maarel et al.. in preparation). Patients U/7 and G8314 show the classical features 
of DFN3 including the typical CT scan changes of the inner ear (4; M.Bitner-
Glindzicz. unpublished data). 
YAC clone screening and construction of YAC cosmid contigs 
YAC 4893 (ICRFy90IE1023) was isolated by hybridization with pHU16 from 
primary library filters of the human ICRF human YAC library (18) YAC 5045 
(ICRFy9O0B12!0) was identified by a PCR screening protocol from pooled DNAs 
from the same library. Yeast cell cultunng and DNA isolation was performed 
as described elsewhere (28). YAC endclones were generated by the ligation 
mediated polymerase chain reaction (LM-PCR) protocol essentially as described 
by Kere et al. (19). Restriction enzyme digestion of yeast DNA prior to ligation 
of adaptors was done with Alul. EcoRV. Rsal. or Pvuli The procedure used 
for constructing cosmid libraries in the SuperCos I vector (Stratagene) has been 
described elsewhere (29). 
Cosmid walking 
DNA was isolated from cosmids 5045F4 and 5045B12 using a Qiagen midi-prep 
kit and digested using either EcoRl or PsA according to manufacturer's instructions. 
Fragments were Southern bloned and hybridized with radiolabelled human placental 
DNA (Sigma), washed in 0.1 χ SSC. 0.1 % (w/v) SDS for 30 mm at 65°C and 
exposed to X-ray film for 3-24 h at -70°C. A band showing no signal was 
selected as a probe for the next part of the walk, excised froYn a 0.8% agarose 
gel and spun through glass wool at 13 000 r.p.m. for 10 min. Probes were 
preannealed with human competitor DNA 
ICRF gridded X chromosome cosmid filters were hybridized as described by 
Nizetic et al. (30) and positive colonies selected. Digests of DNA from positive 
colonies were compared with those of flanking cosmids. blotted and probed with 
the band which had originally been used to select them from the gridded filter, 
to ensure that they were true positive colonies. The whole process of probing 
with human placental DNA and band selection was repeated at the next stage 
of the walk. Three such rounds of hybridization and walking were needed to 
bridge the gap in the cosmid contig around DXS995 and resulted in the 
identification of the following clones: ICI (ICRFcl04P0517), IC2 
(ICRFcl04L0131). IC3 (ICRFcl04B1939). 
Southern blot analysis and DNA markers 
Methods employed for the isolation of high-molecular-weight DNA. restnction-
endonuclease digestion, as well as separation and blotting of DNA fragments have 
been described elsewhere (15). Hybridization of the cosmid inserts in the presence 
of excess human competitor DNA was done as described by Blondene/ al. (31). 
Hybridized filters were washed at 65°C with 40 mM Na 2HP0 4 (pH 7.2)10.5% 
(w/v) SDS for 3x5 min and 1x30 min. Autoradiography took 4 -16 h at -70°C 
using two intensifying screens. 
The markers pJL68 (DXS232). pHU16 (DXS26). pXIfXf (DXS169). and 
AFM207zg5 (DXS995) have been described elsewhere (9.32-34). 
45 
ACKNOWLEDGEMENTS 
The author·, arc indebted 10 Drs Ρ Beighion С Cremerà J Gouldsmnh О Michel 
Ρ Thorpe. R Ruvalcaba W Reardon and К Shaver-Amos lor providing blood 
from patients with X linked mixed deafness We thank S D van der Veldc-Visser 
and E Boender van Rossum for technical assistance in cell culturmg We ihank 
Drs M R«bs. G Zehetner and H Lehrach for access to ICRF YAC and cosimd 
libran fillers PCR pools and the Reference Libran Database The research of 
F Ρ M С has been made possible by a fellowship of the Royal Netherlands 
Academy of Ans and Sciences M B-G is an MRC Clinical Training Fellow. 
Μ Ε Ρ is funded b) Mothcrcare This work was supported by the Netherlands 
Organization lor Scientific Research (NWO) and by the Imperial Cancer Research 
Tund 
ABBREVIATIONS 
C H M choroidcrenua CT computerized loniographv DFN3. X linked mixed 
deafness. M R . menial retardation. YAC yeast amllcial chromosome 
REFERENCES 
1 Reardon V. Bellman S.Phelps P.Pcmhres.M and L u w n . L M (1993) 
Aun Ololaniigul 113 706-714 
2 Michel. О . Breunsbach. J and Matthias. R (1991) HNO 39 486-490 
3 Phelps. Ρ D . Reardon. W . Pcmbrey. Μ E . Bellman. S and Luxom. L 
(1991) Neunmtdrolog\ 33 126-330 
4 Robinson D Lamom. M . Curtis G . Shields. D С and Phelps. Ρ D (1992) 
Hum Genet 90 316-318 
5 Brunner. H G . van Bennckom. С A . Lambemion E M M . Oei T L . 
Cremen. С W R J Wieringa. В and Ropers H H (1988) Hum Genei 
8(1337-340 
6 Wallis. С . Ballo. R . Wallis G . Bcighton. Ρ and Goldblati. J (1988) 
Genomiis i 299-301 
7 Reardon. W . MiddlclonPricc H R Sandkuijl. L , Phelps. Ρ . Bellman. 
S , Luxon. L . Pembrey. M E and Malcolm. S (1991) Genomus 
lì 885-894 
8 Rosenberg. Τ . Schwanz. M , Niebuhr. Ε Yang, H M . Sardemann. H , 
Andersen. О and Lundsteen С (1986) Op/itlinlmtL Paedmrr Gêner 
7 205-210 
9 Nussbaum R L . Lesko. J G . Lewis, R A , Ledberter, S A and Lcdbencr, 
DH (1987)/"ror Miri Acmi Su USA 84 6521 -6525 
10 Cremers. F Ρ M , van de Pol, Τ J R , Wiennga. В , Hoflcer M H , Pearson, 
Ρ L . Pfeiffer R A . Mikkelsen. M , Tabor. A and Ropers. H -H (1988) 
Am. J Hum Genei 43 452-461 
11 Cremen,. F Ρ M . van de Pol. Τ J R . Diergaarde, Ρ J . Wieringa, В . 
Nussbaum. R L . Schwanz M and Ropers. H-H (1989) GÎVKVIIKÏ 
4 41-46. 
12 Reardon. W . Rubens. S . Phelps. Ρ D . Thomas. N S . Beck. L . Issac. 
R and Hughes. H E (1992) Am J Med Genei 44 513-517 
13 Merry. D E . Lesko J G Sosnoski D M Lewis. R A . Lubinskv R M . 
Trask В . van den Engh, G Collins F S and Nussbauin. R L (1989) 
An, J Hum Genei 45 530-540 
14 Crcmerv F Ρ M . Sardella. E -M . Brunsnunn. F . Jay. M . Jay. В . Wnghl. 
A . Pinckers. A J L G . Schwartz, M , van de Pol, Τ J R Wieringa. В . 
de la Chapelle. A . Pawlowilzki. 1 H and Ropers. H H (1990) Am J 
Hum Gêner 47 622-628 
15 Bach. I . Robinson. D Thomas. N Ropers. H H and Cremers, F Ρ M 
(1992) Hum Gêner 89 620-624 
16 Bach. [ . Brunncr. H G . Beighton. Ρ . Ruvakaba. R H A . Reardon. W . 
Penibrey. M E , van der Velde Visser. S D . Bruns, G A P . Cremers. 
С W R J . Cremers. F Ρ M and Ropers, H -H (1992) Am J Hum Gêner 
SI 38-44 
17 Philippe, С . Cremers F Ρ M Chcry, M . . Bach. 1 . Abbadi. N . Ropers. 
H H and Cilgenkrantz S (1993) Gemmiu 17 147-152 
18 Lann, Ζ . Monaco. A Ρ and Lehrach. H (1991) Pmc Nuri Acad Sci 
USA 88 4123-4127 
19 Kerc. J . Nagaraja. R . Mumm. S . Cncodicola. A . D'Urso. M and 
Schlessinger D (1992) Genomics 14 241-248 
20 Zehetner. G and Uhrach H (1994) Nature 367 489-491 
21 Wells, S . Mould, S Robins, D . Robinson, D and Jacobs. Ρ (1991) J 
Med Genei 28 163-166 
22 Ayazi. S (1981) Am J Ophrhalmol 92 63-69 
23 Glasscock. M E (1973) Arch Olnlitnngol »8 8 2 - 9 1 
24 Kcnwnck S Patterson. M . Speer A Fischbeck К and Davies К (1987) 
Cell 48 351-357 
25 Bumieister M . Monaco. A Ρ Gillard. E F . van Ommen. G J В AITara. 
N A . Ferguson-Smith. M A . Kunkel. L M and Lehrach H (19881 
Genomics 2 189-202 
26 Van Ommen. G J В Benelson. С . Ginjaar. H В den Dunnen. J Τ 
Bakker, E Chelly J . Matton, M , van Essen, A J . Bartley. J . Kunkcl 
L M and Pearson. Ρ L (1987) Genomics 1 129-336 
27 van Bokhoven. Η . van den Hurk. J A J M . Bogerd. L Philippe. С . 
Gilgenkrantz, S .de Jong, P.. Ropers, H-H and Cremers, F Ρ M (1994) 
Hum Mol Genet 3 1041-1046 
28 Green. E D and Olson. M V (1990) Proc Nail Acad Sci USA 
87 1213-1217 
29 Berger. W . Meindl. A . van de Pol. Τ J R . Cremers. F Ρ M Ropers 
H H . Doerncr. С . Monaco. A Ρ , Bergen. A A В . Lebo, R Warburg 
M Zergollem. L . Lorenz. В Gal A . Blecker-Wagemakers. E M and 
Meitmgcr Τ (1992) Hum Mol Genei I 199-203 
30 Nizclic. D . ¿eherner. G . Monaco A Ρ . Gellen. L . Young. В D and 
Lehrach. H (1991) Proc Nati Aaid Sri USA 88 3233 - 3237 
11 Blonden L A J . den Dunnen. J Τ van Paassen. Η Μ В . Wapenaar M С 
Grootschollcn. Ρ M . Ginjaar H В . Bakker. E . Pearson. Ρ L and van 
Ommen. G J В (1989) Nullen Αι ids Res 17 5611 -5621 
32 Sankila Ε M . Bruns. G A P . Schwartz. M . Nikoskelainen. E Niebuhr. 
E Hodgson S V . Wnghl. A F and de la Chapelle. A (1990) Hum Genet 
85 117-120 
33 Riddell, D С . Wang. H S . Becken. J . Chan, A . Holden. J J A . Mulligan. 
L M . Phillips. M A . Simpson. N E . Wrogemann. К . Hamenon. J L 
and White. Β N (1986) Смоцепеі Cell Genet 42 123-128 
34 Weissenbach J . Gyapay. G , Dih. С , Vignai, A , Monssene. J , Mdlasseau. 
Ρ . VaysseiT G and Uthrop. M (1992) Nature 359 794-801 
46 
CHAPTER 4 
ASSOCIATION BETWEEN X-LINKED MIXED DEAFNESS AND MUTATIONS IN THE 
POU DOMAIN GENE POU3F4 
de Kok, Y J M, van der Maarel, SM, Bitner-Glindztcz, M, Huber, J, 
Monaco, Α Ρ, Malcolm, S, Pembrey, Μ E, Ropers, Η, and Cremers, F Ρ M 
Science , 267, 685-688(1995) 
Reprinted with permission from Science 

Association Between X-Linked Mixed Deafness 
and Mutations in the POU Domain Gene POU3F4 
Yvette J. M. de Kok,* Silvère M. van der Maarel,* 
Maria Bitner-Glindzicz, Irene Huber, Anthony P. Monaco, 
Susan Malcolm, Marcus E. Pembrey, Hans-Hilger Ropers, 
Frans P. M. Cremerst 
Deafness with fixation of the stapes (DFN3) is the most frequent X-linked form of hearing 
impairment The underlying gene has been localized to a 500-kilobase segment of the 
Xq21 band Here, it is reported that a candidate gene for this disorder, Brain 4 (POU3F4), 
which encodes a transcription factor with a POU domain, maps to the same interval In 
five unrelated patients with DFN3 but not in 50 normal controls, small mutations were 
found that result in truncation of the predicted protein or in nonconservative amino acid 
substitutions These findings indicate that POU3F4 mutations are a molecular cause of 
DFN3 
b e \ e r e , inherited childhood deafness oc-
curs in about 1 out of 1000 births and 
presenti a benous worldwide public heal th 
problem ( / ) In 70% of these cases, deafness 
ь not .iv.oci.ueJ with other clinically rec­
ognizable feature* (2) T o date, genes for 
nonsynJromic sensorineural deafness have 
been m.ipped to five different autosomes 
( i ) , but none of these has been isolated yet 
T h e most frequent cause of X-linked hear­
ing impairment, X-linked mixed deafness 
( H F N 3 ) (McKusick catalog number 
304400), is characterized by a conduct ive 
hearing loss that results from stapes fixation 
.ind progressive sensorineural deafness (4 
5) Howe\er, a profound sensorineural deaf-
Y J M c t e K o k S M v a n d e r Maarel I Huber H H 
Hopers F Ρ M Cremers Departmeni ol Human Genet 
ics Universily Hospila! Nijmegen P O Box 9101 6500 
HB Nijmegen Netherlands 
M Bilner Glindzicz Ξ Malcolm M E Pembrey Institute 
oí Child Health University ot London London WC1N 
1EH UK 
A Ρ Monaco University of Oxford Institute of Molecular 
Medicine John Radchfte Hospital Headingion Oxtard 
ОХЭ9DU UK 
* The first two auihors contnbuted equally to this work 
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ness sometimes masks the conduct ive ele 
ment (6) C o m p u t e n : e d tomography ( C T ) 
studies in people with DFNÌ demonstrated 
an abnormal dilatation of the internal 
acoustic canal (1AC) as well as an ahnor 
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I A C and the inner ear compartment (7) As 
a result, there is an increased perilymphatic 
pressure that is thought to underlie the 
observed "gusher" during the opening of 
t h e stapes footplate T h e gene underlying 
DFN3 has been in ipped to Xq21 by linkage 
analysis (8 , 9) and through molecular char­
acterisation of large and submicroseopic de­
letions (IO, ÌÌ) Yeast irtificial chromo 
some (YAC) clones that span the critical 
region were isolated, and .in 850 kb cosmid 
contig was constructed ( / 2 ) This enabled 
us to identify and characterize two addition 
al microdclenons, as well .is a 150 kb dupli 
cation in patients with DFN 3, and to assign 
the gene underlying DFN3 to a 500 kb 
interval of Xq21 I (12 U ) (Fig IB) 
Recently, the gene Βταιη 4 U\>uìf4), 
which codes for a transcription fictor. was 
mapped between the proteolipid protein lo 
cus Pip and the DXMit6 marker near the 
phosphoglyceratc kinase 1 (Pgkl) gene on 
the murine X chromosome (14) The chro-
mosomal region between Pgkl and Pip is 
e v o l u t i o n a r y conserved between humans 
and mice, which suggests that the human 
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Fig. 1. Localization of the human POU3F4 gene (A) Soulhern blot analysis wiih the use of a mouse 
Pou3f4 probe and a control probe δ-aminolevulinate synthetase (ALAS2) with genomic DNAs trom a 
control male D2Û, and TD (16) Patient D20 has choroideremia (CHM) mental retardation (MR) and 
X linked mixed deafness (DFN3) patient TD shows evidence of DFN3 (12) (B) Physical map of Ihe DFN3 
critical region All patients with deletions have been described elsewhere (12) Patent 50Θ6 carnes a 
150 kb duplication spanning DXS26 The extent oí the cosmid contig is given al the bottom POU3F4 is 
located on cosmids Ю2 (lCRFclO4L0l31) and IC3 (ICRFcl04Bl939) approximately 20 kb distal to 
DXS995 ( 12) Restriction mapping of the cosmid containing the POU3F4 gene indicated that the POU3F4 
gene is onented with its 5' end toward the centromere 
49 
interval T h e rat homolog of P O U 3 F 4 , 
RHS2 is c\pre^ed Juring embryonic devel­
opment in the brnm, the neural tube, and 
the o i к \омсІе at 15 5 and 17 5 days after 
conception ( /^) 
Thus. both lib map position and its tem­
poral and spatial expression pattern in early 
emhr>op.nesis rendered POU3F4 an arrrac-
ti\e (.andidate цепе for DFN3 T o confirm 
and refine the localization of the h u m a n 
P O L ÌF4 цепе, u c amplified a murine 
genomic Pou3f4 i>cnc fragment by poly­
merase chain reaction ( P C R ) and hybrid-
r e d it to Southern ( D N A ) blots c o n t a m i n e 
Eco RI-digested D N A from patients with 
Xq21 deletions (/6) A 12 kb Eco RI frag­
ment w.is seen in the male control but not 
in the HFN3 patients T D and D20 who 
слгг^ ν iri.ihly si:ed deletions in Xq2I {Fig 
1A) The deletions overlap m a small chro­
mosomal segmenr encompassing DXS995 
(Fig IB), which positions the POU3F4 
gene in a 120-kh region of the previously 
constructed 850 leb counid contig that 
spans the D F N 3 locus By hybridizing the 
Pou3[4 probe to cosmids from this contig, 
n e could localize the POUW gene 20 kb 
distal U.DXS995 (Fig IB) 
W e used PCR primers complementary 
to the murine PniH/4 gene sequences to 
amplify a h u m a n POU3F4 fragment from 
cosmid D N A , which was t h e n used as a 
probe to screen a h u m a n letal brain com­
plementary D N A ( c D N A ) library (/7) 
Six overlapping c D N A s were identified 
md ρ irti illy characterized In total , u c 
isolated I 4 kb of rhe h u m a n POU3F4 
c D N A sequence, which c o n t a i n e d t h e 
complete protein coding region of 1083 
base· pairs as inferred from the rat RHS2 
and mouse Pou3f4 sequences {¡5, iS, ¡9) 
(Fig 2) T h e rat and mouse proteins are 
completely identical , and the h u m a n pro-
tein con ta ins only four conservat ive ami-
mi acid substi tut ions (Fig 2) 
To soirch for mutat ions m the P O U Ì F 4 
gene, we examined D N A from 14 unrelated 
patients u i rh X-linked deafness and 50 un-
related control females from different e th-
nic origins for single-strand conformation 
O S C ) variants (20) Because the POLMF4 
gene contains no introns, fi \e different 
PCR primer sets were sufficient to span the 
entire ei tJmg region n(POU3F4 Six of the 
dcainess patients (Table 1) had character-
istic features of D F N Ì — t h a t is, a bony de-
tect observed during C T scanning or a pen-
lymphatic gusher encountered upon stape-
dectomy ( 4 - 7 ) In one case (patient 5823), 
audiologic data were consistent with a pro-
gressive mixed type of deafness, but nei ther 
( Τ scan nor stapes surgery were performed 
^ C shilts indicative of sequence alter 
.nions « t r i lound in four D b N 3 patients, 
two of which are shown in Fig ЗА, hut n o t 
in the 50 control females 
Subsequently, we sequenced the protein 
civhng region of the POU3F4 gene in all 
patienrs with X-linked hearing impairment 
In all four patients with S S C shifts as well as 
in patient 5823, who was not studied by 
PCR-SSC analysis, mutations were observed 
in the POU3F4 gene In three DFN3 pa­
tients, we found small deletions in the 
P O U specific and POL) homcodomains of 
PQU3F4 that would result in frameshifis and 
ACATTATUC1AGTAGCGGATCCTCACCGACC 
АТС GCC « U ССТ GCC ICG AAT CCC TAC A U ATT CTC »CT ТСС »CC ТСС CT* GIC CAI S£C Ы С TCT CCC GCC ΑΤς 
CAG CAC GCC AGT CCT TTC CGC AAC ССТ CA G AAA CTT CTC САЛ AGT CAT TAC TTC Ы С CHA CTI CCC AGC U T CCG 
U T CCC CTC CCC CAT CAC T U CTG ACC AGT CTG AGC ÛAC GCC К С CCA ICG ТСС ТСС *СД CTG U C ACC AGC CCC 
H P I G H H W V I S L S B G G P W S I T I A T I P 
CIC GAC CAC CAG Ы С GTG «AG CCC CCG CGC CA« CAC CTC CAA CTC K T GCC A1C AIC CAT CAC CGC ТСБ C U CAC 
i D O O D V I P G l í S l O L C A t I N и Я S Ρ M 
GIÀ GCC CAC CAC ICA CCG CAC ACT «AC CAC CCC AAC GCC ICG CGC CCC ACC CCG GCA CCC AAC CCG TCT АТС ACG 
ICA ACC GCC CAA CCC O C AAC GTG TAC ICG CAG CCT CCC TTC ACC CTC AGC CGC AIC C I C GAA CAC CGC GGA CIC 
( J C a P L U V T I O P G F T V Ï C I I l E l i C G L 
ACC CCA CCT CCA CCI GCC GCC I C I GCA CAC AGC CTC CAC CCG GTG CIC CCA GAG CCC CCG GAI CAC CCC G U CTG 
POU-sptclflc domain 
CGC ТСС CAC CAT ТСС CAG GAT CAC ТСС CAC CAG GAG ACC CCA ACC TCI GAT CAGlTTG САД CAC T I C CCC AAA C U GAGlTI 
3 I I C A U CAA АСА АСА АТС AAC I T C CGC H C ACC CAC CCC CAC CTG C U TTC CCC C U CfiC АСА CTC TAT ССТ AAC 
F t O f t l l ( I C f T O A O V G l A l C T L T G i 
GIG H C TCC CAG ACC ACC АТС ТСС AGC H C CAG CCC ITC CAC CIC ACC TTC A U U T АТС ICC AAC C t C AAG CCC 
Г Б О І Т I C I f E A L Q L t r i i a C K L K P 
Λ-
1 
CTG CIC U C AAC TGG CTG GAG GAG CCG CAI ICG ТСС АСА CCG AGC CCG ACC AGC ATT CAC AAC АТС CCT GCA CAG 
C S T G I P T S I P K I A A Q 
POU homMdomaln 
CGC CGC U G CGC AAG AAG CCG ACC ТСС АТС GAG GTG AGT GTC AAG CGC СТА CTG GAG ACG CAT TTC CTC U G IGT 
G I I I K C R T I I E V S V K C V L E T N F L K C 
N O I 7 W 
CCC U G CCT CCC CCG CAG GAG АТС TCC ICC CTG CCA CAC ACC CIC CAC П С CAG U G G l GTC GTG CGT GTC T U 
TIC ICI U I CCA AGA C U U À GAG A U АСА I AT G ACI CCG CCA C U GAT CAC CAC CCC CAI CAC C i l TAT ICS CAC 
1 1 U 
123Г 
1116 
ACC G I C A U АСА CAC АСА TCT ICC CAI CAI C I C ICA cfcGAUAAC^CHCCCCCCtCCCCCCACTCUACCACCGCGgfiATTIC 





Fig. 2. Nucleotide sequence and the deduced ammo acid sequence encoded by human POU3F4 (21) 
The oligonucleotides used for PCR SSC analysis are indicated with arrows The POU specific and POU 
homeodomams are boxed The human POU3F4 protein is identical to the protein m mice and rats except 
for the following conservative ammo acid changes from humans to rats and mice T15S P122S A159T 
and T356A The nucleotide changes and deletions (Δ) m the DFN3 patents are indicated, affected 
nucleotides are marked wilh a bar The asterisk indicates a slop codon 
Table 1 Clinical features and POU3F4 mutations of patients with X linked deafness (21) The deafness 
type here is based on audiologtc examinât on The POU3F4 mutations are named stop according to 
the last wild type amino acid thai remains in the predicted protein Blank spaces indicale that no CT scan 
(second column) or stapedectomy (third column) was performed - designates that no mutations were 















































































Some DFN3 affected maternal relatives ol patien' 5 2Э also have cataracts at a young age 
50 
premature stops of translation (Table 1 and 
Fig. 2). Patient 3055 carries a deletion of an 
A nucleotide at position 895 (Figs. 2 and 
3C), patient 3105 has a deletion of one G 
that is part of a GGGG tetranucleotide 
stretch at positions 648 to 651, and in pa­
tient 5274 a CAAA tetranucleotide is delet­
ed that is present in tandem at positions 603 
to 610 of the wild-type VOV3F4 sequence. 
As shown in Fig. 3B by SSC analysis, the 
mutation found in patient 5274 cosegregates 
with the DFN3 phenotype in the whole 
family. Two patients had missense mutations 
in the POU3F4 gene. In patient 5736, we 
found a Τ to G transversion at position 950, 
whereas patient 5823 showed an A to G 
transition at nucleotide 1000. These muta­
tions result in the nonconservative L317W 
and K334E substitutions in the POU home-
odomain (21). 
The leucine residue at position 317 that 
is mutated in patient 5736 is located be­
tween helices 2 and 3 of the POU homeo-
domain, as deduced from nuclear magnetic 
S i 8 8 S § s S S S 
resonance and crystallographic studies (22). 
It is conserved in six of seven members of 
the non-POU domain proteins that belong 
to the homeodomain superfamily (23) and 
in all POU domain proteins, except Oct-2 
and emb. Here, the leucine residue is sub­
stituted for a methionine and a tyrosine 
residue, respectively (24)- The wild-type ly­
sine residue at position 334 th.it is mutated 
in patient 5823 resides in helix 3 of the 
POU homeodomain. This residue is con­
served among all POU domain proteins and 
members of the homeodomain superfamily 
(23, 24) and contacts the DNA backbone 
in the major groove in the proposed crystal 
structure of the engrailed homeodomain-
DNA complex, but not in the Oct-1 POU 
domain-octamer complex (22, 25). Thus, 
these data strongly suggest that all muta­
tions we observed in the POU3F4 gene are 
clinically relevant and give rise to DFN3. 
Because DFN3 is a rare disorder, the total 
number of DFN3 patients that can be in­
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Fig. 3. Mutation analysis of POU3F4. (A) PCR-SSC analysis of the homeodomain of POU3F4 in 14 
patients with X-linked deafness and a male control (46. XY) with the use of the primer set V (20). The 
observed SSC shifts are indicated by arrows (B) PCR-SSC analysis of the DFN3 family of patient 5274 
(indicated by an arrow) with the use of primer set IV. Obligate carrier females are marked as such m the 
pedigree (circles with dols). DFN3 patients are indicated with solid squares: symbols with lines designate 
deceased individuals. The asterisk indicates the presence of a weak wild-type ( WT ) SSC band in lane 12. 
Of the four females at risk of carrying the CAAA deletion, individual 10 carries the wild-type POU3F4 
sequence, whereas individuals 7. 13, and 18 carry the mutation. (C) Nucleotide (nt) sequence of part of 
the POU homeodomain of patient 3055 and a control male. 
less, the identification of five mutations in 
seven DFN3 patients as compared to no 
single mutation in 100 control X chromo­
somes is statistically highly significant (26). 
Unexpectedly, three Xq21 microdele-
tions (G83I4, II/7, and 1/10) and one du­
plication (in patient 5086) that had been 
identified previously in patients with DFN3 
do not encompass the POU3F4 gene. In all 
four cases, the rearrangement is located 
proximal and 5' to POU3F4, with physical 
distances varying between 15 and 400 kb 
(Fig. IB). In none of these patients, nor in 
two others with either a perilymphatic 
gusher during stapes surgery or a temporal 
bone defect (patients 2412 and 2540), were 
point mutations detected in the POU3F4 
gene. Thus, in these cases DFN3 may be 
caused by mutations that affect 5' noncod-
ing or regulatory sequences mapping farther 
upstream. Alternatively, these aberrations 
may affect the gross chromosomal structure 
and thus may affect expression o(POU3F4-
Another, less likely explanation might be 
the presence of other genes in Xq21.1 that 
can cause DFN3. 
In seven patients with X-linked sensori­
neural deafness and in one with X-linked 
conductive deafness, mutations were not 
found in the PQU3F4 gene. This is not 
surprising because previous linkage studies 
had indicated that X-linked deafness is het-
erogeneous. In at least one family with sen-
sorineural deafness, the defect has been ex­
cluded from Xq21 (9). In two other fami­
lies, linkage to the Xq21 and Xpl 1.3-p2l.l 
regions has been found (27). Here, we dem­
onstrate that DFN3 is correlated with mu­
tations that affect the POU3F4 protein. At 
least five POU domain genes are expressed 
in different parts of the developing inner 
ear (28), and defects of POU domain genes 
may play a major role in the etiology o( 
nonsyndromic hearing impairment. 
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X-linked deafness with stapes fixation (DFN3) is 
caused by mutations in the POU3F4 gene at Xq21.1. 
By employing pulsed field gel electrophoresis (PFGE) 
we identified a chromosomal aberration in the DNA 
of a DFN3 patient who did not show alterations in the 
open reading frame (ORF) of POU3F4. Southern blot 
analysis indicated that a DNA segment of 150 kb, 
located 170 kb proximal to the POU3F4 gene, was 
duplicated. Fluorescence in situ hybridization (FISH) 
analysis, PFGE, and detailed Southern analysis 
revealed that this duplication Is part of a more com­
plex rearrangement including a paracentric inversion 
involving the Xq21.1 region, and presumably the 
Xq21.3 region. Since at least two DFN3-assoclated 
minideletions are situated proximal to the duplicated 
segment, the inversion most likely disconnects the 
POU3F4 gene from a regulatory element which is 
located at a distance of at least 400 kb upstream of 
the POU3F4 gene. 
INTRODUCTION 
The most frequent form of X-linked deafness, DFN3, is 
characterized by fixation of the stapes and a perilymphatic 
gusher upon stapedectomy By employing computerized 
tomography, Phelps el at ( I ) identified a unique abnormality 
of the petrous temporal bone consisting of a dilatation of 
the internal auditory meatus (lAM) and an abnormal wide 
communication between the basal tum of the cochlea and the 
IAM The gene underlying DFN3 was mapped to Xq2l by 
linkage analysis and through molecular characterization of 
large deletions associated with choroideremia, mental retard­
ation, jnd DFN3 (2-7) Smaller deletions were found in five 
patients with typical DFN3(8-I I) Yeast artificial chromosome 
(YAC) clones thai span the critical region were isolated, and 
an 850 kb cosmid contig was constructed (9) 
Recently. Douville el at (12) assigned a mouse POU domain 
gene. Brum 4, to a region of the murine X chromosome that 
is homologous lo human Xql3-q22 The rat homolog of 
Bram 4, RHS2, is expressed during embryonic development 
in the brain, the neural tube, the whisker roots, and the otic 
vesicle (13) We cloned and characterized the human homolog 
of Bram 4, POU3F4, and were able to position the gene in 
the critical region for DFN3 In seven unrelated patients with 
DFN3 but not in 100 control X chromosomes, small mutations 
were found in the POU3F4 gene that result in truncation 
of the predicted protein or in non-conservative amino acid 
substitutions (14.15) Surprisingly, the intronless POU3F4 
gene was found to be located up to 400 kb distal to four 
minideletions associated with typical DFN3 (11,14) 
Here, we describe the identification and detailed character­
ization of another, more complex chromosomal rearrangement, 
a duphcation/paracenlnc inversion associated with familial 
DFN3 We show that one of the inversion breakpoints is 
situated 320 kb proximal to POU3F4 Since at least two DFN3 
associated minideletions reside proximal to the duplication, 
this finding suggests that the expression of POU3F4 is regulated 
by a sequence element located several hundred kilobases 
farther proximal 
RESULTS 
Identification of a duplication associated with DFN3 by 
PFGE and Southern blot analysis 
We performed pulsed field gel electrophoresis analysis of 
genomic DNA of several DFN3 patients using a cosmid 
(4893F6, Fig 5) located in the Xq21 I region proximal to the 
POU3F4 gene In the DNA of DFN3 patient 5086, we observed 
a Sfil fragment of 575 kb instead of the normal 675 kb, 
suggestive of a microdeletion or a SfiX restriction fragment 
length polymorphism (Fig la) Southern blot analysis of 
£coRI digested DNA of patient 5086 employing all cosmids 
from a previously established 850 kb contig did not yield a 
deletion In contrast, the hybridization signals of several 
cosmids near the DXS26 locus suggested the presence of a 
duplicated DNA fragment (data not shown) To investigate 
this possibility in more detail, we constructed EcoRl and Taqi 
blots containing equal amounts of DNA from a control female, 
a control male, DFN3 patient 5086. and patient XL45 The 
latter patient cames a microscopically visible deletion com-
*To whom corriApondcnce should be jddrctved 
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Figure 1. PFGE analysis of Sfiì digested high-molecular-weight DNA from a 
male control and DFN3 patient 5086- Hybridization results are shown for 
cosmid 4893F6 (a), cosmid 4893H12 (b), cosmid IC2 (c) and for a control 
probe 50:17 (d>, located in Xql3.l (van der Maarel et al. manuscript in 
preparation). The scale shown on the right is based on the migration of the 
Saccharomyces cerevisiae chromosomes which were employed as size markers. 
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Figure 2. Southern blot analysis of genomic DNAs from a control female 
(lane l), control male (lane 2), DFN3 patient 5086 (lane 3), and the syndromic 
DFN3 patient XL45 (lane 4), The restriction enzymes and hybridization probes 
used are indicated on top of each panel, (a) Cosmid 4893D9 detects restriction 
fragments of equal intensity in patient 5086 and the control male, (b) Cosmid 
4893 AI detects signals of normal and double intensity as well as aberrantly 
sized EcoRI (4.0 kb) and Taql (6.0 kb) fragments in patient 5086. (c) Cosmid 
4893B4 detects signals with a double intensity in patient 5086 compared to a 
male control, (d) Cosmid 4893C4 detects one fragment (indicated with an 
arrow) which is either of double intensity compared to the male control lane, 
or represents a novel aberrantly sized fragment. Size markers are given on 
the right. 
mencing in the region investigated here. In patient 5086, a 
double intensity of EcoRI and Taql bands compared to control 
male DNA was observed for cosmids 4893B4 (Fig. 2c), 
4893K6, 4893B5, 4893K2, and 4893H12 (Fig. 5; Southern 
Figur* 3. Molecular characterization of the duplication/inversion endpomts 
in patient 5086- Southern blot analysis of genomic DNAs digested with the 
enzymes given above the lanes using a 6.5 kb EcoRI fragment of cosmid 
4893 AI (a) and a I 7 kb EcoRI fragment of cosmid 4893C4 (b). Black dots 
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Figure 4. Southern blot analysis of EcoRI digested DNA from patient 5086 
(arrow) and several of his relatives. The 6.5 kb EcoRI fragment of cosmid 
4893 AI was employed as a probe. WT - wildtype. BP = breakpoint. 
blot data not shown). Cosmid 4893Al detects restriction 
fragments with a normal intensity, a double intensity, as well 
as an aberrantly sized ¿TcoRI (4.0 kb) and Taql (6.0 kb) 
fragment (Fig. 2b). All cosmids proximal to 4893A1 showed 
normal hybridization results, as illustrated by cosmid 4893D9 
(Fig. 2a). For cosmid 4893C4, only a 4.0 kb £roRI band 
appeared to be of double intensity compared to control male 
DNA (Fig. 2d); no aberrantly sized fragments were detected. 
All cosmids distal to 4893C4 showed normal hybridization 
results (data not shown). 
Detailed mapping of the duplication endfragments and 
family analysis 
The endfragments of the duplicated segment in patient 5086 
were mapped in detail by analysing genomic DNA from 
patient 5086 and an unaffected control individual with EcoRI 
fragments from cosmids 4893A1 and 4893C4. At the proximal 
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Figure 5. Physical map of Ihe DFN3 critical region. All patients with deletions except AP have been described elsewhere (9,20). Patient AP shows choroideremia 
(CHM) and mental retardation (MR) (20). Deletions are indicated by stippled lines. The duplicated segment in patient 5086 is depicted by a double bar. EcoRl 
maps of the cosmids spanning the duplication breakpoints are given at the bottom. EcoRl fragment sizes are given in kilobases. Only a subset of the cosmids 
from the contig is depicted. DFN3 = X-linked deafness with stapes fixation; HG = hypogonadism. 
kb EcoRl and 6.0 kb Taql breakpoint fragments (Fig. 3a). 
Since we were unable to identify aberrantly sized fragments 
with cosmid 4893C4 in EcoRl and Taql digested DNA of 
patient 5086, blots were constructed containing //indili and 
BumHI digested DNAs. The distal endpoint of the duplication 
could be detected with a 1.7 kb £coRI fragment from cosmid 
4893C4 which, in addition to normally sized restriction frag-
ments, clearly hybridizes to novel //indili and BamHl frag-
ments (Fig. 3b). Based on the signal intensities observed, the 
distal duplication breakpoint is located in a 2.8 kb //indili and 
a 18 kb BamHl fragment. From the previously established 
/TcoRI restriction map of the cosmid contig, we estimate that 
the duplicated DNA segment measures 150 kb (Fig. 5). 
To investigate whether this rearrangement segregates with 
the DFN3 phenotype in the family of patient 5086, we 
hybridized the 6.5 kb EcoRl fragment of cosmid 4893A1 to a 
Southern blot containing EcoRl digested DNAs from several 
family members. Clearly, the breakpoint fragment indicative 
of the chromosomal rearrangement can be seen in all DFN3 
patients and female carriers (Fig. 4). 
FISH and PFGE analysis 
To investigate whether the two copies of the duplicated segment 
are located next to each other near the POU3F4 gene, a cosmid 
located on the duplicated segment, 4893H12, was hybridized to 
metaphase chromosomes prepared from an EBV-immortalized 
lymphoblastoid cell line of patient 5086. In most chromosome 
spreads, the X-chromosome showed two specific, but rather 
diffuse signals (Fig. 6a). To our surprise, we observed four 
discrete signals in approximately one-third of the metaphases 
investigated, indicating that cosmid 4893H12 hybridizes to 
two different regions of the X-chromosome of patient 5086 
(Fig. 6b,c). In a control metaphase X-chromosome, 4893HI2 
identified one distinct locus in the Xq21 band (data not 
shown). The most straightforward explanation for the FISH and 
Southern blotting results is a duplication-paracentric inversion 
event which moved one of the copies of the duplicated segment 
away from the endogenous copy of cosmid 4893H12 (Fig. 7). 
Figure 6. FISH analysis of three X-chromosomes in a metaphase chromosome 
spread of EBV-immortalized peripheral blood cells of patient 5086 using the 
centromere X probe (pBAMX5), detected in red. in conjunction with probe 
4893H12. detected in yellow/green. Chromosomes are counterstained using 
the blue dye DAPI 
To test this hypothesis, cosmid 4893H12 and cosmid IC2, the 
latter of which contains the POU3F4 gene, were successively 
employed as probes on the PFGE blot described above. As 
expected, cosmid 4893H12 detected the 575 kb Sfil fragment 
identified by cosmid 4893F6, corresponding to one of the 
inversion breakpoints, and an additional 475 kb Sfil fragment 
(Fig. lb). Since the latter fragment is also identified by cosmid 
IC2 (Fig. lc), it most likely spans the other inversion-breakpoint 
as indicated in Figure 7. To investigate whether the inversion 
involves chromosomal sequences proximal or distal to the 
POU3F4 gene, FISH analysis was performed with differently 
labeled cosmids from the duplication (4893H12) and the 
choroideremia (CHM) gene (cosmid U98B5) located at Xq21.2. 
In only one X-chromosome, the CHM cosmid could be 
localized between the duplicated sequences; in all other meta-
phase chromosome spreads analysed, the 4893H12 and U98B5 
signals were not resolved (data not shown). 
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Hgur« 7 Model lor the duplication/paracentric inversion event [hat gave nse 
ui the observed rearrangement in DTNl panent S086 The upper drawing 
rclleels the normal siluanon the middle shoves an intermediate siruelure 
resulting from a DNA duplication event (he limer schematic illustrates the 
proposed linai rearrangement observed in patient 11)86 The locations ol the 
itjil (S) sues Hanking the duplicated segment V4.it, derived Irom the cosmid 
conlig (unpublished data) The locations ol the Sfil sites in the Xq2l 3 region 
were deduced from (he observed Sfii fragment si¿es (see Fig I) 
POU3F4 analysis in patient 5086 
DNA of patienl 5086 was examined for single strand conforma-
Uon (SSC) variants, by employing PCR primer sets defining 
five overlapping DNA segments that span the entire coding 
sequence of the POU3F4 gene (14) All five DNA segments 
could be readily amplified indicating no apparent structural 
abnormality in the protein coding region of POU3F4 No SSC 
shifts indicative of sequence alterations were found The entire 
ORF of POUÌF4 was analysed by DNA sequencing but no 
abnormalities were found 
DISCUSSION 
We have identified and characterized a complex: rearrangement 
in a patient with DFN3 The results of PFGE and Southern 
blot analysis are not consistent with a simple tandem duplica-
tion event, ι e insertion of the new copy adjacent to the 
endogenous sequence proximal to the POU3F4 gene Since 
Sfil restriction sues are known to flank the duplicated segment 
(Fig 7) this event would generate a 825 kb Sfil band and not 
the observed 575 kb Sfil band FISH analysis using a cosmid 
from the duplicated segment showed that the duplicated 
segments are separated by several megabascs of DNA Results 
of PFGE and Southern blotting are compatible with a duplica­
tion/paracentric inversion involving sequences at Xq21 1 near 
POUÌI4 and Xql3 1 or Xq21 3 In agreement with this, 
cosmid 4893H12, located on the duplicated segment, and 
cosmid IC2 spanning the POUÌF4 gene detected an additional 
Sfil fragment corresponding to the other breakpoint of the 
inversion (Fig lbc) FISH analysis suggests that the CHM 
gene at Xq2l 2 is located between the duplicated segments 
Also, positioning of the duplicated segments along the 
X-chromosome suggests locations at Xq21 1 and Xq21 3, 
although the involvement of the Xql3 band cannot be ruled 
out completely Both high resolution melaphase FISH analysis 
as well as detailed PFGE analysis using cosmids distal to 
the CHM gene will enable the precise positioning of this 
breakpoint 
The duplication/inversion event proposed here does not 
affect the POU3F4 gene proper which, in the rearranged 
situation (Fig 7), is situated 170 kb proximal to one copy of 
the duplicated segment and 320 kb proximal to the distal 
imersion breakpoint To explain the DFN3 phenotype in 
patient 5086, as well as the aforementioned minideletions 
situated proximal to the POU3F4 gene, a few possibilities are 
considered First, in the normal situation, the 5' part of the 
POU3F4 gene, including us promoter, might be situated farther 
centramene In this situation, the POU31-4 gene would contain 
a single unusually large intron (>400 kb) in us 5' untranslated 
region (Fig 5) We have located the 3 ' end of the POU3F4 
mRNA 2 4 kb downstream of the ORF Since the POU3I-4 
mRNA was estimated to be 3 5 kb in size we can deduce 
that the 5 untranslated region measures less than 200 bp 
(unpublished data) From these findings we deduce that mosi 
probably there is no large 5' intron in the POU3F4 gene 
Second, anolher gene involved in DFN3 might be situated in 
the chromosomal segment proximal to POU3F4 II so, this 
gene would be predicted to span a region of more than 
200 kb the distante between the proximal inversion-breakpoint 
observed in patient 5086 and the DFN3 associated deletion 
mapping farthest centramene (G8314 Fig 5) We believe that 
this is an unlikely possibility, too since this chromosomal 
segment was found to be devoid of sequences transcribed in 
letal brain tissue In a third model the three minideletions 
and the duplication/inversion would juxtapose heterochromatic 
sequences from Xq21 I and Xq2l 1 respectively, near the 
POU3F4 gene, which then might down regulate transcription 
of the POU3F4 gene In D melanogaver translocation of 
genes into heterochromalin is known to give rise to cell 
autonomous gene silencing a phenomenon called position 
effect \anegalion (16) In humans examples of position 
effects are rare Campomelic dysplasia a skeletal malformation 
syndrome and autosomal sex reversal is not only caused by 
mulations in the SOX9 gene, but also by iranslocations invol 
sing sequences located more than 50 kb away from ihe SOX9 
gene (17 18) Similarly translocations up to 85 kb from the 
PAX6 gene are causally related to the aniridia phenotype (19) 
II this mechanism plays a role in the Xq2l region, it is 
directional in nature, since a large deletion 120 kb distal to 
the POU3F4 gene (patient AP, Fig 4), is associated with 
mental retardation and choroidercmia but not with hearing 
impairment (20) ll remains to be investigated whether Iran 
scnptional silencing of the respective genes is due to posi-
tion effects 
To explain the DFN3 phenotype in patient 5086, we favour 
a model in which the proposed inversion separates a control 
element, most likely an enhancer element, from the POU3F4 
transcription unit A similar situation was reported for Ihe 
α and β globin gene clusters in which deletions remove 
important control regions (21,22) To account for the clinical 
findings in all patients with minideletions [patients 1/10, 11/7, 
G83I4 (Fig 4) and patient ML ( l l ) | that do not span Ihe 
POUÌF4 gene, the putative enhancer sequence should be 
located more than 400 kb upstream of the gene Since in none 
of these patients mutations were found in the ORF of the 
POU3F4 gene (14. Y J M d e К and F P M C , unpublished 
data), the deletions must be causative for the observed pheno­
type It is noteworthy that the deletion in patient 11/7 is 
accompanied by a paracentnc inversion The breakpoints in 
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this familial case are in Xql3 1 and Xq2l 2 (23) Thus far. 
we were unable to tesi our hypothesis directly since reverse 
iranscriplion-PCR analysis of the POU3F4 mRNA isolated 
from control lymphoblasl failed, indicating ihat POU3F4 
expression in lymphoblasts is very low 
In three patients with DFN3 we were unable to find causative 
mutations in or outside the DFN3 gene If the expression of 
this gene depends on the presence of an enhancer situated 
proximal to the POU3F4 gene, small mutations or chromo­
somal abnormalities might be found in the chromosomal region 
centromenc to the cosmid contig To investigate this region in 
more detail, a YAC clone from this particular region was 
recently isolated (20) and the construction of a cosmid contig 
is underway Elucidation of the molecular mechanism respons­
ible for the DFN3 phenotype in patients with structural 
abnormalities at a large distante from the POV3F4 gene will 
yield important new insights into the regulation of this gene 
MATERIALS AND METHODS 
DFN3 patients 
Panent S086 is the youngest member of a multigenerution dealness family 
(24. Fig 4) Audiologic examination showed a prol ou nd sensorineural hearing 
loss Two maternal unties of the proband showed a loial hearing loss 
Radiological examination using computerized tomography m patient 50H6 and 
two maternal uncles revealed dilated internal auditory canals and strutturai 
lesions of the cochlea that cause an incomplete separation of perilymphatic 
and cerebrospinal fluids The mother of the proband showed a moderate mixed 
hearing loss in a pure tone audiogram (24) Together these lindmgs suggest 
that the deafness in this family can he classified as DFN3 In most patients 
with DFN3, both sensorineural and conductive hearing loss is lound In this 
case the conductive element is probably masked by the profound sensorineural 
component Patient XL4S suffers from DI~N3 mental retardation and choroid-
eremia. and has been described in more detail elsewhere (7.25 26) 
Pulsed field gel electrophoresis and Southern blotting 
PFGL and Southern blot analysis were performed as described by Bach et ai 
(7) and Huber et al (9) respectively Cosmid IC2 corresponds to the 1CRF 
clone c l l M L O n i Clone SO 17 (DXS6673E) is a cDNA constituting part of 
a gene spanning j n Xq Π I translocation breakpoint which is possibly involved 
in mental retardation (Van der Maarel et ill in preparation) 
Single strand conformation analysis and nucleotide sequencing 
Polymerase chain reaction-single strand conformation (PCR SSO analysis 
(27) was performed employing five partially overlapping PCR segments 
spanning the ORF of POLHF4 as described elsewhere (14) 
Fluorescence іл situ hybr idizat ion 
Al l fluorescence tn situ hybridisation (FISH) procedures used were essentially 
as described previously (28-30) Briefly, cosmid 4891H12 was labeled with 
dig-11 dUTP (Boehnnger) and the X centromere probe pBAMXS with 
Fluorolink Cy3 dCTP (BDS ine Pittsburgh) using a nick translation kit 
(Gibco. Life Technologies) 100 ng labeled 4893H12 probe DNA and 5 μg 
Cot-1 DNA (Gibco Life Technologies) was dissolved in 6 μΐ of a hybridisation 
solution fiOCf- v/v deiomzed formamide, \09t w/v dextrane sulphate, 2XSSC 
\<7{ v/v Twecn 20 pH 7 0) Prior to hybridisation the probe was denalured 
at 80"C lor 10 mm chilled on ice and incubated at 37°C for 30 mm allowing 
preannealing For pBAMXS 20 ng DNA in 6 μ) was used per reaction and 
no competitor D N A was added Metaphase spreads were prepared using 
standard procedures After denaturai ion of the slides probe incubations were 
earned out undir an 18x18 mm со е Ы і р in a moist (.hamber lor 4S h 
Immunocyinchemical detection of the hybridising probes was achieved 
using F1TC conjugated sheep anti-digoxigemn (1 20. Boehnnger Mannheim) 
For evaluation of ihe chromosomal slides a Zeiss epifluorescence microscope 
equipped with appropriate filters for visualisation of Texas Red. DAP! and 
FITC fluorescence was used Digital images were acquired using a high 
performance cooled CCD camera (Photometries. Tucson. USA), interfaced to 
a Macintosh Ilei computer A l l digital image-acquiring -processing and 
analysis functions were accomplished by means of the BDS-lmage FISH 
software package (Biological Detecuon Sysiems Ine Rockville. USA) 
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Abstract 
Mapping studies have been reported for 42 families with non-syndromic X-hnked 
mental retardation (XLMR) (1), and have indicated that the X chromosome 
harbours at least 8 distinct loci for this condition based on the non-overlapping 
intervals of linkage in these families (2) Moreover, in almost half of the families, 
the underlying gene defect maps to the proximal short arm of the X chromosome 
which may be indicative for the presence of one major gene for non-syndromic 
XLMR in this chromosomal segment In this study, we have employed 
fluorescence in situ hybridization of Yeast Artificial Chromosome (YAC) probes 
to map the X chromosomal breakpoints in three mentally retarded lemales 
carrying balanced X.autosome translocations which had been assigned 
cytogcnetically to the Xpl 1 band Identification ot YACs spanning these 
breakpoints revealed that all of them map to different X chromosomal sub-bands, 
ι e Xpl 1 2, Xpl 1 3, and Xp21 1 Moreover, characterization of the autosomal 
breakpoints excluded the involvement of autosomal candidate genes, which 
renders a disruption of an X chromosomal MR-gene the most plausible 
explanation for the observed phenotype Molecular characterization of these 
breakpoints should soon reveal which of the relevant genes plays a role in 
XLMR 
Introduction 
Various population studies have revealed that in males, the incidence of mental 
retardation (MR) is significantly higher than in females These studies suggest 
that X-linked genes account for 20 to 50% of all cases with MR and that between 
1 in 300 and 1 in 500 males are affected On the basis of these data it has been 
estimated that there are at least 7-19 genes on the human X chromosome that pla\ 
a major role in MR (3-7) To date, almost 150 X-hnked conditions have been 
reported where MR is the only clinical feature or where MR is part of a syndrome 
(1) Despite the frequency of this condition, little is known about the underlying 
molecular defects Only a lew of the genes involved in specific forms of XLMR 
could be isolated, including Fragile X syndrome, MASA syndrome (mental 
retardation, aphasia, shuffling gait and adducted thumbs), and the X-hnked 
mental retardation / a-thalassemia syndrome (ATR-X) (8-11) For the great 
majority of patients and their families, however, neither counselling nor diagnosis 
is possible In particular, this holds true for non-syndromic XLMR, ι e MR 
without other clinical features Only recently, two candidate genes for non-
syndromic forms of XLMR were described One of these genes, FMR2, is 
associated with a CCG trinucleotide repeat expansion (FRAXE) (12-14), and the 
second gene, DXS6673E, is disrupted by a balanced X,autosome translocation in 
a mentally retarded female (15) Linkage analysis has shown that at least eight 
genes are involved in non-syndromic XLMR, and there is evidence for a 
clustering of linkage intervals in the proximal region of the short arm of the X 
chromosome (2) This apparent clustering may be due to the presence of one 
major gene for non syndromic XLMR in this chromosomal segment So tar. 
63 
however, linkage intervals are mostly wide because they are derived from single 
families; in the absence of specific clinical features that are characteristic for the 
different forms of XLMR, linkage data from independent families cannot be 
pooled. This does not only preclude reliable carrier detection in these families, 
but virtually rules out the identification of the causative gene defects by 
positional cloning. 
De novo balanced chromosome rearrangements have an incidence of approximately 
1:3000 newborns, and in 6% the rearrangement is accompanied by abnormal 
phenotypes (16). In 50% of these, aberrant clinical features may be causally 
related to the karyotypic changes, as estimated from the incidence of phenotypic 
abnormalities in newborns with and without balanced chromosome 
rearrangements. For X;autosome (X;a) translocations, this proportion may even 
be higher because truncation of X chromosomal genes will usually result in a 
functional nullisomy (16-18). 
Here, we have identified YACs overlapping three X chromosomal breakpoints in 
mentally retarded females with balanced X;a translocations. By conventional 
cytogenetic analysis, all these breakpoints had been assigned to Xpl 1, but our 
data show that they map to distinct physical intervals on the proximal Xp. These 
results argue for the presence of several genes for non-syndromic XLMR on the 
proximal short arm of the X chromosome and pave the way for their isolation. 
Materials and Methods 
Patients 
Patient TC, 46,X,t(X;20)(pl l;ql3.3), a 25 year old female, was born as the fifth child 
of healthy, nonconsanguineous parents. At her birth the father was 31 years and 
the mother was 29 years old. The first born child of this family, a girl, had died at 
the age of 3 months from a cardiac malformation. The other siblings, 3 brothers 
and 1 sister, are normal. Birth weight was 3,1 kg and birth length 49 cm. No 
medical problems were noted in the perinatal period and the first year of life. 
Psychomotor development was retarded and expressive language markedly 
delayed. She could walk without support at the age of 2 years and expressed the 
first words at the age of 4 years. At the same age generalized epileptic seizures 
were noted, with good response on anti-epileptic treatment. At age 6 she was 
integrated in a special school for moderately mentally retarded (IQr50, IQV46, 
IQi>54 - W1SC-R scale). After the age of 14 years severe behavioral problems 
with episodes of aggressive and self destructive behavior became apparent 
necessitating further diagnostic evaluation. Clinical examination revealed a 
moderately mentally retarded adolescent female with general hypotrophy, poor 
muscle development and relative microcephaly (weight 38 kg (third percentile), 
height 159 cm (50th percentile), head circumference 52 cm (third percentile)). 
Secondary sexual development was normal and menstrual cycle regular. On her 
skin disseminated, non telangiectatic, reddish maculae without photosensibility 
were present. These skin changes remained identical in the following years and 
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further dermatological examination did not result in a specific diagnosis. 
Electroencephalography, CT-scan of the brain, routine hematological and 
metabolic screening all gave normal results. Chromosome studies on peripheral 
blood lymphocyte cultures and on a fibroblast culture from a skin biopsy at the 
right forearm revealed an apparently balanced 46,X,t(X;20)(pl 1.2;ql3.3) 
karyotype after G- and R-banding. The karyotype of both parents was normal. 
Patient LMP, 46,X,t(X;17)(pl 1.3;p 13.3) de novo. Born at term, Apgar 10/1-10/5. She 
sat at 11 months and her mother reported that she developed normally until age 1 
Vi years. She then developed squint, hypotonia, poor balance, and nystagmus, 
with regression of former abilities. Hospitalisation at age 19 months revealed 
reduced balance, nystagmus, and truncal and peripheral ataxia. A viral (EBV) 
encephalitis was initially suspected due to elevated IgM against EBV, but EBV-
IgG remained undetectable. No other evidence of immune deficiency has been 
found, and she has normal IgA, IgM, IgG, and IgG subclasses. CT scan was 
normal, but EEG was abnormal with paroxystic spikewaves without clinical 
evidence of seizures. Her development has been retarded, and she only uses a few-
words at age 4 years. An MR scan at age 3 years was normal with exclusion of 
lissencephaly. Ophthalmoscopic examination at age 2 years was normal. 
Chromosome studies revealed an apparently balanced 46,X,t(X;17)(pl 1.3;pl3.3) 
translocation. Although the autosomal breakpoint colocalizes with the Miller-
Dieker syndrome (MDS) region at 17p 13.3, the patient docs not suffer from 
lissencephaly. Replication studies revealed 
Patient VDBP, 46,X,t(X;15)(pll;ql2), a 25 year old female, was bom as the second 
child of healthy, nonconsanguineous parents. At her birth the father was 28 and 
the mother was 27 years old. Her older brother is normal. Pregnancy and 
delivery, at 39 weeks, were normal. Birthweight was 2,4 kg and length 46,5 cm. 
No medical problems were noted in the perinatal period and the first year of life. 
Psychomotor development was severely retarded from the beginning. She started 
to walk without support at the age of 2,5 years. After the age of 5 years, she 
started to express a few, single words. At the age of 11 years she was admitted to 
an institute for the severely mentally retarded (IQT 31, IQV 26, IQ,. 32 W1SC-R 
scale). 
Severe behavioural problems with episodes of selfdestructive behaviour were noted. 
Pubertal development was normal: menarche at 12,5 years with regular menstrual 
cycle; normal secondary sexual characteristics. At the present age of 25 years 
weight is 62 kg, height 167 cm and head circumference 57 cm. Dysmorphic 
features are lacking, except a somewhat high and broad forehead and deeply set 
eyes. Upon neurological examination she was normal. CT-scan of the brain, 
routine biochemical and hematological screening showed normal results. Routine 
chromosome analysis on peripheral blood lymphocytes and on a fibroblast 
culture from a skinbiopsy of the left forearm revealed an apparently balanced 
Xp/15q translocation with karyotype: 46,X,t(X;15)(pl 1 ;q 12). Cytogenetic 
examination of both parents was normal. 
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Fluorescence in situ hybridization (FISH) 
Fluorescence m situ hybridization (FISH) procedures used were essentially as 
described elsewhere (19-21) The X chromosome centromere specific alphoid 
sequence probe pBAMX5 was labeled with digoxigenin-11-dUTP (Boehnnger) 
л ЫІе the YAC clones were labeled with biotin-14-dATP using a nick-translation 
kit (Gibco, Life Technologies) 200 ng labelled YAC probe was dissolved in 6 ml 
of a hybridization solution containing 50% v/v deionized formamide, 10% w/v 
dextrane sulphate, 2xSSC and 1% v/v Tween-20 at pH7 0 as well as 10 mg Cot-1 
DNA (Gibco, Life Technologies) Tor cosmids, 100 ng labelled probe was 
dissolved in the presence of 5 mg Cot-1 DNA Prior to hybridization, the probe 
was denatured at 80°C for 10 minutes, chilled on ice, and incubated for 30 
minutes at 37°C allowing preanneahng For the pBAMX5 probe, 20 ng of DNA 
was used in 6 ml of the hybridization solution without competitor DNA 
Metaphase spreads were prepared using standard procedures After denaturation 
of the slides, probe incubations were carried out under an 18x18 mm covershp in 
a moist chamber for 45 hours 
Immunocytochemical detection of the hybridizing probes was achieved as described 
elsewhere (19-21) 
YAC and cosmid clones 
Tor the mapping of the X-chromosomal breakpoints several YAC clones from the 
Xpl l-p21 regions were used YAC clones used for patient TC are part of 
previously published YAC contigs in Xpl 1 (22,23) For the X chromosomal 
breakpoint in patient LMP, we used YACs isolated from a region between 
ARAF1 and NDP (WB, unpublished data) while YACs for patient VDBP were 
identified from the integrated X chromosome database (IXDB) (24) YACs from 
15q 11 -q 13 encompassing the Prader-Willi and Angelman syndrome region 
(PWS-AS) were identified from the literature (25) The cosmid clones cl 1-3 and 
с 18-2 from 20ql3 were generously provided by O Steinlein (Bonn, Germany) 
Yeast cell cultunng and DNA isolation was done as described elsewhere (26) 
Southern blot analysis 
Hybridizations were performed as described (27) Briefly, genomic DNA was digested 
with restriction enzymes according to the manufacturer's instructions and 
separated on an agarose gel The DNA was transferred to a membrane 
(GeneScreen Plus) DNA was hybridized in a solution containing 40mM NaP04, 
7% SDS, 10% polyethylenglycol 6000 and ImM EDTA supplemented with 
lOmg/mL herring sperm DNA Probes containing repetitive sequences where 
hybridized after preanneahng with sonicated placental DNA for 18 hrs at 65°C 
After hybridization, membranes were washed at 65°C in 40mM NaPOyO 5% 
SDS for 1 hour 
Probe pSyGl 1-2, containing a human clone encompassing the promoter and the first 
exon ofSYN-1, and probe pCMVSylb containing the bovine cDNA for SYN-1, 
were generously provided by G Thiel (Cologne, Germany) The pTIMP probe 
(3 9X) is a 3 9 kb genomic Xbai fragment containing the TMP gene (28) The 
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human properdin probe 5/6 is a genomic 0 8 kb BamHl/Hmdlll fragment 
containing part of the coding sequences oí PFC (29,30) 
Results 
Patient TC, 46,X,t(X;20)(pl 1 ;ql3.3) 
YACs from previously established YAC contigs in Xpl 1 (22,23) were hybridized in 
situ to metaphase chromosomes of the patient Initially, YACs were chosen from 
a region between OATL1 and NDP since this segment ot the X chromosome is 
well characterized and displays a large number of candidate genes for XLMR 
Moreovei, three genes containing a conserved zinc finger motif (ZFP genes) have 
been assigned to this region, ι e ΖΝΓ21, ZNF41, and ZNF81 (22,23,31-34) ZFP 
genes are known to cluster around telomeres and fragile sites, chromosomal 
segments that seem to correlate with translocations and deletions associated with 
clinical disorders (32,35-37) Also, linkage analyses suggest the presence of one 
or several XLMR genes in the ALAS2-DXSÌ003 interval which partially overlaps 
the above mentioned segment (1,2) 
By using in situ hybridization analysis, YAC clone С1022 was shown to span the X 
chromosomal breakpoint in this patient (Fig la) This result was confirmed by the 
hybridization of YAC clones С1228 and C0874 which are known to map distal 
and proximal to YAC С1022, respectively As expected, С1228 only hybridized 
to the der(20) while C0874 hybridized only to the der(X) chromosome (data not 
shown) To rule out the invoKement of synapsin I {SYN-1) a major component of 
synaptic vesicles (38,39), we isolated cosmids from an X chromosome specific 
cosmid library, LL0XNC01 "U", representing a region that includes the genes for 
properdin Ρ factor {PFC), SYN-1, and tissue inhibitor of metalloproteinase 
{TIMP) (22) FISH analysis revealed that all cosmids were located distal to the 
breakpoint (data not shown) Also, hybridization ot these cosmids to a Southern 
blot containing DNA from the patient and a normal female failed to detect novel 
restriction fragments (ïïig 2a) These results rule out a breakpoint in or very close 
to SYN-1 
The autosomal breakpoint have been mapped cytogenetically to 20q 13 3 lo this 
chromosomal segment also the nicotinic acetylcholine receptor a4 subunit 
{CHNRA4) has been mapped, and mutations in CHRNA4 have been lound in a 
family with benign familial neonatal convulsions (BFNC) and a family with 
autosomal dominant nocturnal frontal lobe epilepsy ΑϋΝΓΙΧ (40,41) Since this 
patient also exhibited epileptic seazures during the second and third >ear of life 
we hybridized in situ cosmid с 11-3 and cosmid с 18-2 that are part of a 200kb 
cosmid contig containing the CHNRA4 gene to metaphase chromosomes of the 
patient Both cosmids hybridize to the derivative X chromosome indicating a 
proximal localization of this breakpoint with respect to the ADFNLE and BFNC 
loci (data not shown) 
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Patient LMP, 46,X,t(X;17)(pl 1.3;pl3.3) 
Se\eral YACs from a YAC contig spanning the Xpl 1 3 region between ARAF1 and 
MAOA were hybridized m situ to metaphase chromosomes of the patient With 
one of these, YAC CEPHy904El 1896, split hybridization signals were observed, 
albeit only in a minority of metaphases and indicating that this YAC spans the 
breakpoint (Fig lb) Moreover, the hybridization results obtained with several 
neighboring and partially overlapping YACs confirmed this result In this way, 
the breakpoint could be mapped to the centromenc end of YAC 
CEPHy904El 1896 The 17p 13 3 breakpoint has been shown to reside within the 
Miller-Dieker (MDS) syndrome deletion region, but a previously cloned 
chimeanc lissencephaly (LISI) gene (42-44), is not disrupted by the translocation 
(Ν Τ , personal communication) 
Patient VDBP, 46,X,t(X;15)(pll;ql2) 
YACs used to map the breakpoint in patient LMP were initially hybridized in situ to 
metaphase chromosomes of patient VDBP All YACs mapped proximally to the 
breakpoint (data not shown) Subsequently, several YACs from the IXDB YAC 
contig were hybridized to metaphase chromosomes of the patient Two partially 
overlapping YAC clones, ICRry900H0893, and lCRFy900C0413 were identified 
that recognize the breakpoint (Fig lc) These YAC clones define the distal border 
of a YAC contig spanning the Xpl 1 4-p21 1 region Therefore, at the distal side 
of these YACs, no immediately ad|acent YACs were available to confirm this 
result However, a YAC located proximal to these breakpoint spanning YACs, 
ICRFy900E0501, remains on the derivative X chromosome, while most proximal 
YAC of the nearest distal YAC contig, clone ICRFy900E0101, hybridizes only to 
the normal X chromosome and the derivative chromosome 15 (data not shown) 
The autosomal breakpoint has cytogenetically been mapped to 15ql2 and may 
therefore coincide with the PWS-AS region (45) To map this breakpoint with 
respect to the PWS-AS region, we hybridized in situ several YACs spanning this 
region (CEPHy904 clones HI 111, Bl 171, B05254, A01264, A12307, F06326, 
D01495, and St Louis clones A124A3, and A156E1 ) (46) All YACs hybridized 
to the derivative X chromosome which indicates that the breakpoint on 
chromosome 15 is located proximal to the PWS-AS region (data not shown) 
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Figure 1 
Fluorescence in situ hybridization 
of (a) YAC С1022 to metaphase 
chromosomes of patient TC, 
(b) YAC CEPHy904E 11896 to 
metaphase chromosomes of 
patient LMP, and (c) 
YAC ICRFy900H0893 to 
metaphase chromosomes of 
patient VDBP. All YACs span the 
breakpoints since their hybridization 
signals (red) are seen on the normal 
X chromosome, and the derivative 
chromosomes. The X centromere is 
marked in green. 
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Figure 2 
Characterization of the X chromosomal 
breakpoint in patient TC. 
a: Southern blot analysis of the 
cosmidsl2G10and 139F7to 
EcoRI digested DNAof a female 
control (lane 1), a male control 
(lane 2), and patient TC (lane 3). 
Genomic fragments carrying 
TIMP and PFC are marked by arrows. 
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b:Molecular analysis of the region spanning the X chromosomal breakpoint in patient TC. The upper 
line represents a segment of the Xpl l.23-pl I.3 region containing the genes ARAF1, SYN-1, TIMP, 
ELK1, ZNF41, ZNF2I, and ZNF81. The localization of ZNF4I is not completely clear as indicated 
with the double arrowhead. ELKI is located proximally or distally to the breakpoint. The two small 
lines underneath represent the cosmids from the X chromosome specific cosmid library LL0XNC01 
"U" used for Southern blot analysis. The horizontal bars with the italic numbers represent the YAC 
clones from this region that are used for fluorescence in situ hybridization. The localization of the 
breakpoint is indicated with an arrow. 
70 
Discussion 
About fifty percent of all disease phenotypes found in patients with balanced 
chromosome aberrations may be causally related to the karyotypic changes. 
Balanced translocations and inversions involving autosomes will give rise to 
disease phenotypes if they hit a gene for which two functional gene copies are 
required, so that disruption or down regulation of one allele will result in 
haploinsufficiency (18). Disease phenotypes may also arise when the 
rearrangement results in dominant mutations (47), if the other allele happens to 
be mutated (unmasking of heterozygosity) (48), or if there is only one functional 
gene copy per cell so that its inactivation will result in a functional nullisomy, as 
for imprinted (49-52) or X and Y chromosomal genes. Therefore, in patients with 
balanced X;autosome translocations, disease phenotypes will be more frequent 
than in other balanced translocations. This does not only hold for males but also 
for females where disruption of X chromosomal genes will generally lead to 
functional nullisomy, too, because of preferential inactivation of the normal X 
chromosome (17,53). This renders balanced X chromosomal rearrangements 
particularly valuable as tools for the identification of genes that play a role in 
disease. Indeed, many of the disease genes that have been identified by positional 
cloning strategies are X chromosomal, and X chromosomal rearrangements were 
instrumental for their isolation (reviewed in 54). For the identification of genes 
involved in XLMR, the molecular characterization of X chromosomal 
rearrangements associated with MR may be almost without alternative due to the 
heterogeneity of the disorder and the relatively wide linkage intervals in families 
with XLMR. Here, employing YACs, we have mapped three X chromosomal 
breakpoints that are associated with MR to the Xpl l-p21 region. 
The breakpoint of patient TC in Xpl 1.2 is located in a well-defined segment. Several 
genes in this region may be considered as candidate genes for XLMR like SYN-J, 
a major component of the synaptic vesicles, and the putative transcriptional 
regulators, ZNF21, ZNF4I and ZNF81 (22,23,31-34). Direct involvement of 
SYN-1 in this translocation was ruled out by FISH and Southern blot experiments 
involving a cosmid contig that spans the region from PFC to ARAF1 (Fig.2a). 
However, we cannot exclude a disruption of the SYN-1 transcription unit as a 
result of the X;autosome translocation since the 5' end oí SYN-J is orientated 
towards the breakpoint. These results position the breakpoint to a small segment 
of approximately 200 kb proximal to PFC and distal to YAC C0874 (Fig 2b). 
This region also contains ELK1 and possibly ZNF41, while ZNF21 and ZNF81 
map 200-300 kb proximal to ELK1. Their involvement in the translocation cannot 
be excluded. ZNP genes encode putative transcriptional regulators with key 
regulatory functions during development (55). So far, ZNP's were shown to be 
involved in tumorgenesis in Wilms' tumor, and in limb and craniofacial 
development in the Greig cephalopolysyndactyly syndrome (56-58). The 
respective genes, WT1 and GLI3 together with the three ZNP genes mentioned 
above, belong to the Krüppel gene family. ELK] codes for a member of the v-ets 
oncogene superfamily. It has been suggested that proteins of this superfamily 
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have DNA binding capacities. This gene appears to be transcribed in lung and 
testis which would argue against its direct involvement in MR (59). 
The autosomal breakpoint of this translocation was cytogenetically mapped to 20ql3, a 
chromosomal segment to which three autosomal dominant types of epilepsy, 
ADNFLE, BFNC, and low voltage EEG (EEGV1), have also been mapped. 
Although mutations in the CHRNA4 gene in ADFNLE and BFNC have 
demonstrated genetic allelism for both disorders, the molecular cause for EEGV1 
has not been elucidated yet (40,41,60). The presence of generalized epileptic 
seizures during the fourth year of life in this patient prompted us to assess the 
involvement of the CHRNA4 gene in the phenotype of the patient. The 
observation that two cosmids, representing both ends of a 200kb interval of 
genomic DNA around the CHRNA4 gene, both map distal to the breakpoint on 
chromosome 20 suggests that CHRNA4 gene expression is probably not impaired 
in this patient. 
The X chromosomal breakpoint in patient LMP maps to Xpl 1.3 between DXS1055 
and DXS1708, and there are no obvious candidate genes mapped to this region. 
We estimate that the size of the breakpoint region is smaller than 300kb based on 
the sizes and FISH hybridization results of other YAC clones from this contig. 
The autosomal breakpoint has been mapped in the vicinity of the MDS region but 
its involvement in the clinical phenotype seems unlikely since the patient does 
not show any dysmorphic signs characteristic for MDS. 
The X chromosomal breakpoint in patient VDBP had been cytogenetically mapped to 
Xpl 1. However, our in situ hybridizations indicate a more distal localization in 
Xp21.1 near the McLeod gene {XK) locus (61). Two partially overlapping YAC 
clones recognize the breakpoint and, the phenotype of the patient argues against 
involvement of the XK gene itself. Several patients have been described with 
deletions that include the X chromosomal breakpoint locus (61) and references 
therein). Since these patients are not mentally retarded, the MR in patient VDBP 
may be due to a position effect, or to disruption of a gene on chromosome 15. 
The autosomal breakpoint has been assigned to 15ql2 to which also the genes for 
PWS and AS have been mapped (reviewed in(45). PWS and AS are MR 
syndromes for which imprinting has been implicated. Therefore, disruption of the 
PWS-AS region by a translocation should give rise to a disease if the breakpoint 
involves the only functional copy of these genes. Indeed, a translocation has been 
identified in a patient with PWS directly disrupting the maternally imprinted 
small nuclear ribonucleoprotein (SNRPN) transcript (62). To rule out the 
possibility that the PWS or AS genes are disrupted in patient VDBP, too, we 
hybridized several YACs from the PWS and AS region to metaphase spreads of 
the patient. All YACs, including those that define the proximal limit of deletions 
that are associated with PWS or AS (63) are located distal to the breakpoint on 
chromosome 15. Therefore, involvement of PWS-AS genes on chromosome 15 is 
unlikely. 
Although we have excluded direct disruption of the respective obvious autosomal 
candidate genes in these patients, we cannot rule out indirect effects on their 
transcriptional activity. All these loci are translocated to the derivative X 
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chromosome carrying the X Inactivation Center (XIC) (reviews in 64,65), and 
spreading of X inactivation into the autosomal segment in a small subset of cells 
with incomplete inactivation of the normal X chromosome may influence proper 
expression of these genes (17,53) Alternatively, these translocations may 
juxtapose heterochromatic sequences near the autosomal loci thereby down-
regulating transcription of these autosomal genes This phenomenon, position 
effect variegation (PEV), was first described in D melanogaster (66), and may 
explain some rare observations in humans (reviewed in 67) 
The most straight-forward explanation for the aberrant clinical phenotypes in these 
patients is that these rearrangements result in a functional nullisomy of X 
chromosomal genes Previous linkage analyses have revealed a clustering of 
XLMR loci to the proximal short arm of the X chromosome (1,2) These linkage 
data may indicate that there is a common, particularly important XLMR gene in 
this region, or alternatively, that several XLMR genes may be clustered in this 
chromosomal segment Since the breakpoints described here do not coincide, but 
map to distinct subbands in proximal Xp, our results suggest, but do not prove, 
the presence of several XLMR genes on the proximal short arm of the X 
chromosome The detailed molecular characterization of the X chromosomal 
rearrangements described here, should provide us important clues to their 
identification 
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In several families with non-specific X-linked menial retardation (XLMR) linkage analyses have assigned the 
underlying gene defect to the pericentromeric region of the X chromosome, but none of these genes have been 
isolated so far. Here, we report on the cloning and characterization of a novel gene, DXS6673E, that maps to 
Xq13.1, is subject to X-inactivation and is disrupted in the 5' untranslated region by a balanced X;13 translocation 
in a mentally retarded female. The DXS6673E gene is highly conserved among vertebrates and Its expression is 
most abundant in brain. It encodes a hydrophilic protein of 1358 amino acids (aa) that does not show sequence 
homology to other known proteins. A segment of this protein consisting of neutral and hydrophobic aa with a 
proline residue in every second position may represent a transmembrane domain. Almost complete sequence 
identity was found between the 3' end of the DXS6673E gene and two expressed sequence tags (ESTs) and 
between the 5' end of the DXS6673E gene and a third EST. Moreover, weaker sequence similarity was observed 
between coding regions and two other ESTs. 
INTRODUCTION linkage interval·» arc still too wide to allow reliable genetic 
counselling and the identification of causative gene detects by 
It has long been recognized that the X chromosome contributes positional cloning Cytogenetically recognizable chromosomal 
disproportionally to the total number of loci that are invoked in rearrangements such as X autosome translocations have greatly 
mental retardation (MR) Population studies have revealed that facilitated the positional cloning of disease-associated gene 
the prevalence of X linked mental retardation (XLMR) in males defects (12) Balanced X-autosome translocations and inversions 
varies trom 1 100 to about 1 500 and have suggested that have also been described in several palients withMR(13-16)and 
X linked genes account for approximately 20-50% of all cases l h e characterization of the relevant breakpoint regions on the X 
with MR On the basis of data it has been estimated that at least chromosome is therefore a promising strategy to identity 
seven to 19 X chromosomal genes play a major part in MR ( 1 -5 ) candidate genes for XLMR 
Recently, several gene defects underlying specific forms of Here, we report on the identification and characterization of an 
XLMR were identified, such as the fragile X syndrome (FraXA). x chromosomal gene. DXS667ÌE. that is disrupted by a balanced 
MASA syndrome (mental retardation, aphasia, shuffling gait and χ · π translocation involving the Xqll 1 band in a mentally 
adductcd thumbs) and mental relardation/a-lhalassaemia (ATR- retarded female Apart from mental retardation, scoliosis and 
X) syndrome (6-9) In contrast to these disorders with specific ">Р°"У abdominal hypopigmentation are the only other conspicu-
recognizable phenotypes or karyotypes, there are many forms of o u s clinical features in this patient (15,17) 
non specific XLMR wiihout additional clinical features So far. 
the genetic heierogeneily of non-specific XLMR has prevented RESULTS 
its molecular elucidation and for the majonty of cases with this . , ,.„ ,.
 r
 - , . , , . . . . ,.
 v \ ' ,, Identification or a YAC that recognizes the X 
condition, neither earner detection nor early diagnosis is possible . _ , , , . , 
, , , j ι , r ι ι. , ι L •_ chromosomal breakpoint Linkage analyses in individual families have revealed that there 
are at least six genes on the X chromosome that play a part in A hybnd cell line containing the denvative chromosome 11 as its 
non specific XLMR (10 II) For all of these genes however only human X-chromosomal component (17) was used to 
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Figure 1. Fluorescence in situ hybridization of YAC yXWD940 to metaphase 
chromosomes of patient PMI. The hybridization signals derived from the YAC 
clone (green) are located on the normal X chromosome, the derivative 
X-chromosome and the derivative chromosome 13 indicating that it en­
compasses the breakpoint. The X centromere is marked in red. 
regionally map the X chromosomal breakpoint by Southern blot 
analysis and PCR amplification of markers from the Xql3-q21 
region. The breakpoint could be assigned to a small segment of 
XqI3.1 between the gene encoding the gap junction protein 
connexin 32 (GJBI) (18.19) and the cell cycle gene CCG1 (20) 
(data not shown). Four YAC clones, two of which were identified 
with DXS348 (21,22) and two with CCGÌ, were hybridized in situ 
to metaphase chromosomes of the patient. One of the YACs 
identified with CCG1, clone yWXD940, spans the breakpoint on 
the X chromosome (Fig. 1). Apart from the two X-centromeric 
hybridization signals, three signals were seen representing the 
hybridization of the YAC to the normal X chromosome, the 
derivative X-chromosome and the derivative chromosome 13 
[der( 13)]. respectively. 
Isolation of a cDNA clone that is disrupted by the 
translocation 
By subcloning YAC yWXD940, a partial cosmid contig was 
generated. Employing Southern blot analysis a cosmid, L2, could 
be identified that crossed the breakpoint. This cosmid is located 
approximately 150 kb proximal to the cell cycle gene CCG1 as 
estimated from pulsed field gel electrophoresis (data not shown). 
The human insert of cosmid L2 was hybridized to a fetal brain 
cDNA library which resulted in the isolation of 17 cDNA clones. 
Further screening of the same library with these cDNAs led to the 
isolation of over 45 homologous, partially overlapping cDNA 
clones. Hybridization of the clones 50:11 and 50:17 representing the 
full length cDNA (Fig. 3) to a Southern blot with Pvull digested 
DNA from the patient, the hybrid cell line carrying the der( 13), as 
well as several controls, clearly showed that a gene represented by 
these cDNA clones is disrupted by the translocation (Fig. 2). In the 
DNA of the patient, two aberrant restriction fragments were seen. 
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Figure 2. Hybridization of a full length clone of the DXS6673E gene to a 
Southern blot containing PvuU digested DNA from the patient (PMI), a 
human-hamster hybrid cell line with the derivative chromosome 13 [der( 13)]. 
a female control (46.XX). a hamster control and a human-hamster hybrid tell 
line with the human X-chromosome as its only human chromosomal 
component (X only). Novel aberrant restnction fragments are seen in DNA 
from the patient (arrows). The faint cross-hybridizing restnction fragment is 
labelled with an asterisk. 
human-hamster hybrid cell line containing the der(13) chromo-
some. Aberrant bands were also obtained by hybridization of the 
same probe to a Southern blot containing DNA from the patient and 
a female control digested with several other enzymes (data not 
shown). The DXS6673E gene, from which these cDNAs are 
derived, hybridizes to three adjacent EcoRi fragments of 6, 10 and 
6 kb. The most distal 6 kb £coRI fragment is disrupted by the 
translocation in the patient (Fig. 3). 
Several partially overlapping cDNA clones were characterized 
by restriction mapping and sequence analysis (Figs 3 and 4) and 
two of the clones displayed a poly(A) tail at their 3' end. Also, 
subclones of cosmid L2 were used to elucidate the genomic 
structure of the gene. Two cDNA variants of the DXS667JE gene 
were identified. Both variants consist of 25 exons and differ only 
in their first exon encoding the 5' untranslated region (exon 1A 
and 1B, see below and Figs 3 and 4). All splice donor and splice 
acceptor sites fit the consensus as calculated according to Shapiro 
and Senapathy (Table 1 ) (23). The length of the consensus cDNA 
sequence is 6126 bp (variant 1A) and 5538 bp (variant IB), 
respectively. Both splice variants encode a mRNA with an open 
reading frame of 4074 bp, corresponding to a protein sequence of 
1358 amino acids (aa). The complete cDN A sequence of variant 
1A has been deposited in GenBank, accession number X95808. 
A polyadenylation site is located at position 6075 followed by a 
poly(A) tail 12 bp downstream. In the 5' untranslated region of the 
gene, a highly polymorphic GA repeat sequence was identified. 
PCR analysis revealed that the translocation disrupts exon 1A, 
hence, the breakpoint is located in the 5' untranslated region 
(Fig. 3). The telomere to centromere orientation of transcription 
could be inferred from hybridization of the 5' and the 3'end of the 
DXS6673E gene to DNA from the human-hamster hybrid cell 
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Figure 3 Genomic and ..DNA structure ol the DXS667ÌE gene spanning the X chromosomal breakpoint The DXSM7ÌF gene is located in three adjacent Fm}iS 
fragments of 6 I0and6kb II consists Ol 25 exons of which exon lAand IB encode two alternative splice variants The open reading frame is indicated with black 
boxes Primers used for RT-PCR analvscs are indicated with small arrows beneath the exons The breakpoint is disrupting exon IA as indicated with a doited line 
Four cDNA clones (50 09 50 11 50 17 and 50 11) representing the enure gene are indicated with bold lines al the bulloni ol Ihe figure The position ol a highly 
polymorphic (GA)(,CATA(GAhg repeal in exon IA is indicated with a dotted line The identity between ihreeESTs and the DXS6671E gene as well astheCpG island 
is indicated with double arrow heads while the putativ e transmembrane domain is shown with a wavvline The position ol £coRI BainHl rVmdlll and ΛιιΙΙ restriction 
sites in the cDN A are indicated on a bar at the bottom ol the figure 
Table I Splice sites of the DXSM7ÌL gene 
hxon Splice donor sue*1 Consensush Splice acceptor sttea Consensus*1 Position I xon si/c 
IA RT PCR — 























tgcllccillgcaj; GAGATGGCCT 97% 
tuccgaggtacas AAGAGAAGCG 81% 
ccccaclltctcas TTCCAGTGTC 83% 
gllcccacclclaj; GGAGATCTGG 84% 
latgtglgtggcJi GTCCTGCACG 827r 
ccccatcctcacQi AAAAACACAC 87% 
tclcialgccccdîGCCCTCCCCG 93% 
ItcctlcccleciiCGCACAAGCC 90% 
tgtccccacclcaf GACCAAGTGT 92% 
IctcctclttccjîGCTGTGTGCT 96% 
Itlgacjleclcafi CTGCCCGGTG 81% 
gttllgale tac a i GTCAGTCTCL 94 % 
ctctglclttgcis ATCCCTGTGA ' 2 % 
lllcllatccacoï AAGAGTGGAA 91% 
allcglgcclccas GTGCCTGTGC 89% 
tctclgcltcccas ATCTTGTGAG 92% 
ttccccllcallaj ATCCTCTGGA 79% 
clcltcccclccaxGGTCAAAAGC 957c 
acatalcaagca¿ CCAAACCCAT 78% 
ttllctttccccvuî TACTTGCTGG ' 1 % 
cngaccallgljï ATACGGTGTT 76% 








































































































JLower case leners indicate intron sequences upper cjse are exon sequences 
h
~lhe percentage similarity to splice consensus <«queni.es v*js calculated according to Shapiro and Senapathy (2Í) 
LPosiiion as calculated (rom \anant IA (accession number X9*Í80H) 
83 
gcgagaagagagagaCAGACAAGGACAGAAAGGGGGCTGGAGGAGAAAGAGAGAGAGAGATACAGAGAGAGAGAGAGA 0 06 3 
4 73 7 
GAGAGÄGAGAGAGAGAGAGAGAGAGATCAGCCCTGGTGAGGGAGGAAAACTCCATAGATAATACAGGGAGCTCCTGCAGGA 014 4 













GGGGATGGGGGAGGGTAATCTTGGCAGbCGCCTGCTGCATGGCGTAGGTAGGGACTATTGAGGGGGGCGGACGCCGAGGGG 0 54 9 
379 • 
GTGAACACGAGTGGGAAGCTAAGAGAGACACGGGGAGGGGGAGGGGACCGGGAACCATTTGAATGAGAGGAGGGGATCACG 0 6 0 3 
GGTAGAGTGGGCTCCAGGAGGTAGGGCGAGCAGGGTGTGACGGGGGCCAGACTCTTGAGCCAGGTAAGCGGACCACgtgcg 0706 
actcctaatctgcagTACATATCCAGCCATACTCATGGACCCCAGTGATTTCCCCAGTCCATTTGACCCATTGACC 0767 
M D P S D F P S P F D P L T 
CTGCCAGAGAAGCCCCTGGCTGGAGACCTACCAGTAGACATGGAATTTGGAGAGGATCTACTGGAATCCCAGACTGCCCCA 0Θ4Β 
L P E K P L A G D L P V D M E F G E D L L E S Q T A P 
ACTCGAGGATGGGCCCCCCCTGGCCCTTCTCCATCCTCGGGAGCCCTGGACCTGCTTGATACCCCTGCTGGCCTGGAAAAA 0 92 9 
T R G W A P P G P S P S S G A L D L L D T P A G L E K 
4 96 В 
GACCCTGGAGTCCTGGATGGAGCCACTGAGTTGCTGGGGCTGGGGGGGCTGCTCTATAAAGCCCCCTCTCCCCCGGAGGTG 1010 
D P G V L D G A T E L L G L G G L L Y K A P S P P E V 
GACCACGGTCCTGAGGGAACCCTGGCATGGGATGCAGGAGATCAGACCCTAGAGCCTGGACCAGGGGGCCAGACCCCTGAG 10 91 
D H G P E G T L A W D A G D O T L E P G P G G Q T P E 
GTGGTACCACCTGATCCAGGGGCTGGGGCAAATTCCTGTTCACCTGAGGGGCTACTAGAGCCTTTGGCTCCAGATTCTCCA 1172 
V V P P D P G A G A N S C S P E G L L E P L A P D S P 
ATAACACTGCAGTCCCCACATATTGAAGAGGAGGAGACCACCTCCATAGCTACTGCAAGAAGGGGCTCCCCTGGGCAGGAG 12 5 3 
I T L Q S P H I E E E E T T S I A T A R R G S P G Q E 
GAGGAGCTTCCCCAAGGGCAGCCACAGAGCCCAAATGCCCCGCCTAGCCCTTCAGTGGGAGAGACTCTGGGGGATGGAATC 13 3 4 
E E L P Q G Q P Q S P N A P P S P S V ^ G E T L G D G I 
AACAGTTCTCAGACCAAACCTGGGGGCTCTAGCCCCCCTGCACATCCTTCCTTGCCAGGAGATGGCCTGACTGCGAAGGCG 14 15 
N S S Q T K P G G S S P P A H P S L P G D G L T A K A 
A G T G A G A A G C C G C C T G A A C G G Í A G A G A A G C G A G C G C G T T A G G A G A G C A G A A C C T C C A A A A C C T G A G G T T G T A G A T T C C A C T 14 96 
S E K P P E R K R S E R V R R A E P P K P E V V D S T 
G A G A G C A T T C C A G T G T C A G A T G A G G A T T C T G A T G C C A T G G T A G A T G A C C C C A A T G A T G A G G A C T T T G T G C C A T T C C G G C C C 15 77 
E S I P V S D E D S D A M V D D P N D E D F V P F R P 
C G G C G C T C T C C T C G C A T G T C C C T A C G C T C A A G T G T G T C A C A A A G G G C C G G G C G C T C T G C A G T G G G C A C C A A G A T J A C T T G T 16 5 В 
R R S P R M S L R S S V S Q R A G R S A V G T K M T C 
G C A C A T T G C C G G A C A C C A C T G C A G A A G G G G C A G A C T G C C T A T C A G C G C A A G G G G C T G C C T C A G C T C T T C T G C T C G T C A T C C 17 3 9 
A H C R T P L Q K G Q T A Y Q R K G L P Q L F C S S S 
T G C C T C A C C A C T T T C T C C A A G A A G C C C T C G G G C A A A A A G A C C T G T A C C T T C T G C A A G A A G G A G A T C T G G A A C A C C A A G G A C 1 θ 2 O 
C L T T F S K K P S G K K T C T F C K K E I W N T K D 
T C G G T T G T G G C G C A G A C T G G T T C T G G A G G C T C C T T C C A T G A G T T C T G C A C A T C C G T C T G T C T C T C C C T G T A T G Ï I G G C C C A G 19 01 
S V V A Q T G S G G S F H E F C T S V C L S L Y E A Q 
C A G C A G C G C C C G A T C C C C C A G T C T G G G G A T C C C G C C G A C G C T A C T C G C T G C A G C A T A T G C C A G A A G A C T G G A G A G G T C C T G 19 θ 2 
Q Q R P I P Q S G D P A D A T R C S I C Q K T G E V L 
C A C G A G G T C A G C A A T G G C A G C G T G G T A C A C C G G C T C T G C A G C G A T T C T T G C T T C T C C A A A T T C C G G G C C A A C A A G G G A C T G 2 06 3 
H E V S N G S V V H R L C S D S C F S K F R A N K G L 
A A A A C C A A C T G T T G T G A C C A G T G T G G G G C T T A C A T C T A C A C C A A G A C C G G G A G T C C T G G C C C T G A G C T C C T C T T C C A C G A G 214 4 
K T N C C D Q C G A Y I Y T K T G S P G P E L L F H E 
G G C C A A C A A A A G C G G T T C T G C A A C A C A A C C T G C T T G G G G G C G T A C A A G A A G A A A A A C A C A C G T G T G T A C C C A T G T G T C T G G 222 5 
G Q Q K R F C N T T C L G A Y K K K N T R V Y P C V W 
T G C A A G A C C C T G T G T A A G A A C T T T G A G A T G C T A T C A C A T G T G G A T C G T A A T G G C A A G A C C A G C T T G T T C T G T T C C C T G T G C 2 3 0 6 
C K T L C K N F E M L S H V D R N G K T S L F C S L C 
T G T A C C A C T T C T T A C A A A G T G A A G C A G G C A G G G C T C A C T G G C C C T C C C C G A C C C T G C A G C T T C T G C C G C C G C A G C C T C T C T 2 3 7 В 
C T T S Y K V K Q A G L T G P P R P C S F C R R S L S 
G A C C C C T G T T A C T A C A A C A A G G T T G A C C G C A C A G T C T A C C A G T T C T G C A G C C C C A G C T G C T G G A C C A A G T T C C A G C G C A C A 24 6 В 
D P C Y Y N K V D R T V Y Q F C S P S C W T K F Q R T 
A G C C C T G A G G G G G G C A T T C A C C T G A G C T G T C A C T A C T G T C A C A G C C T C T T C A G T G G C A A G C C T G A G G T C T T G G A C T G G C A G 2 545 
S P E G G I H L S C H Y C H S L F S G K P E V L D W Q 
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GACCAAGTGTTCCAGTTCTGCTGCCGTGATTGCTGTGAGGACTTCAAGCGGCTTCGGGGTGTGGTGTCCCAGTGTGAGCAC 
D Q V F Q . F C C R D C C E D F K R L R G V V S Q C E H 
TGTCGGCAGGAGAAACTCTTCCATGAGAAACTCCGATTCAGCGGAGTGGAGAAAAGCTTCTGCAGCGAAG3CTCTGTGCTG 
C R Q E K L L H E K L R F S G V E K S F C S E G C V L 
CTGTACAAACAGGACTTCACTAAGAAGCTGGGCTTGTGCTGTATCACTTGTACTTACTGCTCCCAGACCTGCCAGCGCGGA 
L Y K Q D F T K K L G L C C I T C T Y C S Q T C Q R G 
GTCACCGAGCAACTGGATGGCAGCACCTGGGACRTCTGCAGTGAGGACTGTAAGAGCAAGTACCTGCTGTGGTACTGCAAG 
V T E Q L D C S T W D F C S E D C K S K Y L L W Y C K 
ÁCTGCCCGGTGCCATGCGTGTAAGCGCCAGGGGAAGCTGCTGGAGACCATCCACTGGCGTGGGCAGATCCGTCATTTCTGC 
A A R C H A C K R O G K L L E T I H W R G Q I R H F C 
AACCAGCAGTGTCTTCTGCGTTTCTATAGCCAGCAGAACCAACCCAACCTGGATACCCAGAGTGGGCCCGAGAGCCTCCTG 
N O Q C L L R F Y S O Q N Q P N L D T Q S G P E S L L 
AACA3TCAGTCTCCTGAGTCAAAACCCCAGACACCCTCTCAAACCAAAGTGGAGAACAGCAACACAATCCCTGTGAAGACC 
N S Q S P E S K P Q T P S Q T K V E N S N T I P V K T 
CGATCAGCTCCCACTGCTCCCACCCCTCCACCCCCACCACCCCCAGCAACACCCCGCAAAAACAAGGCTGCCATGTGTAAG 
R S A P T A P T P P P P P P P A T P R K Ν Κ A A H С К 
CCACTGATGCAGAATCGGGGCGTCTCCTGCAAGGTGGAGATGAAGTCCAAAGGAAGTCAAACANAWIMT3AAJUSCCIYAU3 
P L M Q N R G V S C K V E M K S K G S Q T B B Y . K P Q 
ссБЗті GTGATCGTGCTOCCCATCCCAGTGCCCATCTTCGTOCCAQTGCCTATGCATCTGTACTGCCAGAAAGTCCCttìTGCCITTC 
I V L P I P V P I P V P V . P M H L Y C Q K V P V P E 
TCGATGCCTATCCCGGTGCCTGTGCCCATGTTCTTGCCCACTACCTrGGAGAGCACAGACAAGATTGTAGAGACCATTGAG 
T T L E S T D K I V E T 
GAGCTGAAGGTGAAGATCCCTTCCAACCCCTTGGAGGCCGACATCCTGGCTATGGCAGAAATGATTGCAGAGGCTGAGGAG 
G L К V Κ Ι Ρ S Ν ^ Ρ L E A D I L A M A E H I A E A E E 
TTAGACAAGGCCTCATCTGACCTTTGTGATCTRGTGAGCAACCAGAGTGCAGAGGGACTCCTGGAAGACTGTGACCTGTTR 
L D K A S S D L C D L V S N O S A E G L L E D C D L F 
GGGCCTGCTCGAGATGATGTCCTGGCCATGGCAGTCAAGATGGCCAATGTCTTGGATGAGCCTGGGCAAGACTTGGAGGCA 
G P A R D D V L A M A V K M A N V L D E P G Q D L E A 
GACTTCCCTAAGAATCCTCTGGACATTAATCCCAGTGTAGACTTCCTCTTTGATTGTGGCCTGGTAGGGCCTGAGGATGTG 
D F P K N P L D 1 N P S V D F L F D C G L V G P E D V 
TCTACTGAACAAGACCTTCCCCGAACCATGAGGAAGGGTCAAAAGCGGCTGGTGCTTTCCGAAAGCTGCTCCCAGGACTCC 
S T E Q D L P R T M R K G Q K R L V L S E S C S R D S 
ATGAGCAGTCAGCCTAGTTGTACCGGGCTCAACTATTCATATGGTGTCAATGCTTGGAAGTGCTGGGTGCAGTCAAAATAT 
M S S O P S C T G L M Y S Y
> <
G V N A H K C W V Q S K Y 
GCCAATGGAGAAACCAGCAAGGGTGATGAGCTGCGCTTTGGCCCCAAACCCATGCGTATCAAAGAGQATATTCTCACCTGC 
A N G E T S K G D E L R F G P K P M R I K E D I L A C 
TCAGCTGCTGAGCTCAACTACGGTCTGGCCCAGTTTGTGAGAGAAATCACTCGACCCAATGGTGAACGATATGAACCTGAC 
S A A E L N Y G L A O F V R E I T R P N G E R Y E P D 
AGTATCTACTATTTGTGTCTTGGCATCCAGCA'TACTTGCTGGAAAATAACCGOATGGTGAACATTTTCACOGACCTTTAC 
S I Y Y L C L G I O Q Y L L E M N R M V M I F Τ D L Y 
TACCTGACMTGTTCAAGAACTCAACAAGTCTCTGAGTACCTGGCJÍJCCCACACTCCTCCCCAACAATACGGTGTTCRCT 
V L N S Τ Τ L L Ρ M Ν Τ 
CGAGTGGAGGAGGAGCACCTCTGGGAGTGTAAGCAACIGOGOGTCTACTCGCCCnTGTCCTCCTCAACACCCTCATGTTC 
I V E E E H L U E C K Q L G V Y S P F V L L H T L M F 
TTCAACACTAAGTTTTTTGGGCTGCAGACAGCTGAGGAACACATGCAACTCTCCTTCACCAATGTGGTGCGGCAGTCCCGC 
' N T K F F G L Q T A E E H M Q L S F T W V V R Q S . .R 
AA(^ TGTACCACGCCTCGGGGCACCACCAAaGTGGTGAGCATCCGCTACTATGCCCCAGTCCOGCAGAGGAAAOOaCGAOAC~ 
K C T T P R G T T K V V S I R Y Y A P V R Ç j R X O R D 
ACGGGTCCTGGAAAACGGAAGAGAGAAaATGAAGCCCCTATCrrAGAGCAGCGTGAGAACCGCATGAATCCCCTCCaCTGC 
T G P G K R K R E D E A P I L E Q R E N R M N P L R C 
CCTGTCAAGTTCTATGAATTCTATCTCTCAAAATGTCCTGAAAGCCTCCGGACTCGCAACGATGTGTTCTACCTOCAACCT 
P V K F Y E F Y L S K C P E S L R T R N D V F Y L Q P 
GAACGGTCCTGCATCGCCGAGTCACCTCTCTGGTATrcTGTGATCCCCATGGACCGCAGCATGTTGGAGAGCATGCTCAAT 
E R S C I A E S P L H Y S V I P M D R S M L E 5 H L N 
CGCATCCTGGCTGTGCGCGAGATTTATGAGGAACTGGGTCGTCCTGGGGAGGAAGACCTGGACTGAGCTCGTGTGCCATCC 
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Figure 4 Genomic and cDN A sequent.es of the DXS667ÌE gene Genomic sequence of exons IA Ι В and part of exon 2. cDNA sequence of exons 2-25 Exon 
sequences are in upper case iniron sequences in lower case The predicted protein sequence is given in the one letter code The putative A U G start codons are in bold 
The 13 bp difference in exon IA between RT-PCR products and cDN A clone 50 11 is in bold and italics Primers used for RT-PCR amplification and for amplification 
ol the G A repetitive sequence in exon 1A are indicated with arrows and their respective numbers Splice sites are indicated with double arrowheads while the regions 
identical to the ESTs H S 2 1 W F (I). HS071101 (I I) and HS365200 (I I I) are boxed The putative transmembrane domain is shaded 
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Exon 1A was only found in a single cDNA clone, 50:11. To 
confirm thai this putative exon is transcribed, RT-PCR on total 
RNA from an EBV-transformed human cell line was performed 
(Figs 3 and 4). The PCR product generated with primers from 
exon 1A and 2 was sequenced and found to match the sequence 
of the cDNA clone except for a deletion of 13 nucleotides 
proximal to the splice donor site of exon 1A. This 13 bp 
discrepancy may be the result of alternative splicing. RT-PCR 
products generated with the same primers from total RNA of 
adult muscle, adult kidney and fetal brain gave identical results. 
Also, the remaining sequence of exon 1A could be amplified by 
RT-PCR thereby confirming that this is a true exon (data not 
shown). RT-PCR with primers from exon 1В and exon 2 yielded 
a DNA fragment of the expected length while RT-PCR analysis 
with primers from exon 1A and exon IB did not yield a PCR 
product. This indicates that exon 1В is part of this gene and that 
exons IA and 1В represent alternative starts of transcription (Figs 
3 and 4). 
A Fasta sequence homology search showed an almost complete 
identity of the 3' end of the DXS6673E gene with two ESTs 
(HS04328 and HS448109) and of the 5' end of the DXS667JE 
gene with a third EST: HS21F9F. Also, weaker identity was found 
with two other ESTs at two different positions in the ORF of the 
DXS6673E gene (HS071103 and HS365200) (Figs 3 and 4). A 
BestFit-GCG package comparison (24) of the corresponding 
polypeptide sequences with the DXS6673E protein revealed 58% 
identity over 56 aa for HS071103 and 58% identity over 66 aa for 
HS365200, respectively (Figs 3 and 4). No significant 
homologies were identified when comparing the DXS6673E 
protein sequence to sequences from the protein database 
(Swiss-Prot). Sequence analysis done according to Kyte and 
Doolittle (25) suggested that the protein is largely hydrophilic 
with one putative transmembrane domain between aa positions 





Figure 5. Hybndization of clone 50:17 to a Zoo blot containing EL «RI digested 
DNA from several organisms. In all animals tested except fish (not shown) and 
fly hybridization signals remain visible, even with stringent hybndization at 
65°C and washing conditions (O.lx SSC, 0.1» SDS at 65°C). 
Adult 
e i i • 
* 5 I с 
ta a. _i 
Fetal 
- m - m DXSSC73E 
Conservation and expression of the DXS6673E gene 
cDNA clone 50:17 was hybridized lo a 'Zoo blot' containing 
EcoRl digested DNA from various animal species (Fig. 5). Even 
at stringent conditions of O.lx SSC and 0.1% SDS at 65°C, 
hybridization signals were seen in all animals except fly and fish 
(not shown). The gene could be mapped to the human X 
chromosome by analyzing a human-hamster somatic cell hybrid 
with a single human X chromosome as its only human 
chromosomal component. 
Hybridization of the same cDNA clone to Northern blots 
containing poly(A)+ RNA from different fetal and adult tissues 
revealed a transcript of approximately 6.0 kb in almost all tissues 
tested (Fig. 6) which is in keeping with the size of the cDNA 
consensus sequence. The expression was found to be most 
abundant in brain, moderate in muscle and heart and low in 
several other tissues. In contrast to the Northern blot with RNA 
from fetal tissues, at least three different transcripts of 6, 6.5 and 
7 kb were seen on the Northern blot containing RNA from adult 
tissues. The expression level of these different transcripts varied 
between the tissues tested. 
Figure 6. Hybndization of clone 50:17 to an adult and fetal Northern blot 
containing poly (A)+ RNA from several tissues. In all tissues except placenta 
multiple hybndization signals are visible. The gene is highly expressed in brain 
and muscle and the expression level of the different products varies with the 
tissue in which it is expressed In contrast to the adult tissues, only one product 
is seen in fetal tissues. As a control a ß-actin cDN A clone was hybridized to the 
adult Northern blot. 
X-inactivation of the DXS6673E gene and gene 
expression in the patient 
To determine whether this gene is subject to X-inactivation, its 
expression was studied in human-hamster somatic cell hybrids 
carrying an active or inactive human X chromosome, 
respectively. RT-PCR experiments were performed with primers 
derived from exon 5 and 7; as a control, we used primers specific 
for the SMCX gene that is not subject to X-inactivation (26). In 
the human-hamster somatic cell hybrid with an active human X 
chromosome. PCR products were found for both genes, but in the 
cell line with the inactive X chromosome only a product was 
found when using the 5WCX-specific primers (Fig. 7). These 
results indicate that the DXS6673Egene underlies X-inactivation. 
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SMCX 
blood and EBV transformed lymphoblastoid cell lines of the 
patient and a female control were performed with primers from 
exon 1 A, exon 1В and exon 2. RT-PCR experiments with primers 
from exon IB and exon 2 as well as primers from exon 1A and 
exon 2 that are located proximally to the breakpoint show normal 
gene products (Fig. 8A). In contrast, a nested RT-PCR with 
primers from exon 1A and exon 2 that span the breakpoint, failed 
to result in a normal gene product on RNA of the patient (Fig. 8A). 
DISCUSSION 
Figure 7. RT-PCR analysis with (+) without (-) MMLV reverse transcriptase 
of the /}XSr>rt 7.?/f gene on a human-hamster somatic cell hybrid containing an 
active (Xact) and an inactive (Xinacl) human X chromosome The gene is 
subject to X inactivation. As a control, pnmers from the human SMCX gene 
were used (26). 
Previously, replication studies had been performed in 100 
peripheral blood lymphocytes (PBL) of the patient. Consistently, 
the normal X chromosome was found to be late replicating 
indicating preferential X-inactivation of the normal X 
chromosome (15). It was expected, therefore, that the DXS6673E 
gene would not be expressed in somatic cells of the patient. 
(Nested) RT-PCR experiments on RNA isolated from peripheral 
The positional cloning of numerous disease genes has been 
facilitated by the presence of chromosome aberrations that are 
associated with specific disorders (12). The incidence of balanced 
chromosome rearrangements among newborns is approximately 
1:3000 and 6% of these rearrangements are associated with 
abnormal phenotypes (13). In 509c of these cases, the aberrant 
clinical phenotype may be causally related to the karyotypic 
changes. This proportion may even be higher for X-autosome 
translocations because in males truncation of X-chromosomal 
genes will result in a functional nullisomy. Usually, the same is 
true for females with balanced X-autosome translocations 
because of preferential inactivation of the normal X (13,14,27). 
The molecular characterization of balanced X chromosomal 
PMI 46.XX 




; 1195x968 (463 bp) 
379x969 (184 bp) 
NESTED RT-PCR 
EXON 1AxEXON2 
Figure 8. RT-PCR analysis of the DXS6673E gene in patient PMI. (A) (Nested) RT-PCR analysis- with (+) and without (-) MMLV reverse transcriptase of the 
UXS667.it gene on total RNA from the patient (PMI) and a female control (46.XX) with the pnmer combinations 1196x968 (I) to amplify variant IВ To amplify 
variant IA the pnmers 900x969 (II) and 379x969 (III) were used. (B) Schematic overview of exons 1A. IB and 2 of the DXS6673E gene with the pnmers used for 
RT-PCR analysis The exons are boxed and shaded, the breakpoint is represented by a wavy line and the pnmers are indicated with small arrows. Nested RT-PCR 
products of different pnmer combinations are indicated with solid lines beneath the exons. At their nght sides, the pnmer combination and the expected length of the 
product is indicated. Large arrows indicate the pnmer combinations used for nested PCR expenments on pnmary RT-PCR products. Each distinctive combination 
is boxed: product I is derived from exon IB and exon 2, product Π is a nested PCR product of exon 1A and exon 2 that spans the translocation, while product III 
represents a nested PCR product generated with pnmers from exon 1A and exon 2 that do not span the breakpoint. 
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rearrangements associated with MR therefore is a promising 
strategy tor the identification ot new candidate genes tor XLMR 
Here we have identified and characterized an X chromosomal 
gene DXS6673E that is disrupted in ILS 5' non coding region by an 
X 13 translocation in a mentally retarded female The gene encodes 
two mRNAs of 6126 bp and 5548 bp respectively and consists of 
25 exons spread over approximately 22 kb ot genomic DNA It 
contains two alternative first exons both encoding a 5 untranslated 
region which may be under the control of different tissue specific 
promotors Analysis of cDNA clones and RT-PCR experiments 
demonstrated that these sequences .ire part of the gene Moreover 
the splice junctions of both exons fit the consensus sequence There 
is а Π bp discrepancy between the cDNA clone and the RT-PCR 
product of the first exon from various tissues and cell lines at the 
splice donor site As both variants show con\incing similarity with 
the consensus splice donor site again this may be due to alternative 
splicing For these variants an open reading frame of 1158 aa was 
identified that starts in exon 2 and continues through all downstream 
exons There are two putative AUG start codons a( position 726 and 
807 respectively (Fig 4) The second AUG fits the Kozak 
consensus sequence better thin the first which lacks a purine residue 
at position -3 (28) Therefore we believe that the second AUG is 
the translation initiation site Identity was found with five ESTs when 
comparing the DXS667ÌE gene to the database three of which 
(HS04328 HS448I09 and HS2IF9F) encode the same gene 
Interestingly HS21F9F was isolated by using a methylated DNA 
binding column that selects for CpG like sequences (2У) Moreover 
this region of identity colocalizes with the bieakpoint region 
However a CpG plot (GCG package) did not reveal the presence of 
a CpG island in exon IA (24 30) In contrast a 3(X) bp sequence 
starting in intron 1A and extending through exon IB into intron 1В 
(Hg 3) was identified that meets all entena for a CpG island (data 
not shown) The two other ESTs may be clenved from homologous 
domains of related genes One of these ESTs HS07II03 is similar 
io the puiative transmembrane domain of the DXS667ÌE protein 
which exhibits highly conserved stretches of neutral and 
hydrophobic residues with a proline residue on every second 
position The two ESTs are denved from different tissues 
HS365200 from fetal liver and spleen and HS07II023 from 
postnatal whole brain respectively Siili ihey may represent 
different pans of one gene 
Northern blots containing poly(A)+ RNA from letal tissues 
only show one hybridization signal which corresponds to the 
length of the cDNA As most of the clones from the fetal brain 
cDNA library contained exon IB we assume that this signal 
represents splice vanant 1В and that variant IA is expressed at a 
low level dunng fetal development Moreover the apparent lack 
of a CpG island associated with exon IA and the presence of an 
exon IB associated CpG island supports the ubiquitous 
expression of vanant IB and a tissue specific expression of 
vanant IA as all housekeeping genes and only 40% of all 
tissue restricted genes exhibit 5'CpG islands (30-32) Incontrasi 
to fetal RNA poly(A)+ RNA from adult tissues yielded multiple 
hybndi7ation signals which may represent different splice 
vanants or homologous genes The presence of different cDNA 
variants the identity with two ESTs and a faint autosomal 
restnction fragment seen on the Southern blot (Fig 2) can be 
reconciled with both possibilities Although the expression of the 
gene seems to be ubiquitous the highest expression is found in 
brain and striated muscles Hybndization of the DXS667 ÌE gene 
to DNA from \arious animal species indicates that the gene is 
highly conserved among vertebrates and suggests that it plays an 
important part 
In the great majonty of females with balanced X autosome 
translocations the non rearranged X chromosome is preferentially 
inactivated (14 33) The same holds true for this patient as judged 
from replication studies on PBLs Our RT-PCR experiments have 
shown that no products were generated when DXS667Œ specific 
pnmers were used from both sides of the breakpoint which is 
consistent with a complete inactivation of the non reananged 
DXS6673F allele However when using pnmer combinations 
located proximally from the breakpoint normal gene products were 
identified suggesting that vanant IA of the DXS667JE gene is under 
the control of chromosome 13 sequences This may also be true for 
vanant IB as exon IB is located approximately 600 bp downstream 
from the breakpoint Therefore the phenotype of the patient may be 
due to aberrant temporal and spatial expression or silencing of the 
DXS667JE gene Alternatively the translocation may directly 
disrupt a gene on chromosome 13 may place a chromosome 13 
gene under the control of X chromosomal sequences or indirectly 
interfere with proper expression of other genes on chromosome 13 
as a result of spreading of X inactivation into the autosomal segment 
of the der(l3) If a gene on chromosome 13 is disrupted by the 
breakpoint the phenotype of the patient could be the result of 
haploinsuffieiency (27) or if the other allele is mutated the 
translocation may unmask its heterozygosity (34) Large deletions 
resulting in partial chromosome 13 monosomies have been 
desenbed in a number ot patients with 13q syndrome (reviewed in 
refs 35 and 36) and association ol these deletions with disease 
phenotypes may support the presence of genes in this region that are 
sensitive to haploinsuffieiency This syndrome includes MR as well 
as vanous malformations and the major manifestations in this 
syndrome seem to be associated with a deletion of the 13q32 band 
The breakpoint on chromosome 13 has been mapped between the 
loci D13S755 and D13S747 by PCR analysis ot the der( 13 ) cell line 
(data not shown) This segment is located up to 3 centimorgans (cM) 
proximal to the endothelin receptor В (EDNRB) gene which was 
found to be mutated in patients with Hirschsprung disease (HSCR2) 
(37 38) Although hypopigmentation is also one of the clinical 
features of HSCR2 an effect of the translocation on the expression 
ol the EDNRB gene expression is not very likely Likewise 
inactivation of the EDNRB locus cannot be asenbed to spreading of 
X inactivation into the chromosome 13 since the X inaelivalion 
centre (39) is located on the der(13) and the EDNRB gene on the 
dertX) The observed cutaneous spotting may indicate that there is 
a small proportion of cells in which the der(X) is inactivated instead 
of the normal X (40) Although we cannot exclude the possibility 
that the MR in this patient is due to haploinsuffieiency resulting from 
disruption of a gene on chromosome 13 the disruption ol the 
DXS6673E locus remains by far the most plausible cause for MR in 
this patient A recent overview by Nen ei al ( 10) lists eight families 
with non syndromic MR where the mapping interval includes the 
Xql3 band (MRXI, 4, 5 7 8 12 13 and 17) Also multiple 
syndromic types of XLMR have been mapped to the 
pencentromene region of the X chromosome Mutation screening in 
these families should clanty the role of the DXS6673E gene in the 
aetiology of XLMR 
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MATERIALS AND METHODS cDNA screening and sequence analysis 
Patient PMI; t(X;13)(ql3,q3l) 
Patient PMI is a mentally retarded girl carrying a de nino 
balanced Χ 11 translocation She was the second ol healthy 
non consanguineous parents At the age of I she suffered from 
hyperthermic convulsions Apart I rom menial retardation 
(1Q<45 WISC R scale) she suffers from scoliosis and spotty 
hypopigmentation of the skin She also presents with slight facial 
asymmetry and clinodactily (MRX19)(15 17) 
Fluorescente in situ hybridization (hlSH) 
FISH procedures used were essentially as described elsewhere 
(-+1 —4^ ) The X chromosome centromere specific alphoid sequence 
probe pBAMXS WÍS labelled with Fluorohnk Cyl dCTP (BDS 
Ine Pinsburg) while the YAC clones were 1 ibelled with 
biotm 14 dATP using a nick-translation kit (Gibco I ife 
Technologies) 2(X) ng labelled YAC probe was dissolved in 6 μΐ of 
a hybridization solution containing 50V< v/v deionized formamidc 
107r w/v dextran sulphate 2x SSC and 1 ck v/v Tween 20 at pH 7 0 
as well as 10 mg Cot 1 DNA (Gibco Life Technologies) Prior to 
hybridization (he probe was denatured at 80°C lor 10 nun chilled 
on ice and incubated for 10 min at 17°C allowing preannealing For 
the pBAMX5 probe 20 ng ol DNA was used in 6 μΙ of the 
hybridization solution without competitor DNA Melapha.se spreads 
were prepared using standard procedures Alter denaturation of the 
slides probe incubations were earned out under an 18x18 mm 
coverslip in a moist chamber for 45 h 
Immunocylochemical detection ol the hybridizing probes was 
achieved as described elsewhere (41-44) 
YAC clone and construction of a cosnud conlig 
YAC y WXD940 is a 350 kb YAC containing the CCO / gene ( 20) 
Yeast cell cultunng and DNA isolation were done as described 
elsewhere (44) A partial cosmid contig from YAC yWXD940 
was generated essentially as described elsewhere (45) 
Southern blot analysis 
Methods employed for the isolation ol high molecular weighl 
DNA restriction endonuclease digestion as well as separation 
and blotting of DNA fragments have been described elsewhere 
(45) Hybridization of the cosmid inserts in the presence of excess 
human competitor DNA was done essentially as described by 
Blonden el al (46) Hybridized filters were washed at 65°C with 
40 mM Na-)HP04 (pH 7 2)/0 59c (w/v) SDS lor 1x5 mm and 
1x10 min Autoradiography took 4-16 h at -70"С using two 
intensifying screens 
Northern blot analysis 
Fetal and adult multiple tissue northern blots (Clontech) were 
hybridized in a solution containing 5x SSPE lOx Denhardt s 
solution 100 mg/ml herring sperm DNA 509c forinamide and 
29c SDS for 18 h at 42°C after prehybndi¿ation for 1 h under the 
same condidtion Hybridized filters were washed 10 min in 2x 
SSC 0 05% SDS at room temperature and 30 mm at 50°C in 0 I χ 
SSC 0 \9c SDS Autoradiography Uxik 16-40 h at -70°C using 
two intensifying screens 
A XZaplI human fetal brain cDNA library (Stratagene) was 
screened by standard methods (47) and Bluescript KS(+) 
plasmids containing cDNA inserts were isolated by in m o 
excision according to the manufacturer s instructions 
Double stranded sequence analysis was performed on DNA 
isolated from the cDNA clones and on PCR amplified DNA 
products using TI and T7 oligonucleotides as well as 
gene specific oligonucleotides (Isogen Biosciences the 
Netherlands) Plasmid DNA was isolated using a Qiaprep 8 kit 
(Qiagen) while PCR products were first separated on an agarose 
gel and isolated with a gel extraction kit (Qiagen) Sequence 
analysis was performed radioactively with the T7 sequencing Kit 
(Pharmacia Biotech) and in addition with the Тещ DyeDeoxy 
Terminator Cycle Sequencing Kit (Applied Biosysteins) on an 
Applied Biosystems 171A DNA sequencer according to the 
manufacturer s instructions 
RT-PCR analysis 
Total RNA was isolated from EBV transformed cell lines telai 
brain adult muscle and liver with RNAzol according to the 
manufacturer s instructions (Cinna Biolecx) For synthesis of 
cDNAs 200 ng ot total RNA was reversed transcribed with MMLV 
reverse transcriptase essentially as described elsewhere (48) The 
cDNA products were directly used as template for PCR 
amplification in a buffer containing 10 mMTns SOmMKCI OOK/r 
gelatine 2 mM MgCI2 (DXS667ÌE) or 1 mM MgCh (SMCX) 10 
mM dNTPs 250 ng ol each oligonucleotide 2 5 Taq DNA 
polymerase (Perkin Elmer) Amplification was done in Ю 
(DXS6673E) or 15 (SMCX) cycles of I mm 94°C I mm 60°C and 
1 5 min 72°C Inactivation studies ot the l)XS6671l· gene were 
done with primers 971 (5' TGCTCGTCATCCTGCCTCAC 1 ) 
and 974 (5' ACACTGGTCACAACAGTTGG 1') amplifying 180 
bp from exons 5 and 6 For expression studies ot exon 1A the 
following pnmer combinations located on both sides of the 
breakpoint were used primers 736 (5' AGACAAGGACAG 
AAAGGGGG V) and 968 (5'-CCAGCAACTCAGTGGC 
TCCA 1') followed by a nested PCR with primers 9(X) 
(5 TTACTGCACAGGCGTTGCCA 3') and 969 (5' GGGTCCA 
TGAG TATGGCTGG 1') amplifying 490 bp of exon 1A and exon 
2 Additionally exon 1A sequences Incaled proximally from the 
breakpoint were amplified with the primers 1195 
(5 CTGCATGGCGTAGGTACrGGA-1') and 968 followed by a 
nested amplification with the primers 179 (5' GGTGAACACGA 
GTGGGAAGC 1') and 969 (184 bp) Expression of exon IB was 
studied with the primers 11% (5 CTGTCCCGGCTGCTAGG 
GAG V) and 968 amplifying a product of 156 bp Amplification of 
SMCX cDNA was done with the oligonucleotides S40HX 
(5' GAAGGTGGAGTCAACATCGCCT1') and S4IHX (5 AG 
CCATCACACAGCAGGAGC 1') (26) 
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8. GENERAL DISCUSSION 
In this study we have set out to identify candidate genes for X chromosomal deafness 
(DFN3) and mental retardation (XLMR) through the molecular anal>sis of X 
chromosomal rearrangements in patients with DFN3 or MR This analysis not 
only resulted in the identification of the first deletion in Xq21 associated with 
MR and CHM only, which underlined the presence of a MR gene in this 
chromosomal segment, but also enabled us to identify the gene underlying 
DFN3 This gene, POU3F4, encodes a member of a family of POU domain 
containing proteins which have transcriptional regulating properties 
Moreover, as a first step towards the identification of novel genes for XLMR, we 
mapped four X chromosomal breakpoints in mentally retarded females with 
balanced X,a translocations Detailed analysis of one of these translocations 
resulted in the identification of an X chromosomal gene that is disrupted by the 
breakpoint 
8.1 POU Genes: Roles in Inner Ear and Brain Development 
Λ special subclass of transcriptional regulators are the POU-domam containing 
proteins (reviewed in 1,2) These proteins have DNA and protein binding 
capacities and may act as monomers, homodimers or heterodimers with other 
POU proteins Members of this protein family show different expression 
patterns during development and in various adult tissues They may act as 
positive or negative transcription factors POU proteins consist of two DNA 
binding domains, the amino-terminal POU specific (POU
s
), and the carboxy-
terminal POU horneo (POUh) domain which are separated by a variable linker 
Both domains are required for the specificity and capacity of DNA binding 
The homeodomain is likely to consist of three α helices of which the latter two 
form a helix-turn-helix (HTH) motif which is used for DNA recognition, and its 
three-dimensional structure is probably similar to that of classical eukaryotic 
homeodomains Recently, it was shown that the POU
s
 domain of one member 
of the POU protein family, Oct-], consists of four α helices and its structure is 
highly similar to the λ and 434 bacteriophage repressors (3,4) The POU protein 
family is subdivided into 6 subclasses based on sequence homologies in the 
amino and carboxy terminal regions of the POU-domain, and for several of 
them, expression in the inner ear has been demonstrated (5) One of these POU 
proteins, Brn 3-1 (Ροιι4β), is strongly expressed in the developing rat cochlea, 
and its expression continues in adult cochlear and vestibular hair cells of the 
inner ear This expression patterns suggests a pivotal role for Brn 3-1 in inner 
ear function Indeed, the deletion of the Brn 3-1 gene in knock-out mice results 
in complete deafness due to the lack of inner ear hair cells and supporting cells 
with subsequent loss of cochlear and vestibular ganglia (6) Moreover, these 
mice show deficits in balance and coordination, and are hyperactive The 
human homologue maps to 5q21-q35, and a form of late-onset degenerative 
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deafness has been mapped to 5q31. Therefore, POU4F3 is a strong candidate 
for this form of deafness. Interestingly, deletion of another member of this 
family, Brn.3-2, results in the loss of a large proportion of retinal ganglion cells 
in Brn.3-2' ' mice although its expression is, like Brn.3-1, not confined to this 
tissue (6,7). 
BRN4, or POU3F4, belongs to the third class (POU domain, Class 3, factor 4), has 
no introns, and contains two long Α-rich stretches in the 3' noncoding region 
which indicates that, as all members of this subclass, it has evolved through 
retrotransposition. The mouse homologue. Pou3f4, has been mapped between 
the DXMitó marker and the proteolipid protein locus Pip, a region which is 
evolutionary conserved between mice and humans (8). Moreover, the rat 
homologue, RHS2, is prominently expressed in the otic vesicle between 
developmental days 13.5 and 19.5 after conception (9). These data strongly 
suggested a possible role for POU3F4 in DFN3. Indeed, the presence of 
deletions of POU3F4, as well as four nonsense and five missense mutations in 
POU3F4 in patients with DFN3, but not in healthy controls or patients with 
other forms of X-linked deafness without a temporal bone defect, provided 
convincing evidence for a causal role of POU3F4 in DFN3 {chapter 6, 10,11). 
It is interesting that all missense mutations are located in the POUh domain and 
that no mutations have been identified in other parts of the gene. So far, only 
one other member of the POU protein family, POU 1 FI (PITI), has been 
implicated in human disease (12-15). Mutations in PIT! give rise to a syndrome 
of congenital hypothyroidism, dwarfism, and prolactin deficiency analogous to 
the phenotype of the Snell and Jackson dwarf (dw) mice (16). In contrast to 
POU3F4, POU1F1 mutations are not confined to the bipartite DNA binding 
domain (14). Three mutations are located in the POUs domain and one missense 
mutation has been described al a highly conserved position in the major 
transactivation domain (17). The clustering of missense mutations in the POUh 
domain OÎPOU3F4 in patients with DFN3 suggests that either missense 
mutations at the aminoterminal half of the protein are not tolerated or, 
alternatively, are associated with another disease phenotype. Recently, it was 
shown that class III POU proteins can form heteroduplexes (18) which may 
explain the absence of missense mutations in the aminoterminal half and 
middle parts of the protein. Several observations suggest that this part of POU 
proteins may play an important role in the association of POU proteins with 
other transcription factors. A pivotal role for the POUs domain in DNA 
dependent dimerization of Piti has been demonstrated (17). Moreover, 
activation of the a-intemexin promoter by Brn-За is dependent on the 
aminoterminal region of the protein (19), while an aminoterminal splice variant 
of Bm-3a has oncogenic potential (20). Apart from its expression in the 
developing inner ear, POU3F4 is expressed in fetal brain and fetal kidney. The 
rat homologue OÍPOU3F4, RSH2, is predominantly expressed in the fetal 
brain, in the otic vesicles, and in the outer sheath cells of the whisker roots (9), 
while the mouse homologue Pou3f4 is expressed in the developing and adult 
central nervous system (21,22), and the pituitary gland (23). The Xenopus 
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homologue OÍPOU3F4, XIPOU2, is expressed in the fetal head and the adult 
kidney and brain (24). Several studies concentrating on the role of the POU3F4 
homologues in the developing brain have suggested that POU3F4 has, along 
with other members of its class, a pivotal role in neurogenesis (e.g. 24,25). 
Likewise, both Brn.3-1 and Brn.3-2 show a prominent expression throughout 
the nervous system. This raises the question why the pathological changes 
associated with mutations in these POU genes are confined to the inner ear or 
retina, respectively. Several mechanisms may account for this phenomenon. 
Proper spatial and temporal function of these POU proteins in the affected 
tissues may depend on the presence of other antagonistic POU domain 
containing regulators, resulting in a transcriptional imbalance of the 
downstream cascade (26). Alternatively, interaction with other tissue-specific 
co-factors may be required for proper functioning as has been demonstrated for 
the В cell-specific octamer coactivator BOB. 1 (OBF. 1) which allows Oct! and 
Oct2 to interact with octamer motifs upstream of promotors (27-29). Finally, 
the restricted pathological changes may also be due to a functional redundancy 
of these POU domain proteins in the non-affected tissues (30). However, the 
apparent lack of missense mutations outside the POUh domain may be 
indicative for POU3F4 functions other than those involving inner ear 
development. 
Ten DFN3 patients have been identified so far with deletions upstream from 
POU3F4 (31). These deletions range between 15kb and 1200kb proximal to the 
POU3F4 gene, and share a small deleted region approximately 900kb proximal 
to the POU3F4 gene. 
Several mechanisms can explain the association of these deletions with DFN3. 
Deletions upstream ofPOU3F4 may disrupt a yet unidentified exon of the 
POU3F4 gene. This would mean that POU3F4 contains an unusually large 
intron of 900kb in its 5' untranslated region. Although exceptional, very large 
introns have been described before, e.g. for the dystrophin gene where exon 1 
of the dystrophin variant expressed in brain is located 400kb proximal from 
exon 2 (32). DNAse I footprinting studies have revealed the presence of several 
Pou3f4 binding sites in a region up to 500bp upstream of the Pou3f4 
transcriptional start site (18). Although it is difficult to compare these in vitro 
results with the in vivo transcription mechanisms, they are suggestive for 
autoregulation, a common mechanism for POU genes. Moreover, they make the 
presence of a promotor several hundred kb centromeric less likely. 
Alternatively, silencing of the POU3F4 gene in the larger deletions may be the 
result of a position effect that juxtaposes heterochromatic sequences near the 
POU3F4 gene (chapter 2.2). For the PAX6 gene, another transcription factor 
for which translocations have been described upstream from the gene in 
patients with aniridia (33-35), a fixed position with respect to the scaffold was 
recently demonstrated in extracted metaphase chromosomes (36). The 
chromosomal scaffold is the residual proteinaceous structure that retains when 
chromosomes are depleted of histones and important functional elements such 
as centromeres, replication origins, telomeres, and transcription sites may be 
97 
associated with this scaffold (37-39) Because PAX6 was not expressed in the 
cell line of investigation, it was not possible to show that transcription of this 
gene depends on its fixed position with respect to the mitotic scaffold 
Accordingly, it will be interesting to study the spatial relationship between 
POU3F4 and the mitotic scaffold in normal X chromosomes and in 
chromosomes from DFN3 patients with deletions upstream from POU3F4, 
particularly in cells in which POU3F4 is expressed 
Transcription of the POU3F4 gene may also be due to disruption of promotor or 
enhancer sequences upstream to the gene The recently identified Pou3f4 
binding sites do not exclude the presence of additional binding sites farther 
upstream (18) There is significant evidence now that the locus control region 
of the β globin locus acts by creating domains in which promotor activity is 
permitted, ι e preventing the formation of transcriptional repressive chromatin 
structures rather than regulating the rate of transcription (40,41) This 
mechanism may also apply for enhancers in general, and absence of similar 
transcriptional regulators in DFN3 patients with deletions upstream from 
POU3F4 may keep the chromatin structure around the POU3F4 gene in a 
repressed state Finally, another gene involved in inner ear development may be 
located in this genomic segment, although this seems less likely 
Recently, coexpression of several class III POU proteins (Brn-1, Brn-2, Brn-4, and 
SCIP) during the formation of the mouse hypothalamic-pituitary axis was 
reported (23) Brn2 mice show a normal initial hypothalamic development 
followed by a failure of differentiation and maturation of specific hypothalamic 
neurosecretory neurons (23,42,43) The spatially and temporally overlapping 
expression patterns of Brn-2 and Brn-4, and the critical role for Brn-2 in late in 
the development of neuronal tissues, suggest a functional redundancy between 
Brn-4 and Brn-2 during the initial phases of neurogenesis (23) On the other 
hand, it has been demonstrated that RHS2 activates the gonadotropin releasing 
hormone (GnRH) promotor activity in a GnRH-secreting hypothalamic neuron 
cell line, whereas SCIP, another POU domain protein, represses GnRH 
promotor activity (44) Thus, these POU proteins excert antagonistic effects 
upon GnRH release Similar observations have been made for Oct-1 The POU 
protein Oct-1 binds to the GnRH enhancer in vitro, and its binding is critical for 
the transcriptional activity of this enhancer in GnRH-secreting hypothalamic 
neuron cells (45) GnRH is a neuropeptide secreted by the hypothalamus which 
stimulates the excretion of luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH) by the anterior pituitary In turn, LH stimulates testicular 
Leydig cells to produce testosterone Against this background, it is remarkable 
that hypogonadism has been reported as one of the hitherto unexplained 
additional clinical features in affected family members with DFN3 and a 
deletion of the POU3F4 gene (46) 
X,a translocations with chromosomal breakpoints in the Xql3-q21 region are 
frequently associated with gonadal dysfunction which suggests a critical role of 
this region in ovarian development (47) However, recent studies shed doubt on 
the presence of genes for ovarian development on the X chromosome, and 
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suggest that gonadal dysgenesis in females with sex chromosome 
rearrangements is primarily attributable to failure of chromosome pairing 
during meiotic prophase (48) The apparent clustering in Xql3-q21 may thus be 
related to the particularly late replication of the Xq21 band causing delayed or 
incomplete synapse formation Still, in view of the possible sensitivity of 
POU3F4 transcription to its chromosomal environment {chapter 7), and its 
putative role in GnRH release, it is tempting to speculate that POU3F4 
contributes to the gonadal dysgenesis seen in patients with rearrangements of 
the Xql3-q21 segment The generation of Brn4 deficient mice by targeted 
inactivation of the Pou3f4 gene will further clarify the role of this POU protein 
in mammalian development 
8.2 X-Linked Mental Retardation: Genetic and Molecular Dissection of 
a Common Heterogeneous Disease 
Population studies of MR have suggested that X-hnked genes account for 
approximately 20-50% of all cases with severe MR as judged from the higher 
prevalence of MR in males than in females It has been estimated that at least 7 
to 15 X chromosomal genes play a major role in MR (49-54) At present, 
almost 150 X-linked syndromes have been reported in which MR is one of the 
clinical features (55) 
The most prevalent XLMR syndrome accounting for approximately 30% of all cases 
with XLMR is the fragile X syndrome (FRAXA) The FRAXA syndrome is 
associated with a cytogeneticall> recognizable folate-sensitive fragile site and 
the physical fine-mapping of this fragile site was instrumental for the positional 
cloning of the fragile X mental retardation (FMR-1) gene (56) The 5' non-
coding region of the FMR-1 gene contains a CGG repeat which is unstable in 
FRAXA-families and shows massive expansion in affected individuals The 
gradual expansion of the repeat length in subsequent generations of FRAXA-
families explains the phenomenon of genetic anticipation seen in FRAXA 
families, ι e the increasing seventy, or decreasing age of onset in successive 
generations (57) This new concept of repeat expansion soon led to the 
identification of several other genes containing unstable trinucleotide repeats in 
patients with neuromuscular disorders and MR (reviewed in 57,58) For 
another, albeit non-syndromic form of XLMR associated with a second closely 
linked fragile site on the X chromosome, FRAXE (59), a candidate gene 
(FMR2) has recently been cloned (60-62) Progress has also been made in the 
identification of genes involved in syndromic forms of XLMR One recent 
success was the identification of mutations in the XH2 gene in patients with the 
clinically well-defined ATR-X syndrome which includes MR and a-
thalassaemia (63,64) Mutations in the XH2 gene have also been found in a 
patient previously diagnosed with Coffin-Lowry syndrome symptoms, patients 
with the Jubcrg-Marsidi MR s>ndrome, and in other mentally retarded 
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individuals without α-thalassaemia. Therefore, it is conceivable that the XH2 
gene plays an important role in MR-dysmorphy syndromes (65-67). 
Despite these findings, the majority of the disorders giving rise to XLMR have not 
yet been elucidated at the molecular level. Particularly, this holds true for non-
syndromic XLMR. Here, linkage analysis is confined to individual families due 
to heterogeneity of the disorder. Although these studies have revealed the 
presence of at least eight different gene loci that play a role in non-specific 
XLMR (68), the linkage intervals are still too wide to allow reliable genetic 
counseling in these families and the identification of the causative gene defects 
by positional cloning and related strategies. For the genetic elucidation of non 
syndromic forms of MR, the molecular analysis of MR-associated 
chromosomal rearrangements may be without alternative. Indeed, this 
association has been recognized for a long time. Chromosomal abnormalities 
account for 40% of the severe and 10-20% of the mild forms of MR, and 
already in 1972, Breg et al. reported an elevated incidence of balanced 
translocations in mentally retarded individuals, followed by other reports that 
supported the association of balanced chromosome rearrangements with MR 
(69-71). Moreover, the recent observation that there is a clustering of MR-
associated breakpoints at 50 chromosomal sites in the human genome further 
illustrates the potential of this approach for the elucidation of genes for human 
brain function (N. Tommerup, personal communication). 
Recently, a systematic search for subchromosomal rearrangements in 99 mentally 
retarded individuals resulted in the identification of 3 small subtelomeric 
deletions (72). Taking into account the limited informativity of the DNA 
probes, their physical distance from the telomeres, and the fact that only 20 
subtelomeric regions were studied, it was calculated that cryptic subtelomeric 
deletions may be present in at least 6% of the mentally retarded (72). With 
respect to XLMR, the recent identification of two microdeletions on the short 
arm of the X chromosome in a familiar and sporadic case with MR, should 
enable the cloning of the underlying gene defects (73,74). 
During this study we have focused on the mapping and cloning of genes for XLMR 
by analyzing MR-associated X chromosomal rearrangements. In a large panel 
of patients with MR, CHM, and/or DFN3 numerous deletions of the Xq21 band 
have been identified (75). The molecular characterization of these deletions has 
been the basis for the cloning of the genes underlying CHM (76-78) and DFN3 
{chapter 6). Until recently, MR had only been described in patients carrying 
large deletions of the Xq21 region including the genes for DFN3 and CHM. 
The existence of a locus for non-syndromic MR between DFN3 and CHM was 
based on the identification of a small chromosomal segment that was deleted in 
patients with complex phenotypes including MR carrying large X chromosomal 
deletions encompassing the POU3F4 and CHM genes, but present in all DFN3 
and CHM patients with deletions spanning the POU3F4 or CHM gene, 
respectively. Therefore, the identification of deletions in Xq21 in two patients 
with MR and CHM (chapter 4. 79) substantiates the presence of a non-
syndromic MR locus between DFN3 and CHM. Surprisingly, deletions of the 
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Xq21 band have not been reported so far in patients with non-syndromic MR, 
nor in patients with DFN3 and MR Also, screening of a limited number of 
patients with MR and patients with MR and DFN3, has not resulted in the 
identification of deletions in Xq21 The failure to detect Xq21 deletions in 
patients with non-s>ndromic XLMR may be explained by the considerable 
genetic heterogeneity of the disorder In contrast, the apparent absence of Xq21 
deletions in patients with DFN3 and MR remains enigmatic So far, three 
patients with deletions in Xq21 associated with MR and CHM have been 
reported (MBU, TM and AP (79,80, chapter 4)) Deletion analysis enabled us 
to map the MR gene between POU3F4 and DXS121 while others (79) have 
argued that the MR gene must be located farther distal based on deletion studies 
in an additional patient with CHM and MR Howe\er, the mild MR in one 
patient carrying a microdeletion associated with DFN3 (81), and whose 
deletion defines the proximal boundary of the MR locus, may favour our more 
proximal position of the MR locus These authors proposed ZNF6, a zinc finger 
gene thought to function as a transcriptional regulator (82), as a candidate gene 
for MR in Xq21 on the basis of its localization between DXS326 and CHM and 
its high expression in the brain (79) ZNF6 is a member of a large family of 
zinc finger genes, and gene defects in ZNF6 may be masked by an autosomal 
homologue taking over its function If gene defects in ZNF6 indeed result in 
MR, then this mechanism may explain the apparent discrepancy in the 
localization of the MR gene A similar situation applies to the CHM gene where 
a patient with a large Xq21 deletion including CHM has been described who 
has no clinical symptoms of CHM (83) Here, the autosomal homologue for 
CHM, CHML or REP-2, ma> be able to compensate for the absence of CHM-
features in the patient (84) Complementation by a related gene may also 
explain the absence of deafness in another patient who carries a large deletion 
including the POU3F4 gene (85) 
Recently, a cyclophilin gene-like sequence has been mapped to the Xq21 1 region 
(86) The cyclophilin multigene family comprises of different members, several 
of which are still uncharactenzed, and may play a role in the correct folding of 
specific protein substrates (87) Precise mapping of and sequence analysis of 
this putative gene should reveal whether it plays a role in MR Other candidate 
genes should soon be identified now that the YAC contig of this region has 
been completed 
Mapping studies have been reported for 42 families with non-syndromic XLMR and 
an MRX number has been assigned to these families (55) These studies 
indicate that the Xq24-q25 band seems to be relatively devoid of XLMR genes 
while the clustering of linkage intervals in Xp proximal is particularly evident 
(68) In fact, almost half of the families show linkage to the Xpl 1 2-p21 1 
region which may be indicative for either the presence of one particularly 
important gene for XLMR, or the presence of several genes that play a role in 
XLMR However, for all of these families but one, in which screening with 
microsatelhte markers enabled the identification of an 1 Mb microdeletion that 
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cosegregates with the disorder (73), the intervals of linkage are still too wide to 
allow genetic counselling or the cloning of the underlying gene defect 
To search for candidate genes for XLMR, we have set out to characterize X 
chromosomal breakpoints in mentally retarded females with balanced X,a 
translocations We have collected four of these MR-associated X,a 
translocations and mapped the X chromosomal breakpoints to distinct loci on 
the X chromosome YAC fluorescence in situ hybridization on metaphase 
chromosomes of these patients has enabled us to identify YACs for each X 
chromosomal breakpoint in these translocations Cytogenetically, three of these 
breakpoints had been assigned to the same band, Xpl I, which harbours the 
defect in almost half of the MRX families studied These data may indicate that 
there is a common, particularly important XLMR gene in this region, or 
alternatively, that several XLMR genes may be clustered in this chromosomal 
segment We have shown that these breakpoints do not colocalize, but rather 
map to distinct X chromosomal regions Therefore, our mapping data suggest 
that the clustering of mapping intervals is more likely due to the presence of 
several genes for XLMR, than to one predominant gene 
Although a prion, it is much more likely that in X,a translocations aberrant 
phenotypes are due to disruption or inactivalion of X linked genes (chapter 
2 5), a contribution of the autosomal breakpoints cannot be ruled out 
Therefore, we have also examined the autosomal breakpoint regions in the 
above mentioned translocations In all patients, the direct involvement of 
obvious autosomal candidate genes could be excluded, ι e involvement of the 
a4 subunit of the nicotinic acetylcholine receptor gene (CHRNA4) implied in 
several autosomal dominant forms of epilepsy (88,89), of the small nuclear 
nbonucleoprotein polypeptide N gene (SNRPN) mapped to the Prader-Willy 
syndrome (PWS) region (90,91), and of the hssencephaly-1 (LISI) gene (92) 
encoding the 45 kDa subunit of the platelet-activating factor acetylhydrolase 
(93) which has recently been excluded from beeing involved in Miller-Dieker 
lissencephaly syndrome (94,95) Since imprinting in the PWS region is not 
confined to the SNRPN locus, but extends in both directions, we subsequently 
analyzed the entire YAC contig extending into the proximal deletion breakpoint 
region (96,97) Fluorescence in situ hybridization of these YACs to metaphase 
chromosomes of the patient revealed that the proximal deletion breakpoint 
region in PWS patients is located distally from the breakpoint This makes the 
involvement of the imprinted region on chromosome 15 in the clinical 
phenotype of the patient less likely However, the derivative X chromosomes 
carrying the relevant autosomal genes, also harbour the XIC Therefore, it is 
conceivable that the observed phenotype is influenced b> the variable spreading 
of X inactivation into the autosomal segment in a small subset of cells The 
precise assignment of the breakpoints with respect to these genes should help 
us to clarify this issue 
The fourth translocation maps to Xql3 1 and has been studied in more detail The 
molecular analysis of this X chromosomal breakpoint has led to the 
identification of an alternatively spliced X-linked gene, DXS6673E, of which 
102 
the 5' untranslated region is disrupted by the translocation {chapter 9) Apart 
from MR, the only conspicuous findings in this patient are scoliosis and spotty 
abdominal hypopigmentation of the skin (98) Since the DXS6673E gene 
underlies X-inactivation, and replication studies showed a consistently late 
replicating normal X chromosome, we expected that in the patient this gene 
would not be expressed Surprisingly however, when using primers specific for 
both splice variants of DXS6673E, normal gene products were generated by 
RT-PCR on RNA from the patient It could be demonstrated that one of the 
splice variants is not disrupted by the breakpoint and that a second variant 
encoding the same protein is most likely controlled by sequences from the 
translocated chromosome 13 This finding does not rule out the possibility that 
the abnormal phenotypc seen in this patient results Irom aberrant spatial or 
temporal gene expression, but this hypothesis is difficult to prove A similar 
situation has been reported tor translocations disrupting two variants of the T-
cell translocation gene TTG-2 in acute Τ cell leukemias where both variants 
encode the same protein and are under control of different promotors (99) 
In spite of the clear evidence for disruption of the DXS6673E gene, the possibility 
that genes on chromosome 13 contribute to the observed phenotype of the 
patient can not be excluded Several patients have been reported with large 
deletions of the long arm of chromosome 13 (13q syndrome) including band 
13q31 and resulting in a partial monosomy for chromosome 13 (100-102) The 
translocation may thus disrupt a dosage dependent gene on chromosome 13, or, 
again, spreading of X-inactivation into the autosomal segment of the derivative 
chromosome 13 in a small subset of cells may silence dosage dependent genes 
Cloning ot the breakpoint region on chromosome 13 should soon clarity the 
possible role of other genes, or their promotor regions, in the aetiolog> of MR 
in this patient 
8.3 Outlook 
As pointed out in the introduction, the elucidation of gene defects underlying 
multifactorial disorders will be of extreme importance in the years to come In 
fact, most of the common disorders such as diabetes mellitus or hypertension 
and most of the congenital malformations (e g cleft lip and palate or neural 
tube defects) are not monogenic In polygenic disorders, many genetic factors 
(quantitative trait loci, QTL) contribute cumulatively to the disease phenotype, 
whereas in multifactorial disorders also environmental factors play an 
important role Différent approaches like linkage analysis, allele sharing 
methods, and association studies are at our disposal to unravel these disorders 
(103) The recent successes in the identification of a schizophrenia 
susceptibility locus on chromosome 6p by several groups demonstrates the 
application of linkage analysis for multifactorial traits (104-106) For another 
multifactorial disorder, diabetes, much progress has been made Both allele 
sharing methods (103,107), as well as other strategies (108-111) ha\e been 
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applied succesfiilly lo dissect diabetes genetically. Diabetes research has now 
focused on the positional cloning of genes by whole genome searches along 
with specific testing of candidate genes, particularly in areas of positive 
linkage. Against this background, balanced and unbalanced chromosome 
aberrations that are associated with multifactorial diseases as diabetes may also 
contribute to the identification of important gene defects. Eventually, mutation 
analysis of disease-associated candidate genes in large populations should 
reveal the true value of this approach. 
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9. SUMMARY 
The aim of this stud) was to identify and characterize the gene for both X-lmked 
deafness type 3 (DFN3) and candidale genes for X-lmked mental retardation by 
positional cloning strategies Therefore, we defined and fine-mapped the 
critical regions for DFN3 and non-syndromic XLMR in Xq21 {chapters 4 and 
5) by the molecular characterization of patients carrying interstitial deletions of 
Xq21 with CHM, DFN3 or MR, or a combination of these disorders These 
studies confirmed the previously defined locus for MR and narrowed down the 
critical region for DFN3 The molecular characterization of the DFN3 critical 
region, the mapping oí the mouse POU domain containing gene Pou3f4 on the 
mouse X chromosomal segment homologous to the human Xql3-q21 region, 
and the expression of the rat homologue RHS2 in the otic vesicle, resulted in 
the identification of mutations in the human homologue POU3F4 in patients 
with DFN3 (chapter 6) However, some patients with DFN3 carry a normal 
POU3F4 gene, and have deletions or complex rearrangements upstream of 
POU3F4 One such patient carrying a paracentric inversion/duplication has 
been characterized in great detail (chapter 7) The association between these 
rearrangements and ΟΓΝ3 may be explained by the presence of an additional 
exon or regulatory sequences for POU3F4, a position effect interfering with 
proper POU3F4 expression, or the presence of a second gene involved in inner 
ear development in this chromosomal segment 
Additionally, we have fine-mapped the X chromosomal breakpoints of four balanced 
X,a translocations in mentally retarded females by fluorescence in situ 
hybridization Due to the preferential inactivation of the normal X chromosome 
in cells of these patients, these rearrangements may result in functional 
nulhsomies for X chromosomal genes disrupted by the translocations 
Therefore, these genes will be promising candidate genes for XLMR Three X 
chromosomal breakpoints have been mapped to distinct loci on the short 
proximal arm of the X chromosome indicative for the presence of several genes 
for MR in this chromosomal segment (chapter 8) The fourth breakpoint has 
been mapped to Xql3 1, and has been analyzed in more detail An alternatively 
spliced X chromosomal gene, DXS6673E, has been identified that is disrupted 
by the translocation in the 5' untranslated region RT-PCR analysis of 
DXS6673E on total RNA from peripheral blood lymphocytes of the patient, 
showed that one splice variant is under control of chromosome 13 sequences 
(chapter 9) Future research should reveal the involvement of chromosome 13 
in the phenotype of the patient and the involvement of DXS6673E in the 
etiology of XLMR 
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10. SAMENVATTING 
Het doel van deze studie was de isolatie en karaktensatie \an genen betrokken bij X 
gebonden doofheid (DFN3) en bij X chromosomaal overervende vormen van 
niet-syndromale mentale retardatie met behulp van positionele klonering Ten 
eerste hebben we het kritieke gebied voor DFN3 en niet-syndromale XLMR 
gedetailleerd in kaart gebracht en zo mogelijk verder begrensd door de 
molekulaire karaktensatie van X chromosomale deleties in patiënten met CHM, 
MR of DFN3, of een combinatie van deze ziekten (hoofdstuk 4 en 5) Deze 
karaktensatie van hel DFN3 gebied, samen met de bevinding dal het muize 
Pon3f4 gen gelokaliseerd is in een X chromosomaal gebied dat homoloog is 
aan het humane Xql3-q21 segment en dat de rattehomoloog RHS2 in 
embryonale stadia van het oor tot expressie komt, resulteerde uiteindelijk in de 
identificatie van verschillende mutaties in het humane POU3F4 gen in 
patiënten met DFN3 (hoofdstuk 6) Sommige patiënten hebben echter 
chromosomale afwijkingen buiten het gen zelf Een zo'n afwijking, een 
paracentnsche inversie/duplicatie is nauwkeurig gekarakteriseerd (hoofdstuk 7) 
Deze chromosomale afwijkingen wijzen erop dat er zich mogelijk een nog niet 
geïdentificeerd exon of regulatoire sequenties ccntromeer van POU3F4 
bevinden De doofheid in deze patiënten kan mogelijk ook nog verklaard 
worden door een positie effect dat de POU3F4 expressie beïnvloedt, of door de 
aanwezigheid van een tweede gen in dit chromosomale segment dat een rol 
speelt bij de binnenoorontwikkeling 
Tevens hebben we met behulp van fluorescentie m situ hybridisatie de X 
chromosomale breukpunten van vier gebalanceerde X,autosoom translocaties in 
mentaal geretardeerde vrouwen nauwkeurig gelocaliseerd (hoofdstukken 8 en 
9) Wanneer een X chromosomaal gen door de translocatie verstoord wordt, 
kunnen deze chromosomale afwijkingen als gevolg van de preferentiële X 
inactivatie van het normale X chromosoom in cellen van deze patiënten, leiden 
tot een functionele nullisomie voor dit gen Dergelijke genen zijn dan 
interessante kandidaat genen voor MR Drie breukpunten hebben we 
nauwkeurig kunnen lokaliseren in drie verschillende segmenten van de 
proximale korte arm van het X chromosoom Dit suggereert dat meerdere 
genen op de proximale korte arm van het X chromosoom betrokken zijn bij MR 
(hoofdstuk 8) Het vierde breukpunt, in Xq 13 1, is nauwkeuriger geanalyseerd 
Een X chromosomaal gen werd geïdentificeerd dat onderhevig is aan 
alternatieve splicing en waarvan een van de splice varianten wordt verstoord 
door de translocatie De expressie van deze variant blijkt in de patient onder 
controle te staan van chromosoom 13 sequenties (hoofdstuk 9) Nader 
onderzoek zal moeten buitwijzen wal de rol is van dit gen bij XLMR 
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STELLINGEN 
BEHORENDE BIJ HET PROEFSCHRIFT "CLONING OF A GENE FOR X-
LINKED DEAFNESS (DFN3) AND A CANDIDATE GENE FOR X-LINKED 
MENTAL RETARDATION" 
The association of transcriptional regulators with mammalian position effect 
variegation may reflect the strict stoichiometry that is required for the 
interactions in which they participate (Engelkamp, D. and van Heyningen, 
V. (1996) Curr. Opm Genet Der., 6, 334-342 ). 
POÜ3F4 may play a critical role m primary ovarian failure in patients with 
Xql3-q21 rearrangements (this thesis). 
Differentiation of the inner ear in mammals is controlled by the neural rube 
(Deol, M S., (1966) Nature, 209, 219-220). 
Because each membei of the class HI POL' domain gene family exhibits a 
distinct, yet overlapping, pattern of expression in the developing and 
mature nervous system, it is tempting to speculate that combinatorial 
codes of specific class III POU proteins are responsible for determining 
specific neuronal phenotypes (Alvarez-Bolado, G., et al. (1995) J. Comp 
Neurol, 355, 237-295 and Schonemann, M D., et al (1995). Gene. Dev., 
9,3122-3135). 
Strandstoelen op de zonnige zuidcorridor van het Radboudziekenhuis zouden 
het verblijf van patiënten m het ziekenhuis kunnen verkorten. 
Het verschil tussen het aankopen van relatief weinig kunst en het ophangen van 
relatief veel wandversiering is de kunst van het verstand hebben van 
kunst. 
Het carpoolbeleid van het AZN is een poel van ongemak voor jonge ambitieuze 
wetenschappers die doorgaans langer doorgaan. 
A clean bench is a sign of a sick mind (anonymous). 
Nijmegen, 18 februari 1997 
Silvère van der Maarel 
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